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Diagnosing the severity of blunt trauma injuries is difficult and involves the use of 
diagnostic radiological scanning.  The primary diagnostic radiology modality used for 
assessing these injuries is computed tomography (CT).  CT delivers more radiation dose 
than other diagnostic scanning modalities.  Trauma patients are at an increased risk of 
radiation induced cancer because of the cumulative dose effects from multiple scanning 
procedures.   Current methods for estimating effective dose, the quantity used to describe 
the whole body health detriment from radiation, involves the use of published conversion 
coefficients and procedure specific machine parameters such as dose-length-product based 
on computed tomography dose index and scan length.  Other methods include the use of 
Monte Carlo simulations based upon the specific machine geometry and radiation source.  
Unless the requisite machine information is known, the only means of estimating the 
effective dose is through the use of generic estimates that are published by scientific 
radiation committees and have a wide range of values.  This research addressed a 
knowledge gap in assigning effective doses from computed tomography when machine 
parameters knowledge is either unknown or incomplete. The research involved the 
development of a new method of estimating the effective dose from CT through the use of 
regression models incorporating the use of patient parameters as opposed to machine 
specific parameters. This new method was experimentally verified using two adult 
anthropomorphic phantoms and optically stimulated luminescent dosimeters.  The new 
method was then compared against a real patient population undergoing similar computed 
tomography scanning procedures.  Utilizing statistical procedures, the new method was 
tested for repeatability and bias against the current conversion coefficient method.  The 
analysis of the new method verifies that the estimation ability is similar to recent research 
indicating that the older conversion coefficient methods can underestimate the effective 
dose to the patient by up to 40%.  The new method can be used as a retrospective tool for 
effective dose estimation from CT trauma protocols for a patient population with physical 
characteristics similar to the U.S. Army Soldier population. 
 
 i 
TABLE OF CONTENTS 
Table of Contents .......................................................................................................................... i 
List of figures .............................................................................................................................. iv 
Acknowledgments ..................................................................................................................... vii 
Dedication.................................................................................................................................... ix 
Preface .......................................................................................................................................... x 
Motivation for Research ....................................................................................................... x 
Significance of Research....................................................................................................... x 
CHAPTER 1. Introduction .......................................................................................................... 1 
United States Army Medical Care ....................................................................................... 1 
Echelons of Medical Care in the U.S. Army................................................................. 1 
Radiology on the Battlefield .......................................................................................... 3 
Uniqueness of Research ........................................................................................................ 7 
CHAPTER 2.  Preliminaries ....................................................................................................... 9 
Ionizing Radiation Fundamentals......................................................................................... 9 
Absorbed Dose ................................................................................................................ 9 
Medical Use of Radiation ................................................................................................... 12 
Purpose........................................................................................................................... 12 
Patient Dose ......................................................................................................................... 16 
Method 1 ........................................................................................................................ 19 
Method 2 ........................................................................................................................ 23 
Method 3 ........................................................................................................................ 25 
Retrospective Dosimetry .............................................................................................. 28 
BMI and Effective Dose ............................................................................................... 29 
Cumulative Dose ........................................................................................................... 29 
Research Hypothesis ........................................................................................................... 33 
CHAPTER 3.  Specific Aim 1:  Evaluate the range of effective doses by CT protocols from 
literature and retrospective patient CT studies. ....................................................................... 36 
Statement of the problem: ......................................................................................................... 36 
Monte Carlo Techniques ........................................................................................................... 38 
Background .......................................................................................................................... 38 
Theory .................................................................................................................................. 40 
All Purpose Codes ......................................................................................................... 42 
Limited Functionality ................................................................................................... 46 
Validation of Limited Functionality Codes ....................................................................... 54 
Software Decision ............................................................................................................... 55 
Protocol Specific Effective Dose ....................................................................................... 56 
Conclusion ........................................................................................................................... 62 
CHAPTER 4.  Specific Aim 2:  Develop an improved model capable of predicting 
effective dose based upon a patient’s physical characteristics (height and weight). ............ 64 
Introduction .......................................................................................................................... 64 
Methodology ........................................................................................................................ 65 
BMI Considerations ...................................................................................................... 65 
 ii 
Results .................................................................................................................................. 85 
Uncertainties Involved in Estimating Effective Dose ...................................................... 93 
Sensitivity Tables .......................................................................................................... 94 
Cervical Spine Scan Sensitivity Table ........................................................................ 96 
Chest Abdomen Pelvis Scan Sensitivity Table ........................................................... 98 
Chest Scan Sensitivity Table ...................................................................................... 100 
Thoracic Spine Sensitivity Table ............................................................................... 102 
Lumbar Spine Sensitivity Table................................................................................. 104 
Conclusion ......................................................................................................................... 106 
CHAPTER 5.  Specific Aim 3:  Verify effective dose models by measuring absorbed dose s 
in organs using optically stimulated luminescent dosimetry and anthropomorphic 
phantoms................................................................................................................................... 108 
Introduction ........................................................................................................................ 108 
Theory ................................................................................................................................ 111 
Optically Stimulated Luminescent Dosimetry .......................................................... 111 
Anthropomorphic Phantoms ...................................................................................... 116 
OSL Characterization ................................................................................................. 118 
OSL Depth Response .................................................................................................. 124 
Methodology ...................................................................................................................... 130 
Results ................................................................................................................................ 135 
Brain Scan.................................................................................................................... 135 
Cervical Spine Scan .................................................................................................... 137 
Chest Abdomen Pelvis Scan ...................................................................................... 139 
Chest Scan ................................................................................................................... 141 
Thoracic Spine Scan ................................................................................................... 142 
Lumbar Spine Scan ..................................................................................................... 144 
Experimental Uncertainties .............................................................................................. 146 
Brain Scan.................................................................................................................... 146 
Cervical Spine Scan .................................................................................................... 147 
Chest Abdomen Pelvis................................................................................................ 148 
Chest Scan ................................................................................................................... 150 
Thoracic Spine Scan ................................................................................................... 151 
Lumbar Spine Scan ..................................................................................................... 152 
Discussion .......................................................................................................................... 153 
CHAPTER 6.  Specific Aim 4:  Validate the effective dose models against current DLP 
methods for estimating effective doses using a pilot study of representative trauma patient 
CT scans. .................................................................................................................................. 157 
Introduction ........................................................................................................................ 157 
Methods .............................................................................................................................. 159 
Results ................................................................................................................................ 160 
Brain Scan Comparison .............................................................................................. 160 
Cervical Spine Scan Comparison .............................................................................. 161 
Chest Abdomen Pelvis Scan Comparison ................................................................. 162 
Chest Scan Comparison .............................................................................................. 163 
Thoracic Spine Scan Comparison .............................................................................. 163 
Lumbar Spine Scan Comparison ............................................................................... 165 
 iii 
Brain Scan Bland-Altman Plot ................................................................................... 166 
Cervical Spine Bland-Altman Plot ............................................................................ 167 
Chest Abdomen Pelvis Scan Bland-Altman Plot ..................................................... 168 
Chest Scan Bland-Altman Plot .................................................................................. 169 
Thoracic Spine Scan Bland-Altman Plot .................................................................. 170 
Lumbar Spine Scan Bland-Altman Plot .................................................................... 171 
Discussion .......................................................................................................................... 177 
CHAPTER 7.  Specific Aim 5:  Recommend action points for the U.S. Army based upon 
this research. ............................................................................................................................. 183 
Need for Study (Example) .......................................................................................... 184 
Recommendations ....................................................................................................... 189 
Research Implications ................................................................................................. 191 
Research Needs ........................................................................................................... 191 




LIST OF FIGURES 
Number  Page 
Figure 1.  General design of a computed tomography scanning machine [33].  The x-ray 
tube, detector array, and data acquisition system rotates completely around the 
patient. ............................................................................................................................ 15 
Figure 2.  (a) Cristy-Eckerman phantom commonly used for internal radiation dosimetry 
[78]. (b) ADAM and EVA phantom. .......................................................................... 22 
Figure 3.  a) Rando-Alderson dosimetry verification phantom.  b) CIRS dosimetry 
verification phantom. .................................................................................................... 24 
Figure 4.  CTDI acrylic phantom, pencil ionization chamber, and electrometer 
(www.acr.org). .............................................................................................................. 26 
Figure 5. Graph of published articles concerning the use of Monte Carlo codes in medical 
physics in accordance with the above Pubmed database search terms. .................... 39 
Figure 6.  Monte Carlo flowchart for photon energies less than 150 keV.  Random numbers 
are used for sampling initial photon direction, distance between interactions, type of 
interacting atom within the phantom, type of interaction and scattering angle. ....... 41 
Figure 7. Screen shot of the phantom used in the ImPACT software program.  The red 
portion represents the scanning field of view ranging from a starting point of 72.5 
and having an ending point of 89................................................................................. 48 
Figure 8.  Screen shot of the ImPACT software user input portion.  A GE LightSpeed 16 
scanner used to perform a head scan (shown in red). ................................................. 49 
Figure 9.  Screen shot of the ImPACT software dose calculation portion for the user 
defined inputs shown in Figure 7.  Remainder dose is the mean dose of the 
remainder organs. .......................................................................................................... 50 
Figure 10. Screen shot of the examination input window for PCXMC. The red box on the 
stylized phantom represents the scan field of view. ................................................... 54 
Figure 11.  Representative Scans.  Brain Scan (Figure 11a and Figure 11b (ImPACT)). 
Cervical Spine Scan (Figure 11c and Figure 11d (ImPACT)).  Chest Abdomen 
Pelvis Scan (Figure 11e and Figure 11f (ImPACT)). Chest Scan (Figure 11g and 
Figure 11h (ImPACT)). Thoracic Spine Scan (Figure 11i and Figure 11j 
(ImPACT)). Lumbar Spine Scan (Figure 11k and Figure 11l (ImPACT)). ............. 60 
Figure 12.  Phantom patient parameters.  Vertical groups indicate single BMI values where 
height is held constant and weight varies. ................................................................... 70 
Figure 13.  Varying phantom dimensions.  Figure 13a has dimensions of 175 cm and 40 kg.  
Figure 13b has dimensions of 175 cm and 60 kg.  Figure 13c has dimensions of 175 
cm and 80 kg. Figure 13d has dimensions of 175 cm and 110 kg. ........................... 71 
Figure 14.  Six trauma protocols ((14a) Brain Scan, (14b) Cervical Spine Scan, (14c) Chest 
Abdomen Pelvis Scan, (14d) Chest Scan, (14e) Thoracic Spine Scan, (14f) Lumbar 
Spine Scan) are presented with the left hand picture showing a representative 
patient scan, top right figure showing a depiction of the ImPACT phantom, and 
bottom right two figures showing an anterior-posterior view and right lateral view 
of the PCXMC phantom. .............................................................................................. 72 
 v 
Figure 15.  Cross-sectional view of an axial slice made up of four radiographic projections.73 
Figure 16.  Effects plot of the predictors plotted against effective dose. 95% confidence 
bands are also presented along with the fitted regression line.  (16a) Brain scan, 
(16b) Cervical Spine Scan, and (16c) Chest Scan. ..................................................... 90 
Figure 17.  Effects plot of the predictors plotted against effective dose. 95% confidence 
bands are also presented along with the fitted regression line.  (17a) Chest 
Abdomen Pelvis Scan, (17b) Thoracic Spine Scan, and (17c) Lumbar Spine Scan.93 
Figure 18.  Dose response according to increasing thickness of solid water slabs simulating 
organ depth. ................................................................................................................... 94 
Figure 19.  Landauer Inc. nanoDot OSL dosimeter used in this research (Photo courtesy of 
Landauer Inc.). ............................................................................................................ 109 
Figure 20. Physical processes of the optically stimulated dosimeter [249]. ........................ 112 
Figure 21.  Light stimulation diagram describing how the OSL signal is obtained [266]. 115 
Figure 22.  InLight
TM
 MicroStar® System. ........................................................................... 119 
Figure 23.  Results of dosimeter to ion chamber comparison when placed free-in-air. ..... 121 
Figure 24.  Results of dosimeter to ion chamber comparison when placed on a phantom. 121 
Figure 25.  Ratio of dosimeter to ion chamber angular response. ........................................ 122 
Figure 26. Dosimeter linearity with a coefficient of determination (R
2
) value of 0.9997 
between delivered dose and measured dose. ............................................................. 123 
Figure 27.  Experimental setup for assessing depth response. Figure 23a shows the detector 
set up without slabs of solid water.  Figure 23b shows the setup with the solid water 
slabs on top of the blue support cushions. ................................................................. 125 
Figure 28. Detector response at varying depths of solid water at 80 kVp. .......................... 126 
Figure 29. Detector response at varying depths of solid water at 100 kVp. ........................ 126 
Figure 30. Detector response at varying depths of solid water at 120 kVp. ........................ 127 
Figure 31.  Ratio of OSL and MOSFET detectors with the ion chamber (IC).  Both 
detectors have a response ratio of within +/- 20%.................................................... 127 
Figure 32.  Ratio of the OSL orientation (OSL Flat to OSL Edge) at varying thicknesses of 
solid water for both 80 kVp and 100 kVp. ................................................................ 129 
Figure 33.  Representative photo of an anthropomorphic phantom on the CT scanning 
couch (Figure 33a) and a cross-section view of a 2.5-cm slab of the 
anthropomorphic phantom (Figure 33b). .................................................................. 132 
Figure 34. Bland-Altman plot of two methods for calculating the effective dose from a 
brain scan.  DLP-CC method represents the average of the doses from the two 
different conversion coefficients................................................................................ 167 
Figure 35. Bland-Altman plot of two methods for calculating the effective dose from a 
cervical spine scan. DLP-CC method represents the average of the doses from the 
three different conversion coefficients. ..................................................................... 168 
Figure 36. Bland-Altman plot of two methods for calculating the effective dose from a 
chest abdomen pelvis scan. DLP-CC method represents the average of the doses 
from the two different conversion coefficients. ........................................................ 169 
Figure 37. Bland-Altman plot of two methods for calculating the effective dose from a 
chest scan. DLP-CC method represents the average of the doses from the three 
different conversion coefficients................................................................................ 170 
 vi 
Figure 38. Bland-Altman plot of two methods for calculating the effective dose from a 
thoracic spine scan. DLP-CC method represents the average of the doses from the 
three different conversion coefficients. ..................................................................... 171 
Figure 39. Bland-Altman plot of two methods for calculating the effective dose from a 
lumbar spine scan. DLP-CC method represents the average of the doses from the 
three different conversion coefficients. ..................................................................... 172 
Figure 40.  Comparison of scanning areas for the chest scan.  (40a) Mathematical phantom 
and scanning range used to calculate the effective dose conversion coefficient [64].  
(40b) Representative patient scan and mathematical phantom scanning areas used in 
model development. .................................................................................................... 179 
Figure 41.  Lifetime cancer mortality risks as a function of age at exposure based on 
updated atomic bomb survivor data as reported in BEIR VII [28] (Courtesy of Li et 
al [290])........................................................................................................................ 181 
Figure 42.  Hypothetical Soldier effective dose chart showing how the ERR decreases over 
time but is greater for a higher initial effective dose.  Age-time patterns represent 
the radiation-associated risks for all solid cancer mortality. .................................... 189 
 vii 
ACKNOWLEDGMENTS 
The author wishes to thank all the people who have assisted, supported, and motivated me 
through this amazing opportunity. My life has truly been blessed by God.  As always, He is 
my Rock upon which to lean when times get tough.  I could not have succeeded without 
my loving wife (Joanie) and daughter (Molly Jane) who have been incredibly supportive 
and understanding.  I receive motivation just watching the two of them juggle their 
numerous tasks and yet still have time to help me with mine.  I would like to thank my 
advisors (Marco Zaider, Larry Dauer, Greg Freyer, Ross Schmidtlein, and Cheng-Shie 
Wuu) for their understanding and their insight into this research.  I couldn’t ask for a better 
advisor than Larry who has provided me the logistics and knowledge necessary to complete 
the research within the Army’s timeframe.  His friendship, guidance, and support have 
been instrumental in my research.  I will miss our commutes together. His zest for 
knowledge combined with his commitment to safety places him in upper level of all the 
Safety professionals with whom I have blessed to work.  I am also extremely fortunate to 
have Marco as an advisor.  He is truly one of the great minds of medical physics. Even 
though he is extremely busy with his medical physics responsibilities, he always had an 
open door for me when I needed advice and guidance.  I owe my existence within 
Columbia University to Greg who has been extremely supportive in my research and 
development as an academician.  Ross’ knowledge of the science is on a plane that I will 
probably never be able to achieve.  While we may not be office mates as we once were, I 
have been lucky to once again work with him.  Cheng-Shie has also been incredibly 
supportive and understanding throughout this process.  I am extremely fortunate that he has 
made the time to meet with me and provide me with his guidance.  No research is ever 
completed by one person alone.  I have been blessed to have an outstanding office mate 
(Pierre Elnajjar) whose friendship I often leaned on to get through my day.  My fellow 
students, Megan and Allan, have been extremely supportive and helpful.  Allan Just has 
forgotten more about statistics than I will ever know and has always been available to help 
with suggestions and advice.  The writing group that he set up within the department 
provided the right amount of motivation to kick me in my rear when a kick was needed.   
 viii 
The Health Physics staff at Memorial Sloan Kettering Cancer Center was also instrumental 
in my achievement.  Brian Quinn has been my research “buddy” for all my experiments.  
His willingness to come in and help regardless of the time of day was amazing and I could 
not have done any of the experiments without his assistance.   Developing a passion for the 
research though came down to observing the experiences of one particular friend, LTC 
Kenny McDonald.  What he has done and experienced in the Army provided me daily with 
the motivation that I needed.  Thanks again to my loving wife, Joanie, and daughter, Molly 




This research is dedicated to Joanie and Molly Jane for all their love and support.  This 
research is also dedicated to the Soldiers in the United States Army who have committed 
and on occasion sacrificed their lives for our wonderful Country.  I am truly fortunate to be 
given an opportunity to be a husband, a father, a leader of Soldiers, and a citizen of the 
United States of America. 
 x 
PREFACE 
Motivation for Research 
In 2004, one of my dear friends, deployed to Southern Iraq in order to build a children’s 
hospital, was severely wounded when the vehicle in which he was riding struck an 
improvised explosive device (IED).  The explosive force of the IED caused fatalities and 
numerous casualties among the Soldiers in this convoy.  The medical evacuation of my 
friend back to Walter Reed Army Medical Center (WRAMC) in Silver Spring, Maryland 
was relatively quick, occurring over a couple of days.  Fortunately, after at least a month in 
intensive care and subsequent long term rehabilitation, my friend has made a remarkable 
recovery.  While visiting my friend at WRAMC, he made the comment that doctors 
seemed to be constantly ordering new diagnostic scans in order to stay on top of his 
recovery.  At that time, most of my knowledge in cumulative dose centered on the radiation 
dose health effects of weapons of mass destruction and radioactive isotopes.  My friend and 
countless other heroes fighting for our Country have inspired me to learn more about the 
cumulative radiation dose from medical diagnostic scans.  I am extremely thankful and 
appreciative of the dedicated Army physicians, surgeons, and medical staff for their efforts 
in saving the lives of these heroes.   
 
Significance of Research 
Operation Iraqi Freedom (OIF) officially began 19 March 2003 with a theater of operations 
primarily in the nations surrounding the Persian Gulf.  Operation Enduring Freedom 
(OEF), 7 October 2001, included other nations in the Middle East and North Africa.  Both 
 xi 
operations are part of a greater effort termed the Global War on Terror (GWOT) by Former 
President George W. Bush. Since 2001, more than 1.6 million military members have 
deployed in support of the Global War on Terror.  
 
Casualties and fatalities have been sustained by the service members supporting the 
operations. As of 7 February 2011, there have been a total of 29,136 casualties sustained in 
the U.S. Army [1]. Most of the fatalities on the battlefield are caused by total body 
disruption (blunt force trauma), severe brain injury, or hemorrhage [2]. Whereas little can 
be done on the battlefield when total body disruption or severe brain injury occurs, military 
medicine has made great strides in saving the lives of those of who have experienced 
hemorrhage [3]. Additionally, advances made addressing battlefield trauma have led to 
more Soldiers surviving traumatic wounds than in any of the previous wars [4].  
 
Soldiers in previous wars have not had the benefit of the rapid medical evacuation abilities 
seen today.  In Vietnam, evacuation of casualties back to a large medical center could take 
close to forty-five days.  Today, casualties arrive back to Germany within twelve to forty-
eight hours after injury and are back in the United States in four to five days. Medical 
advances can be inferred through the statistic that less than 5% of the casualties in Iraq die 
of their wounds after reaching a medical facility [5].  
 
Blast injuries and blunt traumas have increased as the use of improvised explosive devices 
targeting vehicle flow increased.  Victims of terrorist attacks tend to have higher injury 
severity scores, greater requirements for intensive care, more prolonged hospital stays, and 
 xii 
a higher rate of mortality than other trauma victims [6]. Managing patient information on 
the battlefield continues to be difficult as severely wounded personnel are evacuated from 
the point of injury through the support combat support hospital back to Germany where 
greater stability care is performed [3].  
 
Conducting medical maneuvers on the battlefield requires an extreme amount of flexibility, 
diligence, and competence. Medical professionals have to be capable of performing their 
specialty in austere conditions and still be able to ensure that all clinical medical 
information remains with the patient through the entire evacuation process (as needed). 
However, there has been a basic problem seen in the relative paucity of clinical patient 
information transferred with the patient to the succeeding next higher level of care.  
 
Early in the Global War on Terrorism, there were instances of narratives being written in 
marker on patients’ dressings to convey clinical information. In order to address this 
information gap, the Joint Patient Tracking Application was developed to allow users to get 
real-time information on the status of their injured troops [7]. However, the trauma record 
still doesn’t show how many radiographic procedures were performed in the trauma 
diagnosis.  Advances in diagnostic imaging have not made the management of patient 
imaging records easier.  One combat hospital switched from film radiography to digital 
radiography and then back to film radiography because of increased throughput during 
trauma situations and the inability of outside facilities to read the compact disks with the 
films saved on them [8].  
 
 xiii 
When failure to transfer relevant understandable radiographic information along with the 
patient occurs, the patient often undergoes multiple repeat diagnostic procedures covering 
the same area of the body.  Additionally, as the level of integrated hospital care increases, 
the radiographic technology also increases resulting in multiple diagnostic procedures on 
the same area with different diagnostic modalities (standard radiographic x-ray, and 
computed tomography).   
 
Increasing numbers of radiographic procedures is not unique to military medicine.  Victims 
of trauma receive multiple diagnostic scans and thus are at an increased risk of detrimental 
health effects from cumulative radiation dose [9-11].  Previous methods for assigning 
computed tomography effective doses under these circumstances involve the use of 
generalized rules of thumb that are inadequate for retrospective dose analysis.  This 
research addressed a knowledge gap in assigning effective doses from computed 





CHAPTER 1. Introduction 
 
United States Army Medical Care  
The United States Army Medical Department (AMEDD) is charged with providing 
seamless medical care to all members of the U.S. Army regardless of location.  In order to 
carry out this responsibility, the AMEDD has both field medical units which belong to the 
combatant commanders in order to coordinate the movement and control with the fighting 
forces, and fixed hospitals which are directly commanded by the leadership of the 
AMEDD.  Unique challenges occur with coordination and integration of assets throughout 
the AMEDD.   
 
Echelons of Medical Care in the U.S. Army 
As described in the AMEDD Combat Health Support doctrine, the wartime mission of the 
AMEDD is to: 1) save lives, 2) clear the battlefield of casualties, 3) provide state-of-the-art 
care, 4) return a soldier to duty as rapidly as possible or evacuate the soldier back to a 
higher echelon of care for more definitive treatment, and 5) provide the most benefit to the 
maximum number of personnel [12].  There are five echelons of medical care within the 
Army ranging from battlefield medical care to fixed hospital care [13]. 
 
Echelon I – first medical care a soldier receives when wounded [13].  This level of care is 
considered unit-level health care and includes treatment and evacuation from the point of 
injury or illness to the unit’s first aid station.  This echelon includes immediate lifesaving 
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measures.  Medical care is limited to self-aid, buddy aid, combat lifesaver, combat medics, 
and a treatment squad consisting of about ten medically trained personnel (similar to 
emergency medical technicians). The highest level of medical competence is usually 
performed by a general physician or physician’s assistant capable of providing advanced 
trauma management. 
 
Echelon II – supports Echelon I treatment and extends the treatment competence to include 
dental, laboratory, x-ray, and patient holding capabilities [13].  This level of treatment 
serves to examine the casualty and determine if further evacuation is needed or if the 
soldier can be returned to duty with the unit. 
 
Echelon III – expands the level of care to include surgical care [13].  The surgical care can 
be co-located with Echelon II care in the form of forward support surgical hospitals or 
remain in the main base operating area.  Evacuation hospitals are also found in Echelon III 
care. 
 
Echelon IV – highest level of care found close to a battlefield [13].  This echelon of care 
serves to further stabilize patients requiring evacuation to fixed hospitals within Europe 
(Landstuhl Army Medical Center) prior to evacuation to Walter Reed Army Medical 
Center.  Echelon IV facilities are staffed and equipped for general and specialized medical 




Echelon V – definitive medical care [13].  Echelon V hospitals are fixed hospitals with 
extensive medical specialties providing all the necessary functions for the most definitive 
medical care. 
 
Phases of medical treatment include: first aid, medical care delivered by a trained combat 
medic (similar to an emergency medical technician), emergency medical treatment, initial 
resuscitative treatment, resuscitative surgery or care, definitive treatment, convalescent 
care, and restorative/rehabilitative treatment. 
 
Radiology on the Battlefield 
While not as robust as at a fixed hospital, radiology on the battlefield is still fully capable 
of the full range of diagnostic radiology from general purpose x-rays to CT.  Echelon II is 
the first echelon of medical care where deployed radiology units are staffed.  Increasingly, 
CT scanners are found at Echelon II facilities where they are used to assist in determining 
the internal damage to a casualty.  In deployed areas, combat support hospitals respond 
primarily to battle casualties suffered from improvised explosive devices, shrapnel, and 
gunshot wounds. 
 
The number of radiographic procedures performed annually by the military mimcs the 
same dramatic increase as in the United States-civilian medical establishment.  As a result, 
the annual effective dose per individual has increased as well, due primarily to the 
increased usage of computed tomography, interventional fluoroscopy, and nuclear 
medicine [14].  The National Council on Radiation Protection and Measurements (NCRP) 
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Report 160 states that 24% of the collective effective dose from medical scans can be 
attributed to computed tomography [CT] scans.  Since its inception in 1972, CT usage has 
steadily increased due to faster computer processing, advanced techniques (i.e. helical 
scanning), and better detector and geometric efficiencies.  Current CT machines are able to 
scan an entire body in under 30 seconds [14].    
 
Military medical standards of care include the use of computed tomography scanning in 
initial diagnosis of traumatic injuries.  For head traumas, CT scans are to be performed for 
any patient with a neurological score of less than 15 as assessed using the Glascow Coma 
Scale, prolonged loss of consciousness and/or focal neurological signs.  CT scans are also 
used for any core body area (whole body without extremities) where bony abnormalities 
are present or suspected [15].  As blunt trauma injuries in OIF and OEF have increased, use 
of CT scanning has also increased. 
 
Computed tomography can be used as an effective patient triage tool on the battlefield [16].  
Between June 2008 and May 2009, almost 87,000 radiographic procedures were performed 
by U.S. Army combat support hospitals in Iraq (Echelon II through Echelon IV).  However, 
prior to January 2009, the medical system in Iraq did not track radiographic procedures by 
modality.  Initial modality tracking showed that from January 2009 to May 2009, out of the 
33,000 procedures performed, 8,000 were CT scans [17].  At a combat support hospital in 
Afghanistan, more than 600 x-rays and 259 CT scans were conducted to assist with 57 
surgeries on 47 admitted patients who were in 39 trauma events, all in one 38-day period in 




Justifying (ensuring that the benefit is greater than the risk) the use of a CT scan is 
important because the risk, albeit small, is measureable [19-20].  A single whole-body CT 
examination in a 45-year old adult would result in an estimated lifetime attributable cancer 
mortality risk of around 0.8% [21].  Another study performed in a hospital emergency 
department, determined that patients undergoing CT of the neck, chest, abdomen, or pelvis 
have high cumulative rates of multiple or repeat imaging.  The study also determined that 
these patients have a heightened risk of developing cancer from cumulative CT radiation 
exposure [11, 22].  Whereas the risk to the individual patient is small and can be readily 
balanced by the medical benefits, the problem becomes greater when trauma patients 
undergo multiple procedures for diagnostic assessment [23].    
 
Concerns are also noted that diagnostic procedures are repeated unnecessarily or when 
higher dose modalities are used instead of lower dose modalities without necessary 
justification [19].  These concerns have prompted the Food and Drug Administration to 
study whether or not tighter guidelines should be established seeking to limit the amount of 
radiation dose per diagnostic procedure [24]. 
 
Accurately recording all radiographic procedures is important to both assessing lifetime 
attributable risk to radiation induced cancer and in the physician’s justification process for 
determining whether or not a procedure is needed.  In a battlefield trauma situation, initial 
medical care seeks to stabilize and save life and limb.  Later, after the Soldier has been 
stabilized and during the rehabilitation period following the incident, assessment of the 
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lifetime attributable risk becomes even more important to helping in the physician 
justification process.  Different radiographic modalities provide varying degrees of 
diagnostic information. Trauma patients often require multiple imaging tests [9-11].  The 
diagnostic modality that is typically associated with high radiation dose rates is computed 
tomography.  
 
However, for a particular person, determination of whether a radiographic procedure 
caused an increased incidence of cancer is generally not possible.  Radiation induced 
tumors are not distinguishable from other types of tumors.  Epidemiologic studies can only 
present the carcinogenic effect of radiation through statistical excess [25]. A means of 
estimating the lifetime attributable risk of radiation-induced cancer to a wounded Soldier is 
by thoroughly capturing and recording the accumulated effective dose.  Effective dose 
provides an indicator of potential detriment from ionizing radiation [26].  As the long term 
survival rates go up, so does the risk of a radiation-induced cancer [27-28]. 
 
CTs have distinct advantages over other diagnostic imaging devices when imaging victims 
of severe trauma.  These advantages include rapid acquisition and processing of patient 
images.  Unlike magnetic resonance imaging, CT can acquire and process and image in less 
than a minute enabling rapid physician diagnosis based upon a tomographic reconstruction.  
Since the image can be acquired so quickly, patient movement, which reduces image 
quality, is significantly reduced.  This is one of the reasons why MRI is not used in imaging 
the thoracic region of the body.  The benefits (rapid diagnosis) of using CT greatly 




Uniqueness of Research 
This research is unique from published research in that it explores the development of a 
patient specific methodology using patient parameters (height and weight) for determining 
the effective dose from specific trauma CT protocols.  Current methods for determining the 
effective dose rely upon a priori knowledge of specific CT machine characteristics and a 
posteriori knowledge of dose-length product (DLP) based on machine output. The 
methodology of this work focuses on the use of patient parameters rather than machine 
specific values. Verification of the methodology was performed using in phantom 
dosimeters to measure radiation doses to specific organs.  Thermoluminescent dosimeters 
have been primarily used to measure dose within phantoms and there is no published 
research concerning the use of optically stimulated luminescent dosimeters within 
anthropomorphic phantoms for assessing radiation dose from CT trauma protocols, 
therefore this study represents a unique use of this dosimetric methodology.  The adult 
phantoms utilized in this study adhere to International Commission on Radiation Protection 
(ICRP) reference man and woman standards.  They have been specifically milled to study 
specifications and are representative of the U.S. Soldier population.  Finally, validation of 
the methodology was performed against information from a population of actual patient 
images collected under a Memorial Sloan-Kettering Cancer Center Institutional Review 
Board agreement granted for retrospective imaging studies. 
 
This research is expected to contribute to the Biological Effects of Ionizing Radiation 
(BEIR) Report VII established Research Need 8, Future Medical Radiation Studies [29].  
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This was identified as a need for future studies to include individual dose estimates to sites 
of interest along with evaluations of the uncertainty in dose estimation:   
 
“Of concern for radiological protection is the increasing use of computed tomography 
scans and diagnostic x-rays.  Epidemiologic studies of these exposures would be 
particularly useful if they are feasible, particularly the following:  follow-up studies of 
cohorts of persons receiving CT scans, especially children…The widespread use of 
interventional radiological procedures in the heart, lungs, abdomen, and many vascular 
beds, with extended fluoroscopic exposure times of patients and operators, emphasizes the 
need for recording of dose and later follow-up studies of potential radiation effects among 
these populations.  There is a need to organize worldwide consortia that would use similar 
methods in data collection and follow-up.  These consortia should record delivered doses 
and technical data from all x-ray or isotope-based imaging approaches including CT, 




CHAPTER 2.  Preliminaries 
Ionizing Radiation Fundamentals 
Ionizing radiation, hereafter referred to as radiation, consists of neutral (neutrons, photons, 
neutrinos, etc.) and charged particles (electrons, positrons, protons, etc.) that carry 
sufficient energy to liberate electrons from atoms or molecules.  Use of radiation in 
medicine has been explored since the early Twentieth Century [28] and whereas the 
concern for dose to radiation occupationally exposed workers has a long history, the long 
term health effects of radiation were not well understood until cohort populations (Life 
Span Study (Hiroshima and Nagasaki bomb survivors), radiation workers, etc.) emerged 
[29].   
 
Absorbed Dose 
Radiation absorbed dose is defined by the amount of average energy absorbed per unit of 
mass at a point in matter [30].  The SI unit of absorbed dose is Gray (Gy), which is one 
Joule per kilogram.  The distribution of the absorbed dose within a tissue is not uniform 
and depends on the penetration and range of the radiation within the tissue.  The dosimetric 
quantities described below are based upon the average absorbed dose in a specified organ 
or tissue. 
 
Low Dose vs. High Dose 
As an ionizing charged particle travels through a medium, energy is lost.  The (unrestricted) 
linear energy transfer (LET) is defined as the average energy lost by a charged particle due 
to electronic interactions per unit length of its trajectory [29].  The amount of energy 
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transferred to the medium depends upon the atomic number of the medium and on the type 
of radiation in terms of the LET.  Typically, for low LET radiation low dose is considered 
less than 100 mGy.  In terms of background radiation, the dose equivalent from low-LET 
radiation is approximately 1 mSv per year and the average background exposure in the 
United States can range from approximately 3 mSv to 6 mSv per year [29]. 
 
Understanding that different ionizing charged particles interacting in a tissue results in 
different biological effects, the International Commission on Radiation Units and 
Measurements (ICRU) introduced the quality factor, Q, to weight the absorbed dose for the 
biological effectiveness of the particles producing the absorbed dose, D [31].  The quality 
factor is based on the type and energy of the radiation at a point in a specific tissue.  The 
product of the quality factor and the absorbed dose at a point in tissue is defined as the dose 
equivalent, and has units of Sievert (Sv).  The International Commission on Radiological 
Protection (ICRP) replaced the dose equivalent concept with the quantity, equivalent dose, 
in 1991 to account for absorbed dose in a tissue rather than at a specific point.  Equivalent 
dose is defined as the absorbed dose averaged over a tissue or organ and weighted for the 
radiation quality that is of interest [32].  The radiation weighting factor, wR, used in 
calculating equivalent dose is analogous to the quality factor used in calculating dose 
equivalent when considering radiation emitted by an internal source in the body, but for 
external radiation the radiation weighing factor is a function of the type of radiation 
incident on the body and doesn’t depend on the location in, or orientation of, the body [31].  
The radiation weighting factor accounts for the relative biological effectiveness of the 





Effective dose is the mean low-LET absorbed dose from a uniform whole-body irradiation 
that results in the same total radiation detriment as from the non-uniform, partial-body 
irradiation in question [33].  The effective dose concept was introduced by the ICRP in 
1975 to represent the radiation detriment for the general population or the specific 
population of radiation workers and to assess compliance with dose limits.   
 
In 1991, the ICRP [32] recommended that the term effective dose be used to describe the 
relationship between the probability of stochastic effects and equivalent dose.  Effective 
dose is the multiplicative result of the equivalent dose and the individual tissue weighting 
factors.  Effective dose represents the total health detriment from uniform radiation to the 
whole body by summing all the tissues and organs in the body.  The mathematical 
representation of this concept is shown in equation 1. 
                  1                                                                      
The units for effective dose, E, are Sievert (Sv).  The dose factor,     , accounts for the 
dose in a particular tissue from a particular type of radiation.  The radiation weighting 
factor,    , accounts for the difference in energy imparted by each type of radiation.  The 
tissue weighting factor,    , helps to describe how each tissue or organ responds to the 
radiation insult.  The tissues or organs where the cells are rapidly dividing (gonad region) 
will be more affected by radiation than those tissues or organs where the cells are not 
dividing as frequently (brain) and will have a higher tissue weighting factor.  Each tissue 
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dose, radiation weighting factor, and tissue weighting factor is summed up to account for 
all tissues and organs involved.  
 
Medical Use of Radiation 
Purpose 
Radiation is involved in medical procedures for both imaging (diagnostic) and treatment 
(therapy).  The primary radiation used is photons.     
 
Diagnostic 
Medical imaging primarily uses x-rays to create an image of the patient’s internal structure.  
The x-rays are created via electron interaction with (typically) a high atomic number 
material.  This interaction occurs within an x-ray tube.  Electrons are accelerated from 
cathode to anode made up of a high atomic number material (typically Tungsten) via a 
large potential difference (i.e. 120 kVp).  The electrons interact with the material in the 
anode and produce Bremsstrahlung x-rays. Although the x-rays are emitted in an isotropic 
manner, the x-ray tube has a small window from which the x-rays are allowed to escape in 
a direction towards the patient.   
 
The x-rays emanating from the x-ray tube are described in terms of quantity, quality, and 
exposure.  The quantity of x-rays is the number of photons within the beam typically 
quantified in mAs.  As the mAs is increased, the resultant image is often better because 
more photons are being detected by the detector but more photons are also being absorbed 
so that the dose to the patient increases.  The quality of x-rays describes the energy 
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spectrum of the x-rays within the beam and can be characterized in terms of the half-value 
layer (HVL) which is related to the potential energy difference between the cathode and the 
anode.  The unit associated with the quality of x-rays is the electron-volt.  In diagnostic 
radiology, the typical beam quality for a given HVL is from 40 kVp up to 140 kVp and 
measures the tube potential or nominal energy of the x-ray beam.  The x-ray beam is a 
spectrum of energies.  Because of the photoelectric effect, the lower energies in the 
spectrum will tend to be absorbed within the body contributing to the overall radiation dose 
without contributing to the image because of the higher absorption cross section at the 
lower energies for the tissue medium.  Manufacturers use filters of various materials to 
remove lower energy x-rays from the x-ray beam but allow the higher energy x-rays to 
remain within the beam.  Depending upon what portion of the body is being imaged, the 
beam quality must be higher or lower.  For those portions of the body with high density 
tissues (e.g. bones), a higher quality (higher kVp) must be used to ensure that the x-rays 
have enough energy to pass through the patient without all being absorbed and thereby not 
contributing to the image.   
 
Exposure is nearly proportional to the energy fluence of the x-ray beam.  Together, 
quantity, quality, and exposure are determined by six major factors:  x-ray tube target 
material, voltage, current, exposure time, beam filtration, and generator waveform [34].  
 
When the x-rays interact with the patient, they are absorbed, scattered, or pass through the 
patient completely.  Therefore, diagnostic imaging contrast is a factor of the density of the 
material.  The areas of the body that have the greatest electron density (e.g. bone) will 
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absorb the most x-rays and appear lighter in color than those areas which do not have a 
high density of material (e.g. lung) which will result in a dark color.  The colors range from 
black (no absorption of photons) to white (total absorption of photons).  Therefore, 
radiographic images are often referred to as negative images.    
 
COMPUTED TOMOGRAPHY 
Computed tomography (CT) has been used to make medical diagnostic images since the 
early 1980s and is well described in literature [34].  Increasingly, CT has been used 
throughout hospitals in order to rapidly acquire images aiding in patient diagnosis.   
 
Design 
Computer algorithms are capable of transforming the information from thousands of 
detectors into an image.  The manufacture of the physical CT scanner is very important.  At 
the most basic level, a CT scanner is made up of an x-ray tube, rotating around a patient, 
and x-ray detectors capable of transforming the x-ray detection into a signal to be processed 
to create an image (Figure 1).  In most CT machines, the x-rays are emitted in the shape of 
a fan beam.  The x-rays then undergo interactions within the patient prior to being detected 
by the detector array.  The number of x-rays emitted by the x-ray tube is controlled by 
adjusting the current and the exposure time.  The energy of the x-rays is controlled by 




Figure 1.  General design of a computed tomography scanning 
machine [35].  The x-ray tube, detector array, and data acquisition 
system rotates completely around the patient.  
CT scanner detectors are made of crystals which scintillate (emit light) when interacting 
with radiation.  Manufacturers seek to use those elements within the scintillation crystal to 
achieve a high degree of both absorption efficiency and scintillation efficiency precisely 
tuned to the spectrum of photon energies produced by the x-ray tube.  The x-ray tube is 
often compact in geometry.  A compact geometry (distance from the x-ray tube to the 
detector) yields a more efficient performance ratio of the scanner’s tube and generator.  
With all other variables being constant, a more compact geometry will use less photon 




Tomography, meaning imaging by slices, utilizes the process of taking multiple x-ray 
projection images of a patient and summing their back-projections in order to create the 
individual slices for a three dimensional rendering of the patient over the patient scanning 
length [34].  Single transmission measurement through a patient made by a single detector 
is called a ray.  A series of rays is a projection.  Parallel beam geometry is a beam in which 
all the rays are parallel to each other.  Fan beam geometry (modern CT scanners) is a beam 
in which all the rays diverge from each other.  Acquisition of a single axial CT image 
(slice) may involve approximately 800 rays taken at 1,000 different projection angles for a 
total of 800,000 transmission measurements. Before the next slice, the table is moved 
(along the z-axis). 
 
Patient Dose 
Radiation dose is a result of many different CT machine parameters.  Some of these 
parameters can be adjusted by the CT technologist in accordance with the prescribed 
technique protocol for each individual scanning region of the body and other parameters 
are non-adjustable CT machine parameters. 
 
Non-adjustable CT machine parameters contributing to patient dose include x-ray tube 
filtration and focal spot size.  The x-ray tube filtration serves to filter (absorb) serves to 
remove low-energy x-rays from the beam spectrum.  These low-energy x-rays would 
otherwise have only contributed to the radiation dose and not the image.  A measure of the 
filtration is the Half-Value Layer (HVL), which together with the tube potential (kVp), 
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serves to describe the beam quality (penetrability of the beam through the patient).  The 
HVL increases as filtration increases for a given kVp.  Increasing the amount of filtration 
will reduce overall patient dose.  The filtration has a greater effect on the absolute organ 
dose but little effect on the relative patient dose [36].  The focal spot size is considered a 
non-adjustable parameter because it is typically set by the manufacturer or medical 
physicist in accordance with the type of scanning procedure.  Larger focal spot sizes are 
used for scanning when the region being scanned does not require a high degree of spatial 
resolution.  Smaller focal spot sizes are used when a high degree of spatial resolution is 
required [34].  Use of smaller focal spot sizes will result in higher patient doses than use of 
larger focal spot sizes.   
 
The adjustable parameters contributing to patient dose include the beam quality, beam 
quantity (mAs), slice thickness, gantry rotation speed, CT pitch, and perhaps most 
importantly patient size.  Beam quality is described by the HVL and the tube potential.  
The adjustable parameter within beam quality is the tube potential.  The tube potential is 
typically 120 kVp for all body regions.  Tube potential is directly related to patient dose but 
is inversely related to image contrast.  As tube potential is increased patient dose also 
increases [37] but image contrast is reduced due to the decreasing probability of the 
photoelectric effect. Beam quantity describes the number of photons resulting from the 
interaction of the electrons with the rotating anode.  This quantity is known as tube current 
measured in milli-Amperes (mA). The CT technologist will adjust the mA in accordance 
with the different regions of the body in order to obtain an image with the least amount of 
noise (signal-to-noise) which varies with the square root of the number of photons.  
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Scanning regions with greater tissue densities (bony structures) and greater patient 
thicknesses will require higher mA than other scanning regions.  Patient dose is directly 
related to the mAs.  As the mAs increases, the absorbed organ dose also increases [38].  
Slice thickness has a linear influence on the number of photons used to produce the image 
and thus have a direct relationship with patient dose.  Thicker slices require more photons 
to produce the same image quality.  However, fewer slices are needed to cover a scanning 
range as slice thickness is increased.  Using smaller slice thicknesses can lead to more areas 
of the body where the slices overlap.  Overlapping areas have higher doses than areas 
within the middle of the slice.  Gantry rotation speed (revolution time) can be varied to a 
certain extent by the technologist.  Faster rotation speeds are easier to achieve with CT 
machines having a smaller gantry diameter.  X-ray intensity varies as the square of the 
distance measured from the isocenter to the x-ray tube [39].  Adjusting the CT pitch, a 
measure of the length of body transcribed by one full revolution of the x-ray tube divided 
by the slice thickness, allows a CT technologist to decrease the scanning time and 
indirectly the patient dose.  However as the CT pitch increases, the image spatial resolution 
decreases [34].  Therefore most CT pitch values are near unity.  Patient size also has a 
direct relationship with radiation dose.  For a given x-ray technique, larger patients will 
attenuate more x-rays which reduces the number of x-rays being detected thereby reducing 
the image quality.  In order to adjust for this, a CT technologist will increase the mA which 
as described above, increases the dose. 
 
Current methods of determining the radiation dose to individual patients are largely patient 
generic.  Measuring the radiation dose to patients from CT scans is difficult and complex.  
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Generally, there are three main methods of performing the measurement.  The three 
methods are: 
1. Monte Carlo simulations using mathematical phantoms [40-51].   
2. Experimental measurements using physical phantoms (a tissue equivalent 
apparatus) and radiation detectors [52-61]. 
3. Calculation of organ and effective dose from CT doses index (CTDI) or dose-
length product (DLP) using conversion coefficients derived via the first two 
methods [62-75]. 
Often a combination of the three methods is used to assess dose from a procedure so that 
comparisons can be made.   
 
Method 1 
There are several popular Monte Carlo codes available on the public domain that have been 
used to model radiation dose.  Three of the more popular codes are Monte Carlo N-Particle 
(MCNP) [76], Monte Carlo N-Particle eXtended (MCNPX) [76], and Electron Gamma 
Shower (EGS) [77].  These codes will be explored in more detail as part of Specific Aim 1.   
Monte Carlo [MC] calculations employ random numbers to approach the solution to a 
problem.  MC methods can be used to look at radiation interactions because the interactions 
are governed by stochastic (random) events.  Therefore, MC can be applied to determine 
the established equivalence between the desired result and the expected behavior of the 
stochastic system [78].  The random numbers are used to simulate the known distribution 
of a variable about a given probability.  Large numbers of random events can be used to 
form an estimate about the true solution.  As more random events are used, the estimate of 
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the solution becomes more consistent and converges to the correct solution.  The behavior 
of the random variables adheres to the Central Limit Theorem which explains how the sum 
of a large number of independent random events is normally distributed as long as the 
expectations are finite with known variances.   
 
Generating random numbers have been widely studied over the years and falls into three 
categories [79]:  
1. Drawing samples from specially constructed tables, 
2. Monitoring the output of a physical device or process (i.e. radioactive decay 
of an isotope), and 
3. Calculation by a specified mathematical algorithm. 
The most common random number generation today is using the third category which has 
been classified as a deterministic production of random numbers (also called pseudo-
random). This category is limited by the period of the random number sequence.  The 
period of the sequence occurs when a certain number of distinct elements have been 
produced and starts to repeat itself.  This limitation can be overcome by ensuring that the 
period is sufficiently large through modeling a large number of random numbers. 
 
Mathematical/Voxelized Phantoms 
In order to assess the interactions of the photons in tissue and make a determination of 
dose, mathematical or voxelized phantoms serve as the “target of interest” within which the 




The first mathematical phantoms replicated the human structure using a series of geometric 
elliptical cylinders and cones.  The different shapes modeled not only the overall shape of a 
human but also the organs contained within the human structure.  One of the initial 
assumptions was that all the tissue was homogeneous within an organ.  As modeling ability 
increased, more elaborate phantoms were created to account for tissue heterogeneity.  One 
of the first heterogeneous phantoms was created by the Medical Internal Radiation 
Dosimetry (MIRD) Committee of the Society of Nuclear Medicine [80].  This phantom 
(general dimensions of a 70 kg 170 cm reference man), commonly known as the MIRD5 
phantom, consisted of a skeleton, lungs, and soft tissue as the remainder.  Gradually, these 
phantoms were advanced to more complex geometric organ shapes and overall sizes.  Two 
of the more famous phantoms that have been used for many years were designed by Cristy 
and Eckerman et al [81] (Figure 2a) at Oak Ridge National Laboratory in 1980 and Kramer 
et al (Figure 2b) from the National Research Center for Environment and Health (GSF) in 
Germany [82].  These phantoms became known as the Cristy-Eckerman phantom and the 
ADAM and EVA phantoms. 
2a.  2b.  
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Figure 2.  (a) Cristy-Eckerman phantom commonly used for internal 
radiation dosimetry [80]. (b) ADAM and EVA phantom. 
The phantom models followed the guidance of the International Commission on 
Radiological Protection (ICRP) Report 23 and have been updated as appropriate according 
to ICRP Report 110 [83].  In ICRP Report 110, a Reference Man is defined as 176 cm tall 
with a mass of 73 kg.  A Reference Female is 163 cm tall with a mass of 60 kg.  A 
summary of the organs is presented below (Table 1). 
 
 Table 1.  Summary of organ masses from ICRP 110 [83]. 
Organ 
Mass of Organ (g) 
Male Female 
Adrenals 14 13 
Brain 1450 1300 
Breast 25 500 
Eyes 15 15 
Eye Lenses 0.4 0.4 
Gall Bladder 68 56 
Gastro-Intestinal Tract 150 140 
Heart 840 620 
Kidneys 310 275 
Liver 1800 1400 
Lungs 1200 950 
Esophagus 40 35 
Ovaries  11 
Pancreas 140 120 
Pituitary Gland 0.6 0.6 
Prostate 17  
Salivary Glands 85 70 
Spleen 150 130 
Testes 35  
Thymus 25 20 
Thyroid 20 17 
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Uterus  80 
 
Alternate uses of Monte Carlo programs include assessment of energy imparted to derive 
effective doses.  Absorbed doses can either be calculated directly to specific locations or 
can be derived using energy imparted formulism.   
 
Method 2 




Physical phantoms are also designed in accordance with ICRP 110 guidance [83].  They 
are often used as the comparison benchmark for computational phantoms.  The physical 
phantoms are designed for insertion of radiation detectors and dosimeters.  Each organ in 
the phantom will have many different locations in which the detectors and dosimeters can 
be placed.  Because the tissue composition of the organ and surrounding areas is equivalent 
to a real human patient, measurements within the organ accurately reflect the radiation dose 
from a selected procedure.  The disadvantage of physical phantoms is that their structure is 
rigid. However, these phantoms are very useful and can also be used for image and 
dosimetric verification analysis.  Two of the more common developers of physical 
phantoms include Alderson Research Laboratories (Figure 3a) and Computerized Imaging 
Reference Systems (CIRS), Inc (Figure 3b). 
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3a.  3b.  
Figure 3.  a) Rando-Alderson dosimetry verification phantom.  b) 
CIRS dosimetry verification phantom. 
Radiation Detectors 
The most common types of radiation detectors used to measure dose within a physical 
phantom designed to assess computed tomography scans are thermoluminescent dosimeters 
(TLD), metal oxide field effect transistor (MOSFET), and radiochromic film.  A relatively 
new use for optically stimulated luminescent dosimeters (OSL) is in phantom organ dose 
assessment.  OSL dosimeters will be used in this research.    
 
TLD and OSL dosimeters operate under the same basic theory of ionizing radiation causing 
electrons to be trapped and when stimulated with energy recombining.  The amount of 
electrons trapped is proportional to the radiation dose.  The difference between TLDs and 
OSLs is primarily with the stimulation energy source.  Heat is used as the stimulation 
source in TLDs whereas light is used as the stimulation source in OSLs.  The stimulation 
sources are used to provide energy to the trapped electrons so that they can leave the traps.  
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As the electrons return to the ground state, the electrons release energy in the form of 
measureable luminescent light.  The amount of luminescent light that is measured is 
proportional to the number of electrons which were trapped and is therefore proportional to 
the dose.  MOSFET operates in accordance with semiconductor theory.  Ionizing radiation 
within the active detection chamber of a MOSFET causes electrons to be released.  The 
movement of electrons results in an electric charge being produced.  The amount of electric 
charge produced is proportional to the radiation dose.  Radiochromic film operates on an 
entirely different principle.  Radiochromic film responds to different energies by different 
degrees of darkening.  The amount of darkness relates to the amount of radiation absorbed.  
Radiochromic films work well in the measurement of small fields and at the edges of large 
fields of radiation due to its ability to measure a high dose gradient and sustain relatively 
high absorbed dose rates [84].   
 
Method 3 
Effective dose calculations are most often performed using CT machine produced 
quantitative factors derived from manufacturer listed machine values known as the 
computed tomography dose index (CTDI).  The CTDI quantity describes the radiation dose 
distribution from the CT machine.  The Food and Drug Administration defines the CTDI as 
the integral of the dose profile along a line perpendicular to the tomographic plane divided 
by the product of the nominal tomographic section thickness and the number of tomograms 
produced in a single scan (21CFR1020.33). CTDI is a quantity describing the average 
dose.  CTDI is measured using a PMMA acrylic phantom and a 100-mm pencil chamber 
detector (Figure 4).  In order to further describe how the radiation dose is distributed within 
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the body and on the surface of the body, the weighted CTDI (CTDIw) is measured.  The 
CTDIw is computed by summing up one-third of the CTDI measured dose inside the 
phantom and two-thirds of the measured CTDI value on the surface of the phantom.  When 
the CTDIw is divided by the pitch of the CT machine, the CTDI volume (CTDIvol) is 
computed.  CTDIvol is the quantity which the CT manufacturer provides in the dose report 
provided for each scan.  In order to convert the average dose to effective dose a new 
quantity is introduced called the dose length product (DLP).  The DLP is calculated by 
multiplying the CTDIvol by the total length of the CT scan. 
  
Figure 4.  CTDI acrylic phantom, pencil ionization chamber, and 
electrometer (www.acr.org). 
Use of the DLP value and conversion coefficients (different for each type of scan) is the 
current method of choice for determining the effective dose [72, 85].  In 2000, the 
European Commission published a report which developed a method to convert DLP to 
effective dose.  This method was based off of a study in which compared a wide range of 
effective dose values estimated from the DLP for a wide range of scanners and ICRP 
tissue-weighting coefficients for a series of anatomic regions (head, neck, chest, and 
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abdomen and pelvis).  The method derived a series of coefficients for the conversion of 
DLP to effective dose.  Many manufacturers of CT units now compute and display the DLP 
for each scanning procedure.  Many studies have been performed which assess the validity 
and accuracy [86-88].  Martin et al reports the inherent relative uncertainties in estimating 
effective dose (using organ doses) to a reference patient to be about +/- 40% and should not 
be used to assess an individual patient [89]. 
 
As mentioned above, DLP can be converted to an effective dose via conversion 
coefficients.  These conversion coefficients have been calculated from mathematical 
phantoms representing both adult and pediatric patients.  The below table (Table 2) shows 
the results of a study of patient dose from computed tomography within the United 
Kingdom [90]. 
 
Table 2.  DLP conversion coefficients. Child data normalized to CTDIw measured in the 
16-cm diameter CT dosimetry phantom.  Adult data for head and neck regions is 
normalized to CTDIw in the 16-cm diameter CT dosimetry phantom, with all other regions 
being normalized to a 32-cm diameter CT dosimetry phantom [90]. 
Region of Body 






0 years 1 year 5 years 10 years 
Head 0.011 0.0067 0.0040 0.0032 0.0021 
Neck 0.017 0.012 0.011 0.0079 0.0059 
Chest 0.039 0.026 0.018 0.013 0.014 
Abdomen/Pelvis 0.049 0.030 0.020 0.015 0.015 
 
A survey of how DLP conversion coefficients vary in literature is presented (Table 
3).  Use of DLP conversion coefficients to estimate effective dose should be 
restricted to the same CT machine model, scanning region, and x-ray parameters 
(quality and quantity).  
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B (2004) [91] 
EC Appendix 







Head 0.0021 0.0023 0.0023 0.0021 0.0019 16 
Head and 
Neck 
NA NA NA 0.0031 NA 16 
Neck 0.0048 0.0054 NA 0.0059 0.0051 16 
Chest 0.014 0.017 0.018 0.014 0.0145 32 
Abdomen 0.012 0.015 0.017 0.015 0.0153 32 
Pelvis 0.019 0.019 0.017 0.015 0.0129 32 
CAP NA NA NA 0.015 NA 32 
 
Retrospective Dosimetry 
Performing a retrospective dosimetry study on patients is difficult due to the many different 
variables involved and the rapid evolution of CTs over the past 20 years.  CT evolution has 
focused primarily on how the x-ray tube rotates around the body and image acquisition.  
Early CT machines used a step-and-shoot method which is commonly referred to as axial 
scanning.  This method involved the 360 degree rotation of the x-ray tube along an axial 
plane.  As technology advanced, helical scanning, with the table moving through the x-ray 
tube gantry as the x-ray tube rotates 360 degrees, has become much more prevalent 
resulting in a reduction of dose for the patient.  More recent advances have reduced doses 
even more as “smart” capability has been added to the CT machines.  Smart scanning 
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automatically adjusting the quantity of radiation (mA) based upon the anatomic features 
within the field of view; more dense areas like the pelvic region will have more mA 
whereas less dense areas of the body like the chest region or abdomen region will have less 
mA.  Current estimates of effective dose are listed (Table 4).  
 
Table 4.  CT effective dose estimates for given anatomical regions. 
 
Covered Anatomy Assigned Effective 












Head,Face 2.0 1.5 2.0 1-2 
Cervical Spine, 
Neck 




8.0 5.8 7 5-7 
 
BMI and Effective Dose 
Several studies have explored the relationship of BMI and the signal-to-noise ratio.  As 
body size increases the noise present in an image increases [96].  Therefore, as patient size 
increases, machine parameters (i.e. tube current and tube potential) must also increase in 
order to achieve a diagnostic quality image.  Obese (BMI>30) patients can experience 
higher radiation doses than normal sized patients [72, 85, 97].   
 
Cumulative Dose 
Ultimately, the concern over radiation lies in the not in the production, interaction, or 
benefits, but in how radiation may cause cancer.  Biological Effects of Ionizing Radiation 
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(BEIR) VII predicts a baseline cancer incidence of 42% and a cancer mortality of 20% 
[29].  The current estimated threshold by which an increase in solid cancer incidence risk is 
seen is thought to be between 100 mSv and 150 mSv [98-99].  Although this threshold is 
much higher than any one diagnostic radiology scan, multiple recurrent scans can approach 
this threshold.  Patients who are imaged more frequently have a higher cumulative health 
risk than the typical patient.   
 
Higher radiation doses are definitely of concern when patients experience multiple 
computed tomography scans.  Broder et al [100] estimates that the average renal colic 
patient presenting to an emergency room will experience 2.5 computed tomography scans.  
In a similar study, Katz et al [101] found that 4% of patients with suspected renal colic will 
undergo 3-18 computed tomography scans over a six year observation period.   
 
The advent of computed tomography scanners in emergency rooms is a result of increased 
sensitivity of specific injuries [102].  Patients are undergoing more total body scans which 
are either used to supplement prior normal radiography scans or used as the primary 
diagnostic scanning medium [103].  Huda et al estimates that the average effective dose per 
trauma patient in a Level 1 trauma center emergency room can be as high as 40 mSv [104] 
per visit. Yet once the patient leaves the emergency room, the patient evaluation scanning 
continues. 
 
Kim et al [10] reported that at an urban Level I trauma center, severely injured blunt-
trauma patients (injury severity score greater than 30) accumulated a mean number of 70 
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plain radiographs, approximately 8 computed tomography scans, and almost 3 fluoroscopic 
studies over an average stay of more than 40 days in the surgical intensive care unit.  
Although the quantity of plain radiographs outnumbered the quantity of computed 
tomography scans, the computed tomography scans accounted for the greater portion of the 
overall radiation dose.  Kim estimated that cumulative dose per patient was more than 100 
mSv.  Also noted was the variation in the number of scans each physician ordered due to a 
lack of an institutional policy concerning daily scans for intubated patients.  Noted in the 
article was that dose estimation techniques did not account for variation among the patients 
weight. 
 
Tien et al [105] performed a study in which dosimeters were placed on a trauma patient 
upon presentation to at Level I trauma center in Toronto, Canada.  Study patients were 
separated by injury severity score so a wide variety of patient scores were represented in 
the study.  The mean number of CT scans per patient was approximately 5 and the mean 
number of plain film radiographs was approximately 14.  Tien suggests that approximating 
effective dose by counting radiological procedures underestimates the true dose.  Tien’s 
method of using dosimeters better accounts for the patient dose but the dosimeters were 
superficially located and thus approximations still had to take place to transform the surface 
dose to internal organ doses.  Tien estimated that whereas the cumulative effective dose per 
patient was approximately 23 mSv, the cumulative equivalent dose to the thyroid was over 




Sodickson et al [11] performed a retrospective study at a New England hospital assessing 
the quantity of CTs performed over a 22 year period.  The cohort numbered over 31,000 
patients who underwent a diagnostic CT examination.  33% of the patients underwent more 
than five CT examinations, 5% underwent more than 22 examinations, and 1% underwent 
more than 38 examinations.  In terms of cumulative effective dose, 15% of the patients 
received more than 100 mSv, 4% received over 250 mSv, and 1% received over 399 mSv.  
Most of the recurrent CTs can be explained by the patient’s underlying disease and 
subsequent complications.  However, there were 350 patients with no malignant history.  In 
the sample medical detail provided of these patients, four patients had an abstracted 
medical history similar to a Soldier.  Three of the patients were female (age 49, 53, and 58) 
with recurrent pains in the abdominal and back region.  They experienced an average of 16 
CT exams each (max 18, low 13).  Average number of examinations by regions was 8.33 
for abdominal pelvis, 1 for chest, 1 for head, 4 for spine.  The lifetime attributable risk of 
radiation induced cancer for each of these patients was about 1.4% based upon BEIR VII 
methodologies.  The one male patient with an abstracted medical history similar to a 
Soldier was for alcoholism and frequent trauma.  This patient (53 years old) underwent a 
total of 36 CT examinations with the most frequent region scanned being the head (19) and 
abdomen-pelvis (6).   
 
Diagnostic scanning of Soldiers who have experienced severe trauma doesn’t necessarily 
end upon initial release of the Soldier from the hospital.  Other factors can contribute to 
cumulative doses, i.e. diagnostic scanning for long-term mild traumatic disorders which 
might lead to alcoholism.  Alcohol misuse has been documented among Soldiers returning 
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from OIF and OEF [106-110].  Also widely documented is the link between alcohol use 
following trauma experiences and alcohol use as an initiator of a traumatic experience 
[111-113]. If we use the above mentioned male patient with abstracted medical history of 
alcohol and trauma, the Soldier population is at an increased risk of experiencing recurrent 
CT examinations and thus higher cumulative effective doses.  Foreseeing increased CT 
examinations in the Soldier population is definitely arguable as Soldiers are deploying 
multiple times and have an increased incidence of post traumatic stress [111, 114-119]. 
 
As CT scans are increasingly being used in trauma diagnosis [120-122], our research is 
very appropriate for formulating an improved method that utilizes minimal available 
information, such as patient height and weight and the number and types of CT scans for 
estimating effective doses from different trauma scans.  Additionally, since no two patients 
have the same size and dimensions, patient variability must be considered in developing an 
effective dose paradigm.  In this manner, as individual organ sizes differ [123], better 
estimates of the effective dose can be calculated.   
 
Research Hypothesis 
A patient’s height and weight is correlated with the effective dose from computed 
tomography scans and such a correlation can be used to develop a model which will allow 
for estimating effective dose with minimal information and will result in increased 
accuracy of those estimates than current methods.  Use of current effective dose estimating 
methods (dose-length-product and conversion coefficients) will significantly underestimate 
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the accumulated radiation dose from multiple computed tomography diagnostic trauma 
scans. 
 
Overall layout of the thesis is to investigate five different specific aims.  Each specific aim 
will be a different chapter in the dissertation. Each specific aim chapter will address the 
methodology used to investigate the specific aim. Specific aims will address the evaluation 
of effective dose ranges by CT protocol, development of predictive model, verification of 
predictive model, validation of predictive model against real patient scans, and 
recommendation for the initiation of a systematic long-term Soldier study of multiple 
diagnostic scanning.  The five specific aims are: 
Specific Aim 1:  Evaluate the range of effective doses by CT protocols from literature and 
retrospective patient CT studies. 
Specific Aim 2:  Develop an improved model capable of predicting effective dose based 
upon a patient’s physical characteristics (height and weight). 
Specific Aim 3:  Verify effective dose models by measuring absorbed dose s in organs 
using optically stimulated luminescent dosimetry and anthropomorphic phantoms. 
Specific Aim 4:  Validate the effective dose models against current DLP methods for 
estimating effective doses using a pilot study of representative trauma patient CT scans. 
Specific Aim 5:  Recommend action points for the U.S. Army based upon this research. 
 
Developing an accurate predictive model will allow health professionals to better determine 
the cumulative individual patient dose for low-dose health effect research.  Studying 
cohorts (U.S. Army) that will routinely receive more than 100 mSv (cumulative dose) will 
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allow researchers to establish follow-up methods for future epidemiological studies 
evaluating how medical x-rays and future cancers may be linked.  This research is is 
urgently needed at this time, when the public’s awareness to radiation from computed 
tomography scans is heightened. 
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CHAPTER 3.  Specific Aim 1:  Evaluate the range of effective doses by CT protocols 
from literature and retrospective patient CT studies. 
Statement of the problem: 
Nearly 50% of all injuries to Soldiers in Operation Iraqi Freedom and Operation Enduring 
Freedom were to the head/neck, abdomen, and thorax region of the body [124-126].  There 
are six computed tomography (CT) trauma protocols commonly used to assess and 
diagnose Soldier injuries from blunt trauma.  These protocols are used to image the brain, 
cervical spine, chest, chest abdomen pelvis (whole body), thoracic spine, and lumbar spine.  
Each CT trauma protocol will be evaluated to estimate the effective dose per scan.  The 
effective dose resulting from a CT scan primarily depends upon the location of the scan, the 
scan length, and the x-ray tube current (mA).  Effective doses can vary widely from one 
procedure to the next as a result of differences in machine techniques, x-ray technician set-
up procedures for patient scanning, and variation in patient sizes.   
 
Table 5 lists generally accepted nominal effective doses for common diagnostic 
procedures.  The typical nominal effective dose per CT procedures ranges from 2 mSv (CT 
Head) up to 20 mSv (CT Abdomen and Pelvis) for an average patient (Table 5).  
 
Table 5.  Effective doses for common radiology procedures [127]. 
Radiology Procedure Effective Dose (mSv) Comparison to natural 
background radiation 
Abdominal Region 
  CT-Abdomen and Pelvis 10-20  3-6 yrs 
  CT body 10  3 yrs 
  CT colography 10 3 yrs 
  Intravenous Pylegram 3 1 yr 
  Radiography Lower GI 8 3 yrs 
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  Radiography Upper GI 6 2 yrs 
Bone  
  Radiography Spine 1.5 mSv 6 months 
  Radiography Extremity 0.001 mSv less than 1 day 
Central Nervous System 
  CT Head 2 mSv 8 months 
  CT Spine 6 mSv 2 yrs 
  Myelography 4 mSv 16 months 
Chest Region 
  CT Chest 7 mSv 2 yrs 
  Radiography Chest 0.1 mSv 10 days 
Children's Imaging  
  Voiding Cystourethrogram 5-10 yr old: 1.6 mSv 6 months 
  Infant: 0.8 mSv 3 months 
Face and Neck 
  CT sinuses 0.6 mSv 2 months 
Heart 
  Cardiac CT for Calcium    
  Scoring 
3 mSv 1 yr 
Men's Imaging  
  Bone Densitometry 0.001 mSv less than 1 day 
Women's Imaging  
  Bone Densitometry 0.001 mSv less than 1 day 
  Galactography 0.7 mSv 3 months 
  Hysterosalpingography 1 mSv 4 months 
  Mammography 0.7 mSv 3 months 
 
While nominal values are useful for comparing the expected effective doses between 
typical procedures, they are not specific to the patient.  A method other than the use of a 
look-up table is required to more accurately assess specific patient (or Soldier) effective 
doses (and associated risks) from CT procedures.  Chapter 3 will explore the use of Monte 
Carlo techniques in estimating effective doses, assess the functionality of four different 
Monte Carlo codes commonly used for such a purpose, and evaluate which codes are most 
appropriate for meeting the goals of this present research.  
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Monte Carlo Techniques 
Background 
Over the past forty years, the use of Monte Carlo radiation transport techniques in 
medicine, diagnostic radiology, and radiation therapy has become widespread.  The use of 
computers to model the interaction of photons and electrons with matter enables 
researchers to understand how energy is expected to be deposited in the human body under 
a wide variety of conditions.     
 
In order to identify the most appropriate Monte Carlo code to use for this research, I 
evaluated the historical usage of Monte Carlo codes in estimating radiation doses.  I 
performed this evaluation in a similar manner as that presented by D.W.O. Rogers in his 
review on the past 50 years of Monte Carlo simulations for medical physics [128], I 
performed a search of the Pubmed (http://www.ncbi.nlm.gov/pubmed) database to identify 
how many articles were published in journals since 1970 (Table 6) for the following search 
terms:  Monte Carlo, Therapy, Diagnostic, GEANT, PCXMC, PENELOPE, EGS, and 
MCNP in the Title or the Abstract.  I stratified the search dates into decades.    
 
Table 6.  Results of Pubmed article search related to the use of Monte Carlo techniques 
for radiation transport calculations. 
Decade Diagnostic Therapy GEANT PCXMC PENELOPE EGS/EGSnrc MCNP 
1970-
1979 
4 3 0 0 0 0 0 
1980-
1989 
33 21 0 0 0 0 0 
1990-
1999 
61 174 5 0 2 2 55 
2000-
present 




Perhaps the easiest way to visualize the growth of the use of Monte Carlo techniques within 
the diagnostic and therapy radiation arenas is through the use of a graph (Figure 6).   
 
Figure 5. Graph of published articles concerning the use of Monte 
Carlo codes in medical physics in accordance with the above Pubmed 
database search terms. 
As computer technology has evolved and processing speed has increased, modeling large 
numbers of photon and particle interactions with matter has become easier.  We see that the 
number of articles written about Monte Carlo techniques and radiation therapy has greatly 
increased since the 1980s relating to the rise in radiation therapy for treating cancer.  Monte 
Carlo techniques have also been used to simulate radiation doses from diagnostic imaging 
procedures.   
 
Monte Carlo simulations use stochastic numbers to approximate a deterministic solution.  
This is performed by using random numbers within statistical models which are themselves 
applied to mathematical functions in order to model complex systems.  If enough random 
numbers are used, the functions will then begin to converge upon calculated results that can 
be validated with results obtained through physical experimentation.  Early Monte Carlo 

























improved, unknown deterministic systems were explored.  In this manner, deterministic 
problems were solved by finding a probabilistic analog [129].  This “modern” technique 
was widely used to model neutron propagation through mediums during the Manhattan 
Project.  Researchers use Monte Carlo computational experimentation to understand 
otherwise unfeasible or impractical realistic situations.  The computational time demand is 
high though and powerful computers are needed to not only process the huge amounts of 
information but also achieve faster computational speeds.  Monte Carlo coding is 
dependent upon user input information and models and should be validated when 
applicable to physical experimental results. 
 
Theory 
Most Monte Carlo software codes follow three basic steps: model a system as a probability 
density function, repeatedly sample from the probability density function, and finally, 
tally/compute the statistics of interest (i.e. energy deposition) [130].   In general, photons 
are emitted from a virtual point source into a solid angle defined by the field size and 
distance from the photon source to a mathematical phantom.  The photons are then 
followed as they interact within the phantom according to the probability distribution of the 
primary physical processes that the photons may undergo. At diagnostic energies less than 
150 keV, the primary physical processes are photo-electric absorption, coherent (Rayleigh) 
scattering, and Compton (incoherent) scattering.  The probability distribution which 
governs the interaction possibilities is a measure of the energy of the photon and the atomic 
number of the medium within the phantom.  Energy deposition at each interaction point is 
calculated and recorded.  Photons will continue to be tracked through the different 
interactions until the photon either exits the phantom or loses enough energy that the 
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energy of the photon is less than a lower threshold limit.  Radiation dose in an organ within 
the phantom is calculated as the mean value of all the energy depositions within that organ.  
Central to the Monte Carlo process is the use of random numbers.  The random numbers 
are used for sampling the initial photon direction, distance between interactions, type of 
interacting atom within the phantom, type of interaction (and subsequent energy loss), and 
scattering angle following an interaction.  As one can see, a simulation might involve many 
different probability density functions and summation of huge numbers of recorded events 
along a photon’s track (history) (Figure 6).   
 
Figure 6.  Monte Carlo flowchart for photon energies less than 150 keV.  Random 
numbers are used for sampling initial photon direction, distance between interactions, 
type of interacting atom within the phantom, type of interaction and scattering angle. 
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The relative differences in determining organ and tissue doses from CT scans generally 
result for one of five different areas; organ dimensions, exposure parameters (spectrum and 
geometry), organ distance from the primary beam field of view, limitations of the Monte 
Carlo code concerning the x-ray source and patient modeling characteristics, and how the 
codes deal with basic physics parameters (photon interactions resulting from linear 
attenuation coefficients and elemental compositions). 
 
All Purpose Codes 
I considered two extensively used two all purpose Monte Carlo codes currently being used 
in medical physics, EGS and MCNP.  These codes are extremely powerful and are fully 




EGS (Electron Gamma Shower) is an open source Monte Carlo code distributed, updated, 
and managed by the National Research Council of Canada [131-132]. 
  
EGS is based on a version of the FORTRAN computing code called MORTRAN.  
Originally, developed at Stanford Linear Accelerator Center (SLAC) in the early 1970s, 
EGS was used to study the cascade effect of nuclear disintegrations caused by high-energy 
particles.  The original code accounted for bremsstrahlung, electron-electron scattering, 
ionization-loss, pair production, Compton scattering, and the photoelectric effect.  
Additionally, Coulombic scattering was considered.  However, the lower energy limit was 
0.25 MeV for photons and 1.5 MeV for electrons.  The code, EGS1, was tested and found 
to have good agreement with internal tests at SLAC.  More complex modeling geometries 
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stimulated the advancements of newer versions of EGS.  EGS soon became a program 
made up of many sub-programs and sub-routines.  Improvements were also made for the 
handling of multiple scoring planes in the multiple region structures. The use of EGS for 
medical physics applications emerged with the fourth version of EGS, EGS4.  This version 
of EGS added the capability of radiation transport in any element, compound, or mixture 
with the dynamic energy range being extended down to 1 keV.  Photons and charged 
particles were transported randomly through a medium while undergoing physical 
interactions in accordance with their probability of occurrence in that medium at their 
energy.   
 
Application 
EGSnrc (Electron Gamma Shower National Research Council) is the current version of 
EGS and has been used extensively in medical physics applications.  BEAMnrc, an EGS 
subroutine, has been used extensively to model medical linear accelerators for radiation 
therapy [133-142].  Another subroutine, DOSXYZnrc is used to model radiation internal 
dosimetry [143-144] and brachytherapy [145-148] sources.  The code has been used to 
benchmark treatment planning systems [149-151].  Modeling ionization chambers 
continues to be popular with researchers [152-160].  Most of the referenced applications 
have been associated with megavoltage radiation beams.  Very little research using EGS to 
model low energy radiation beams (diagnostic energies below 140 keV) has been 
performed although cone-beam computed tomography is seeing increased interest [56, 161-





EGS has been widely compared with GEANT4, MCNP, and PENELOPE yielding good 
results [167-169].  EGS claims an advantage over other Monte Carlo codes in terms of 
computation times.  Computation times are a result of the differences between how the 
codes handle the transport of the charged particles.  Numerous studies have been performed 
in the development of EGS ensuring that physical processes are modeled efficiently and 
accurately [170-174].   
 
Computed Tomography Modeling 
Using EGS to model computed tomography beams and the resultant radiation dose is 
somewhat of a new research field.  Previously, EGS subroutines in DOSXYZnrc have been 
written to convert CT images into 3-dimensional voxelized phantoms [175].  This 
technique has proven valuable in understanding dose to specific locations within the body 
and has been used in treatment planning.  Validation of the modeled beam is often 
performed using detectors [176].  MOSFET detectors and thermoluminescent dosimeters 
are commonly used as the comparison base.  Once validated, the code allows for a better 
understanding of how scattered photons contribute to dose.  This can even be performed for 
deforming anatomy, i.e. lungs [161].    Future work in this field looks to develop tools for 
more accurate dose accumulation to a 3-dimensional organ integrated over time.  Modeling 
cone-beam CT units has seen increased research in the areas of pediatric [177] and adult 
imaging [162-163, 178].  In general though, EGS use with CT stems more in the ability of 
creating voxelized phantoms which are then used for input into treatment planning systems.  
Although some research has been performed utilizing EGS as a code for determining 
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Monte Carlo N-Particle (MCNP) transport code was developed by Los Alamos National 
Laboratory in order to develop solutions of radiation transport problems.  MCNP is capable 
of solving transport problems of neutrons, photons, or coupled neutron-photon systems.  
MCNP was originally designed for criticality safety, shielding design, design of nuclear 
instrumentation, calculation of material activations, radiological dose determination, 
spacecraft modeling, nuclear weapons design, and reactor design and analysis[180].   
Similar to other general purpose Monte Carlo codes, a user can supply/define a full input 
file of materials and surfaces for source terms to propagate radiation through.  As the 
radiation interacts with the various media, tallies are generated concerning the deposition of 
energy and histories are kept describing the total amount of energy deposited or transported 
through an area of interest.  The output results provide information concerning the behavior 
of the modeled system. 
 
Application 
Since the inception of MCNP in 1980, the code has been used to extensively in modeling 
medical applications.  The code is widely used in cancer therapy treatment planning, 





MCNP has been compared with GEANT for the purposes of radiation detection efficiency 
[182-183] and low energy neutron transport, shielding, and dose calculations [184].  
Similarly, MCNP and FLUKA have also been used for detector efficiencies and radiation 
transport studies [185-189].  MCNP compares favorably, with less than a 10% statistical 
deviation of the results, with the other Monte Carlo codes. 
Computed Tomography Modeling 
MCNP has been used for many specific applications in computed tomography dose 
modeling.  Tzedakis et al [190-191] used MCNP to model patients of different ages and 
sizes using cylindrical polymethyl-methacrylate (PMMA) phantoms.  MCNP has also been 
used as the primary radiation transport simulation code for addressing absorbed doses from 
CT-SPECT and microCT/PET systems [192].  In comparison research on uterine absorbed 
doses in pregnant women from CT scans, MCNP simulations were validated against a 
deterministic simulation code (TORT 3.2) and achieved agreement within experimental 




Limited functionality or hybrid Monte Carlo programs (e.g. ImPACT and PCXMC) have 
been designed for explicit purposes.  They are highly capable and are based off of the same 
fundamental principles as EGS and MCNP.  However, the limitations generally arise as to 
the energy and type of particle that can be modeled.  In medical physics applications, the 
limitations also involve the phantom used and the most commonly used phantom is a 
mathematical phantom originally designed by Cristy [194].  Although these Monte Carlo 
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programs are not as fully functional as EGS and MCNP, if the researcher’s environment 




ImPACT (Image Performance Assessement of CT scanners) is a widely used Monte Carlo 
based diagnostic radiology software program designed to simulate radiation doses from 
computed tomography machines.  The program was developed by the National Radiation 
Protection Board (NRPB) of England.  It has been used for estimating CT dose conversion 
coefficients [91, 195-198] for many general CT scanning procedures and widely used for 
effective dose estimation in the assessment of radiation dose health risk [67, 74, 101, 199-
203].  At present, ImPACT provides an accepted standard estimate on the effective dose for 
a standard phantom associated with CT scanning protocols. 
 
Purpose 
ImPACT has been designed to specifically simulate photons from CT scanners in order to 
assess the radiation dose to specific organs within a stylized human body for the express 
purpose of estimating the effective dose from the diagnostic radiology CT scan. 
 
Theory 
ImPACT simulates the radiation dose in a mathematical MIRD-style phantom (Figure 7) 
[204].  This “adult” hermaphrodite phantom represents the human body with a variety of 
geometrical shapes.  The different shapes approximate the various shapes and tissue 
densities of human organs and body structures.  Due to the crudeness of the model, the 
program is not intended to provide precise measurements of effective dose.  The program 
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allows the user to select the approximate scanning field of view for a desired CT imaging 
protocol.  In the figure (Figure 7), the red portion represents the scanning field of view 
ranging from a starting point of 72.5 up to an ending point of 89.     
 
Figure 7. Screen shot of the phantom used in the ImPACT software 
program.  The red portion represents the scanning field of view 
ranging from a starting point of 72.5 and having an ending point of 
89. 
User inputs (Figure 8) in the ImPACT program include scanner model information, 
acquisition parameters, and organ weighting scheme selection (ICRP 103 [20]).  Central to 
the program is the ability to match 23 previously coded and calculated Monte Carlo data 
tables (data sets) among the more than 50 different types of CT machines.  The data sets 
were calculated using Monte Carlo methods to model the original CT machines in the 
NRPB survey performed in 1993.  As new CT machines were manufactured an ImPACT 
factor was determined based upon the CTDI measured in air of the new machine compared 
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with the CTDI measured in air of the machines for the already existing data sets.  CTDI 
was used for the matching because it is a simple standardized means to measure the dose 
output from a CT scanner [205].  Therefore, comparisons can be made about the radiation 




Figure 8.  Screen shot of the ImPACT software user input portion.  A 




Based on user inputs, the program calculates the radiation dose to 32 different organs.  
Then, using the appropriate tissue weighting factors, the effective dose is calculated using 
the values from the calculated organ absorbed doses (Figure 9).  
 
Figure 9.  Screen shot of the ImPACT software dose calculation 
portion for the user defined inputs shown in Figure 7.  Remainder 
dose is the mean dose of the remainder organs. 
ImPACT’s simplified user interface combined with the ability to simulate many different 
types of CT machines has resulted in it being one of the primary tools for assessing CT 
effective dose among researchers in the diagnostic imaging field. A major limitation of the 
software is that all calculations are performed with the single mathematical phantom shown 







PCXMC (PC-based program for X-ray Monte Carlo) is a Monte Carlo code originally 
written in 1997 at the Radiation and Nuclear Safety Authority, Finland [206-207].  The 
strengths of the software program are that is allows for computation of organ doses for a 
range of patient sizes and ages linearly interpolating organ sizes from 6 standard 
mathematical phantom representations (newborn, 1 year old, 5 year old, 10 year old, 15 
year old, and adult) of the 1987 Cristy and Eckerman phantom models (modifications were 
made to include extrathoracic airways, oral mucosa, prostate and salivary glands).  Organ 
doses are calculated from user input defining adjustable x-ray projections and examination 
conditions.   
 
Purpose 
The main purpose of the program is to derive the effective dose from projection 
radiography and fluoroscopic procedures.  The effective dose is calculated in accordance 
with ICRP 103 tissue weighting factors and formulism.  Organ doses are calculated relative 
to the incident air kerma at the point where the central axis of the x-ray beam enters the 
patient with the photon paths and interaction calculated using Monte Carlo methodologies.   
 
Theory 
Monte Carlo methodology is used to simulate photon transport and subsequent interactions 
between the photons and matter (Figure 6).  Primary interactions considered are 
photoelectric absorption, coherent (Rayleigh) scattering, and incoherent (Compton) 
scattering.  Photon information is collected at each interaction point as energy is deposited 
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and combined into histories.  The upper limit on the user defined energy of the x-ray beam 
is 150 keV.  Within this range of energies, the kerma in tissues is approximately equivalent 
to the absorbed dose within the same tissues, except at the interface between bone and soft 
tissue [207].  Secondary electrons are approximated to be absorbed at the site of the photon 
interaction within tissue due to the low energy of the secondary electrons and the small 
range.  Dose is calculated from the average values of the energy depositions, obtained from 
the photon histories, in the organs.  Energy spectra are assumed to be an integral of 
monochromatic photons of specific energies up to 150 keV.  The precision of the dose 
estimate increases and the statistical error decreases as the number of initial photons in the 
simulation increases.  Precision is also affected by the organ dose (to low will cause high 
errors) and/or size of the organ. 
 
PCXMC uses a hermaphrodite phantom to calculate the effective dose from a radiology 
procedure.  This differs from ICRP 103 methodology for effective dose in that ICRP 103 
defines the effective dose within separate reference male and female phantoms, where the 
equivalent organ dose is averaged and the effective dose is a weighted sum of the sex 
averaged organ doses [207].  Since PCXMC utilizes one hermaphrodite phantom, there is 
no need to perform sex averaging for the organ doses.  
 
PCXMC allows for the user to vary the shape of the mathematical phantoms by changing 
the height and weight.  The ability to change the shape of the mathematical phantom by 
changing the height and weight cannot be over-emphasized.  It is well known that as the 
human body grows from infancy through adulthood, organs also grow.  However, some 
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organ weights also change as an adult’s total body weight increases.  In an autopsy study 
performed measuring organ sizes and mass for bodies of different ages, heights, weights, 
and race, Young et al [208] determined that certain organs and their associated dimensions 
change as a person grows.  For example, the female kidneys will increase in mass as the 
total body weight increases up to 200 kg.  Similarly, the lung mass changes increases as the 
body weight increases up to 150 kg and the thyroid mass increases as the body weight 
increases up to 125 kg.  There are six standard phantoms which PCXMC uses as the base 
for the variation (Table 7). 
 























Newborn 3.40 50.90 21.60 9.80 10.94 12.70 16.80 
1 year old 9.20 74.40 30.70 13.00 15.12 17.60 26.50 
5 year old 19.00 109.10 40.80 15.00 19.64 22.90 48.00 
10 year old 32.40 139.80 50.80 16.80 23.84 27.80 66.00 
15 year old 56.30 168.10 63.10 19.60 29.66 34.50 78.00 
Adult 73.20 178.60 70.00 20.00 34.40 40.00 80.00 
 
As the user changes the height and weight of the phantom within PCXMC (Figure 10), the 
program calculates scaling factors in accordance with the primary phantom dimensions.  




Figure 10. Screen shot of the examination input window for PCXMC. The red box on the 
stylized phantom represents the scan field of view. 
Validation of Limited Functionality Codes 
Mathematical phantoms are used to provide flexibility in phantom design but may result in 
anatomical descriptions that are not very realistic.  Comparison of recent software 
programs that may utilize more representative human phantoms (anthropomorphic) has 
been performed and has shown good agreement with PCXMC [61, 209] and ImPACT [46, 
67, 210]. Such voxel image-based phantoms are more realistic anatomically but are limited 
in the flexibility of organ placement, shape, position, depth, and posture.  University of 
Florida is beginning to use computational phantoms that utilize the best characteristics of 
the mathematical and voxel phantoms.  This new class of phantoms is called a hybrid 
computational phantom [144, 211], but are not yet generally available to the research 




ImPACT has been validated against EGS for new voxel phantom based dose assessment 
[52, 77].  Comparisons to CT scans often used in trauma diagnosis offer good agreement 
between the mathematical phantom of ImPACT and voxel phantom calculations; between -
6 to 11% for chest scans, -22 to -1% for abdomen chest scans, and -4 to 11% for pelvis 
chest scans.   
 
Although PCXMC is primarily designed for projection radiography, it has been used to 
calculate effective doses from scan projection radiography and tomosynthesis procedures 
where radiographic examinations are taken on a patient from the posterior-anterior (PA) 
and left lateral (LLAT) sides [212]. It has also been used to compare CT and conventional 
radiography doses from assessment of patients with arthrodesis [213].  In addition, 
comparisons have also been performed in order to assess absorbed doses in cardiac 
angiography from C-Arm computed tomography machines.  Current literature shows that a 
CT rotation can be effectively modeled by using multiple projections per slice [36, 203, 
214-215].   
 
Software Decision 
There are many different CT machines being utilized in the Army (Table 8).  These 
machines are not only being used at fixed facilities but also in close proximity to the 
battlefield.  As a result, a Soldier that is scanned at different facilities might be scanned 
with a different machine each time.  Therefore, a predictive model seeking to estimate the 
radiation dose from a procedure should be capable of estimating the effective dose for each 
trauma scanning protocol for a wide variety of different CT machines.  The predictive 
model should also be capable of predicting the effective dose for a wide variety of patient 
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types.  For this reason, I chose to use limited functionality Monte Carlo programs in order 
to formulate the predictive model.  Use of EGS or MCNP would require knowledge of 
specific machine dimensions and proprietary information concerning the systems involved 
in the radiation delivery.  In addition, such models would be machine specific and would 
not be capable of predicting dose across the wide variety of machines in use by the Army.  
Therefore, in developing my effective dose predictive model, I will utilize PCXMC 
(allowing for varying patient heights and weights) with the results being compared against 
ImPACT and with direct measurements (see chapter 5).  
 
Table 8.  Survey sample of the different computed tomography machines in use at Army 
medical facilities. 
Manufacturer Type Different Army Locations 
GE 
LightSpeed 16 3 
LightSpeed VCT 64 Slice 1 
Discovery DST PET/CT 1 
LightSpeed VCT 1 (2 at this location) 
LightSpeed Plus 1 
LightSpeed RT 1 
Toshiba Aquilion 64 4  
Philips 
ACQSim 1 
Brilliance Big Bore 16 3 
Brilliance EXP 1 
MX8000 1 
Siemens 
Somatom Definition 1 
Symbia T6 SPECT-CT 1 
Biograph PET-CT 1 









Protocol Specific Effective Dose 
In order to determine the effective dose for a given CT procedure, a retrospective study was 
conducted within the Memorial Sloan-Kettering Cancer Center patient archiving and 
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communication system (PACS) under an approved Institutional Review Board (Table 9). 
The purpose of the study was to collect real patient retrospective data (CTDIvol, DLP, 
machine type, and scan range) on at least 30 patients for input into the ImPACT software in 
order to provide an additional comparison for the PCXMC results. 
 
Table 9.  Summary of retrospective PACS study for determining appropriate inputs in 
ImPACT software. 
Procedure Number 






















Brain Scan 71 GE 
LightSpeed 
16 







































Chest Scan 32 GE 
LightSpeed 
16 











53  GE 
LightSpeed 
16 
























The PACS database patient information was randomly collected and filtered only by CT 
scan type.  The majority of the CT machines are manufactured by General Electric 
(General Electric Healthcare, Waukesha, Wisconsin) and the most common model being 
the GE LightSpeed 16.  This type is also the CT system on which the anthropomorphic 
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verification study (Specific Aim 3) will be performed.  Although there are some apparent 
differences (mean ages and amount of muscle mass per patient) between the MSKCC 
patient population and the U.S. Army Soldier population, the two populations can be 
compared against each other since CT scanning fields of view are set based upon 
anatomical landmarks [216].  The variation of patient height is seen in the variation of the 





 quartile range is the brain scan (8.5%) and the most variation occurs 
with the lumbar scan (31%).  Arguably the most common CT scan for trauma protocols, 




 Quartile) in the 
scanning range.  However, this scan will also be affected the most by patient height when 
comparing the minimum range (18.38 cm) and the maximum range (90.33 cm) to other 
scanning lengths.   
 
As discussed previously in Chapter 2, CTDIvol is a machine specific parameter that can be 
used to evaluate the machine produced radiation dose characteristics in a quality assurance 
quality control phantom using a 100-mm detector.  This parameter allows for radiation 
dose comparisons to be made among different types of CT machines.   CTDIvol multiplied 
by the scanning length results in the dose-length-product (DLP).  The mean of the PACS 
reported DLP for each CT protocol is compared against the ImPACT calculated DLP when 




The inputs for ImPACT are listed below (Table 10).  These inputs were physician verified 
(Dr. Raymond Thornton, Department of Radiology, MSKCC) and compared with the 
patient images in PACS. 
 
Table 10.  ImPACT inputs based upon PACS data (most common CT model is the GE 
Lightspeed 16) and physician input.  












CTDIvol nCTDIw DLP 
Brain  120 Head 78 94 155 2 1.375 10 43.3 19.2 693 
Cervical 
Spine  
120 Head 64 87 155 1 1.375 10 26.1 23.2 600 
CAP  120 Body 5 75 300 1 1.375 20 15.1 6.9 1054 
Chest  120 Body 33 72 270 1 1.375 20 12.2 6.2 475 
Thoracic 
Spine  
120 Body 37 72 270 1 1.375 20 27.9 14.2 976 
Lumbar 
Spine  
120 Body 17 48 270 1 1.375 20 28.1 14.3 870 
 
Representative scans are shown below comparing an actual patient scan with the scanning 
field of view inputted into ImPACT (Figure 11). 
a.   b.   
c.  d.  
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e.  f.     
g.  h.       
i.  j.   
k.  l.        
Figure 11.  Representative Scans.  Brain Scan (Figure 11a and Figure 
11b (ImPACT)). Cervical Spine Scan (Figure 11c and Figure 11d 
(ImPACT)).  Chest Abdomen Pelvis Scan (Figure 11e and Figure 11f 
(ImPACT)). Chest Scan (Figure 11g and Figure 11h (ImPACT)). 
Thoracic Spine Scan (Figure 11i and Figure 11j (ImPACT)). Lumbar 
Spine Scan (Figure 11k and Figure 11l (ImPACT)). 
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Table 11.  Comparison between ImPACT DLP values and the mean DLP values from the 
patient retrospective PACS study. 
Procedure ImPACT DLP value 
(mGy cm) 
Mean Study DLP 




Brain Scan 693 679.11 2% 
Cervical Spine Scan 600 617.91 3% 
Chest Abdomen 
Pelvis Scan 
1054 1015.90 4% 
Chest Scan 475 470.70 1% 
Thoracic Spine Scan 976 972.50 0.4% 
Lumbar Spine Scan 870 842.90 3% 
 
Since the difference between the DLP values are so small, the effective dose calculation in 
ImPACT will adequately describe the effective dose for the patient retrospective PACS 
study and can be used as a representation of the expected effective dose for each of the six 
trauma protocols (Table 11).  Note that the effective doses are within the NRCP 160 range 
for the listed scans (Table 12).  Effective dose for the chest abdomen pelvis scan from 
ImPACT is slightly higher than the listed NCRP 160 effective dose for an abdomen/pelvis 
scan.  This is a result of the slightly longer scanning range (therefore more organs directly 
in the scanning field of view) of the chest abdomen pelvis scan than for the shorter 
scanning range of an abdomen pelvis scan. 
 
Table 12.  Effective dose per trauma protocol as calculated in ImPACT and reported in 
the NCRP Report 160 [14]. 
Procedure Effective Dose (mSv) Effective Dose (mSv) 
NCRP 160 [14] 
Brain Scan 1.7 0.9 – 4 Head Scan 
Cervical Spine Scan 2.4 Not listed 




Chest Scan 15 4 – 18 Chest Scan 
Thoracic Spine Scan 13 Not listed 
Lumbar Spine Scan 11 Not listed 
 
Conclusion 
Monte Carlo programs investigate the deposition of energy (dose) in the human body from 
radiative particles.  Many Monte Carlo programs are fully functional for modeling the 
transport of particles through a plethora of different mediums.  Some Monte Carlo 
programs while more limited in functionality, are still quite capable of investigating 
radiation dose albeit in a more limited environment.  Although EGS and MCNP are 
extremely powerful Monte Carlo programs, each CT machine type would have to be 
individually designed and modeled prior to full characterization and validation against a 
physical machine.  While this is certainly doable over a long period of research time (many 
years), this is impractical for the purposes of this research.  Therefore, due to the wide 
variety of CT machine types and manufacturers currently being used in the throughout the 
U.S. Army medical facilities, the decision was made to use a limited functionality Monte 
Carlo program specifically designed to assess only CT scans but capable of modeling the 
radiation dose from over 50 CT machines.  Since many conversion coefficients are based 
upon the ImPACT software, the ImPACT effective dose calculations are useful for 
comparing against my predictive model effective dose per trauma procedure results.  User 
inputs into the ImPACT software were determined based upon a retrospective CT study of 
patient scans and CT scanning parameters in the Memorial Sloan-Kettering Cancer Center 
patient archiving and communication system (Brain Scan, Cervical Spine Scan, Chest 
Abdomen Pelvis Scan, Chest Scan, Thoracic Spine Scan, and Lumbar Spine Scan).  When 
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the effective dose calculated by the software was compared against accepted values (NCRP 
160), all values were within acceptable ranges (Table 12).  Since the ImPACT software 
only models the effective dose based upon a single mathematical phantom in which patient 
dimensions (i.e. height and weight) cannot be varied, another Monte Carlo program 
(PCXMC) will be used to build a predictive model with which the effective dose from the 
six trauma scans can be determined based upon a patient’s height and weight at the time of 
the scan (Chapter 4).  
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CHAPTER 4.  Specific Aim 2:  Develop an improved model capable of predicting 
effective dose based upon a patient’s physical characteristics (height and weight). 
 
Introduction 
This chapter will address the development of effective dose estimation models to be used 
for the six different computed tomography (CT) trauma protocols discussed in the previous 
chapter (Chapter 3).  The models will be developed from Monte Carlo simulations 
performed with mathematical phantoms with physical parameters common with Soldiers. 
  
Current methods for determining the effective dose require knowledge of the CT machine’s 
output (dose-length-product, CTDIvol, etc.) [67, 86, 203].  The machine’s output is then 
converted to effective dose via use of a conversion coefficient developed for a specific 
scanning area.  However, computing the effective dose without knowledge of the CT 
machine output is difficult and radiation professionals will often utilize National Council 
on Radiation Protection and Measurements (NCRP) general estimates which have a wide 
range and only are applicable for a few specific procedures [14].  While useful for general 
comparisons, application of these effective doses do not allow for patient specificity 
required to track cumulative radiation doses from multiple procedures.  In order to track 
cumulative radiation from CT trauma protocols, a more patient specific methodology needs 
to be developed. 
 
The U.S. Army requires that each Soldier complete a physical fitness test twice a year.  The 
test measures upper body fitness (push-ups), lower body fitness (sit-ups), and lung stamina 
(two-mile run).  An additional component of the physical fitness test is determining 
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whether or not a Soldier meets certain body fat standards determined by measuring the 
Soldier’s height, weight, and age.  For Soldiers that do not meet the body fat number in 
accordance with their age, more advanced body fat measurements are performed beyond 
simple height/weight measurements.   The U.S. Army therefore is indirectly tracking, on a 
semi-annual basis, how a Soldier’s height and weight changes from the initial date of entry 
into military service.  U.S. Army Soldiers are generally within 18 – 45 years old and can be 
thought of as young, healthy, and physically fit [13, 217]. 
 
The development of the methodology for the six previously mentioned CT trauma 
protocols (Brain, Cervical Spine, Chest/Abdomen/Pelvis, Chest, Thoracic Spine, and 
Lumbar Spine) will be based upon a patient’s height and weight.  Therefore, patient 
parameters (height and weight) appropriate for a typical U.S. Army Soldier population will 
be used as inputs into the PCXMC Monte Carlo code for effective dose determination.  
Regression analysis will then be used to develop the mathematical model capable of 




In order to ascertain the ranges of heights and weights for the typical U.S. Army Soldier 
population, research was conducted using Body Mass Index (BMI).  BMI is a common 
parameter used in epidemiology studies and is calculated according the below algorithm. 




           





The Center for Disease Control (CDC) separates BMI into four separate categories and 
defines a generalized health indicator (Table 13). 
 
Table 13.  CDC Body Mass Indicator (BMI) table. 
BMI Definition 
< 18.5 Underweight 
18.5 – 24.9 Normal 
25.0 – 29.9 Overweight 
> 30.0 Obese 
 
BMI indirectly measures the overall size of the human body, thus individual organ sizes, 
and can be an effective indicator as to how much radiation dose a body organ will receive 
during a diagnostic imaging procedure [208, 218].  Even though BMI is limited by being 
unable to differentiate between the measures of fat content a person possesses as opposed 
to muscle mass.  BMI measures relative weight to height and will differ between race and 
gender.  BMI doesn’t however differentiate between a physically fit person with a high 
BMI (for example a Soldier that is very physically fit and muscular with a high body mass) 
and a person who is not physically fit but with the same BMI.  The U.S. Army population 
can be considered a physically fit population.  However, BMI has been used as a 
mechanism for determining radiation dose. 
 
BMI has been correlated to radiation dose for many radiology procedures [85, 219-227] 
and has been primarily used for cardiac procedures.  As the patient’s BMI increases, the x-
ray tube output must also increase in order to maintain an acceptable image noise level and 
compensate for the increased tissue thickness.  Since the tube output is a factor of the 
overall radiation dose, the radiation dose increases proportionally.  The size of a person 
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affects the x-ray tube output and thus has an overall effect on the amount of radiation 
absorbed in the body [219, 224].   
 
There is currently no known research on correlating BMI to the effective dose from CT 
trauma protocols.  This research will address this knowledge gap. 
 
U.S. Army Soldiers are primarily in the Normal and Overweight category.  One will 
initially think that a Soldier’s BMI will vary according to the job with active jobs (Infantry, 
Special Forces, etc.) having a BMI much less than a Soldier with more of administrative 
job.  However, across the spectrum of jobs (combat-related, combat support, or combat 
service support) the BMI is generally the same (Table 14).  This is a result of the younger 
more active Soldiers having a higher degree of muscle mass and less fat as opposed to an 
older Soldier, who is less active, more likely to be in an administrative position, having less 
muscle mass, more fat, and therefore a similar BMI.  For example, a study performed by 
Reynolds et al [228] looking into injuries and risk factors from a 100-mile road march 
found that 218 Soldiers (average age 21.4 years old) participating in the study, had a mean 
BMI of 24.5 +/- 2.6 (median = 24.1).  A similar unpublished study performed by the author 
looking into Soldier cholesterol levels with 62 Soldiers (average age 43.5 years old) at a 
major command headquarters, found a mean BMI of 26.1 +/- 3 (median = 26.1).  Another 
study showed that regardless of Army specialty, BMI is similar throughout the Army 






Table 14.  Summary of studies showing how BMI is similar across the age groups in the 
Army regardless of job performed. 
Study Participant Type Number Age (std dev) BMI 
Reynolds, 1999 Infantry 218 21.4 24.5 (2.6) 
Prins (Unpublished) Administrative 62 43.5 (7.7) 26.1 (3.0) 
Reynolds, 2009 
Infantry 181 21.2 (1.4) 23.8 (2.5) 
Construction 
Engineers 
125 24.1 (5.5) 25.5 (2.6) 
Combat Artillery 188 26.6 (6.0) 25.5 (4.0) 
Special Forces 162 30.5 (6.0) 25.9 (2.8) 
 
There are many arguments against using BMI as a predictor of body fat.  BMI 
overestimates the body fat of members of a population who are athletes and/or body 
builders.  BMI can also underestimate the body fat of other members of a population who 
are elderly.  Therefore, my new research methodology, henceforth to be called the Ht/Wt 
model, used BMI as a means of determining the height and weight of the theoretical U.S. 
Army population.  The Ht/Wt methodology was based upon BMI’s ranging from 18 
(underweight) to 36 (obese).  Corresponding heights and weights were calculated from the 
BMI values.  One hundred hermaphrodite phantoms were developed for use in PCXMC 
simulating heights ranging from 5 feet 1 inch up to 6 feet 7 inches.  Phantom weights 
ranged from 95 pounds up to 317 pounds.  As can be observed in Table 15, the 
methodology for determining the number of phantoms of varying height and weight 
follows commonly used guidelines of ten observations for each predictor [230-231].  
Extreme values are rare in a typical U.S. Army Soldier population.  Table 15 shows the 
height/weight values for each of the 100 hermaphrodite phantoms and also shows how a 





Table 15.  100 hermaphrodite phantoms based upon each BMI value. 
 Body Mass Index (kg/cm
2
)  
















160 46 51 56 61 67 72 77 82 87 92 
165 49 54 60 65 71 76 82 87 93 98 
170 52 58 64 69 75 81 87 92 98 104 
175 55 61 67 74 80 86 92 98 104 110 
180 58 65 71 78 84 91 97 104 110 117 
185 62 68 75 82 89 96 103 110 116 123 
190 65 72 79 87 94 101 108 116 123 130 
195 68 76 84 91 99 106 114 122 129 137 
200 72 80 88 96 104 112 120 128 136 144 
 
Figure 12 depicts how the phantom population varies when height is plotted versus 
weight.  The phantoms were purposefully developed so that each BMI value is 





Figure 12.  Phantom patient parameters.  Vertical groups indicate 
single BMI values where height is held constant and weight varies. 
Based upon the inputted height and weight, PCXMC scales the hermaphrodite 
mathematical phantom with a linear scaling factor for height (equation 10) and width 
(equation 11) [232].  
   
 
  
                                                                 10 
and  
     
   
   
                                                              11 
M is the user inputted mass of the phantom.  All phantom dimensions are scaled according 
to the two above equations and organ masses are linearly changed as a result. Figure 13 
shows a typical size progression where the mathematical phantom depicts different 




a.  b. c. d.  
Figure 13.  Varying phantom dimensions.  Figure 13a has dimensions of 175 cm and 40 
kg.  Figure 13b has dimensions of 175 cm and 60 kg.  Figure 13c has dimensions of 175 
cm and 80 kg. Figure 13d has dimensions of 175 cm and 110 kg. 
A radiologist (Raymond Thornton, MD, Memorial Sloan-Kettering Cancer Center) assisted 
with determining the scanning ranges (upper and lower anatomical limits) for each of the 
six trauma protocols.  This was compared against the field of view of real patient scans 
viewed in the PACS database.  The scanning field of view for six trauma protocols (brain 
scan, cervical spine scan, chest abdomen pelvis scan, chest scan, thoracic spine scan, and 





14c.    
14d.  
14e.  
 14f.  
Figure 14.  Six trauma protocols ((14a) Brain Scan, (14b) Cervical 
Spine Scan, (14c) Chest Abdomen Pelvis Scan, (14d) Chest Scan, 
(14e) Thoracic Spine Scan, (14f) Lumbar Spine Scan) are presented 
with the left hand picture showing a representative patient scan, top 
right figure showing a depiction of the ImPACT phantom, and 
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bottom right two figures showing an anterior-posterior view and right 
lateral view of the PCXMC phantom.  
Four projections (anterior posterior (AP), posterior anterior (PA), right lateral (RLAT), 
and left lateral (LLAT)) simulating a 360 degree exposure were used to model a CT 
machine with PCXMC (Figure 15).  Each projection has the same slice thickness as the 
desired CT axial slice.  Although theoretically a researcher can use as many projections as 
they wish (for example 16 projections per slice), dose accumulation in that slice increases 
drastically.  In order to equate the total effective dose (as calculated by PCXMC) to the 
effective dose as calculated by our accepted standard (ImPACT), calibration factors are 
determined and applied for the specific phantoms (height, weight, and machine output 
parameters).  Calibration factors are a function of the number of projections.  The 
decision was made to use the four projections described above in keeping with other 
published literature [214].  
 
 
   




The x-ray spectrum was modeled based upon the most common CT machine in use at 
Memorial Sloan-Kettering Cancer Center, the General Electric (GE) LightSpeed 16.  This 
same machine will be used to verify the code values.  The GE LightSpeed 16 scans all 
patients at a focus-to-skin distance (FSD) of 54.1 cm.  In accordance with appropriate 
protocols, all scans are performed at an x-ray tube energy potential of 120 kVp.  The half-
value layer of a scan about the body is 7.4-mm aluminum and the half-value layer of a scan 
about the head is 6.3-mm aluminum.  The anode target angle is 7-degrees.   
 
Entrance air kerma (air kerma measured at the surface of the phantom) values for each 
projection were obtained from the scans of an anthropomorphic phantom using detectors 
(Unfors PSD-4, SN; 162351, calibration date: 2010-01-11) placed at the center point of 
each scanning field-of-view at the anterior-posterior (AP), posterior-anterior (PA), left 
lateral (LLAT), and right lateral (RLAT) positions on the anthropomorphic phantom.  
Entrance air kerma values are listed in Table 16.  
 
Table 16.  Measured Entrance air kerma value (mGy) by scanning procedure for input 
into PCXMC. 
Entrance Air Kerma (mGy)  
Scanning 
Procedure 
Patient LLAT Patient PA Patient RLAT Patient PA 
Brain Scan 30.98 41.38 32.59 32.06 
Cervical Spine 19.90 22.95 27.92 22.25 
Ch/Ab/Pel 13.40 21.11 15.07 13.75 
Chest 13.10 29.52 16.70 19.73 
Thoracic Spine 6.22 6.75 6.83 7.88 
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Lumbar Spine 17.00 10.69 11.39 9.99 
 
 
Variation in the EAK value by location is expected since the x-ray tube is rotating prior 
to initiation and the exact location of the x-ray tube upon activation is unknown.  The 
variation in the EAK value is also a function of the x-ray tube current modulation 
adjusting for the various thicknesses of material (body, table, etc.) between the x-ray tube 
and the detectors.  Change in x-ray tube position also results in variation of the entrance 
radiation dose along the z-direction for contiguous axial and helical scans.  
Measurements of entrance dose will be subject to entrance, exit, and scattered radiation 
or a combination depending upon where the entrance point is measured and the angle of 
the x-ray tube relative to the entrance point of the radiation beam on the patient.  
Comparison of the effective dose from the methodology will need to be made with the 
accepted standard method which does allow for changes in pitch [48].   
 
The number of photons simulated by the Monte Carlo process is important.  As the 
number of photons is increased, the Monte Carlo results will begin to approach physical 
results.  However, there is a tradeoff between the number of photons and the increased 
computer time needed to perform the calculations. The goal is to balance the amount of 
photons with the computer time needed for calculations while minimizing the statistical 
error in the results.  Published research has shown that simulations of 20,000 photons per 
scanning projection within the PCXMC code is adequate for estimating absorbed dose to 
tissues and organs and achieves an accuracy in tube output of within ±4% [36].  
Increasing the number of photons results in an overall increase of computer time from 
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days to weeks for each simulation run with only a minimal gain in percent error in 
estimated accuracy.  The percent error was accounted for in the overall sensitivity study.     
 
Reference Specific Aim 1, ImPACT is used as the “accepted standard” to compare the 
PCXMC results against.  Calibration factors (Table 17) were calculated in order to 
correct for differences between using four projection methodology (AP, PA, LLAT, 
RLAT) and continuous axial scanning.  Each calibration factor was calculated based 
upon the comparison of reference phantom within ImPACT to the mean phantom results 
within PCXMC.  In general, good agreement without the calibration factor exists for the 
cervical spine scan (within 10%), chest abdomen pelvis scan (within 10%), and chest 
scan (within 30%).  The calculated calibration factor is then applied to each of the 100 
phantoms prior to regression analysis. 
 
Table 17.  Initial calculation of effective doses by accepted standard Monte Carlo 
program (ImPACT) and model methodology.  Correction factors are presented in order to 
account for differences in the way the effective doses are calculated for the axial scans. 
Scan Initial Model Mean 
Effective Dose (mSv) 
Accepted Standard 
Effective Dose (mSv) 
Calibration Factor 
Brain 0.809 1.7 2.1 
Cervical Spine 2.223 2.4 1.08 
CAP 27.57 27 0.98 
Chest 19.80 15 0.76 
Thoracic Spine 5.975 13 2.2 




Regression analysis was conducted to describe the relationship between patient 
dimensions (height and weight) and radiation effective dose.  Linear regression is 
possible because effective dose (predicted outcome variable) is continuous.  R is very 
powerful and capable of performing all the necessary regression studies.  Regression 
analysis was performed using the open source statistical program R (www.r-project.org/).  
An R subcode, RExcel, was used to perform all R coding through Microsoft Excel.  A 
sample of the regression language is below.  
 




Microsoft Access was used to manage the PCXMC output and perform necessary 
database functions such as record consolidation and simple calculations prior to exporting 
data into Microsoft Excel for analysis by R. 
 
Overall size of the patient has an effect on the effective dose.  Perisinakis et al [46] used 
MCNP and ImPACT to study the effect of increasing BMI for contiguous axial CT exams 
and found that as the BMI increased, normalized effective dose values from contiguous 
axial CT exams decrease.  My mathematical models for determining the effective dose 
from trauma scans confirms the relationship between BMI and effective dose.  DeMarco et 
al [233] observed similar negative trends and attributed the negative trend to the protection 
nature of an increasing patient trunk size covering the radiosensitive tissues beneath for 
individuals with a high BMI.  The negative trend will hold true when machine technique 
factors are held constant between patients of varying BMI.  However, when the tube 
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current is allowed to modulate, the effective dose is directly related to an increase in the 
BMI.  This is due to the increasing tube current attempting to ensure that the image noise 
level remains constant for the same diagnostic quality.  Because the absorbed dose to an 
organ is also directly related to the tube current, as the tube current increases, so does the 
overall effective dose from the scan [233]. 
 
In order to account for uncertainties in the Ht/Wt model development, an analysis has been 
performed following previous published literature describing sensitivities in medical 
physics [198, 234-236].  The sensitivity tables presented in the results section of this 
chapter account for the sensitivity of each portion of the overall radiation absorbed by 
accounting for the error in the measurement (u) or the device output and determining the 
sensitivity coefficient of the error on the measurement (c).  This methodology as outlined 
for each component below is explicitly covered in an article by Gregory et al [236].  The 
methodology has subsequently been adapted for each individual trauma protocol.   
 
Initial sensitivity components involve characteristics of the CT scanner.  CT scanner 
sensitivities are published in the manufacturer documentation accompanying the machine.  
Very strict regulations govern the variance of the radiation output [237].   
a. Tube Current – typical variance by manufacturer specifications is +/- 
5%.  This error estimate is assumed to represent the true value within a 
95% confidence interval.  In this case, u = a/2.  So that u = 5/2.  Therefore 
+/- 5% is considered +/-2u so the uncertainty, u, is 2.5%.  The sensitivity 
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coefficient, c, is estimated at 1 since a change in the tube current will 
realize an equal change in the effective dose.  
b. Exposure Time – Manufacturer specifications states +/-5%.   Therefore, u 
= 2.5 and c=1 
c. Tube Voltage - Patient effective dose varies with the tube voltage as a 
power function,          .  According to the manufacturer’s 
specification, tube voltage can vary by +/- 3%.  Therefore, u = 1.5 and c = 
2.5, (the effective dose difference between 120 kVp and 123.6 kVp is 
approximately 8 % lower as the voltage is raised by 3%, therefore if the 
voltage is raised by 1%, then the effective dose difference will be 
approximately 2.5%. 
d. Slice Width/Table Movement - Manufacturer specifications are generally 
within +/- 2 mm.  GE LightSpeed 16 is +/- 1mm.  Therefore the u = 0.5.  
In accordance with CTDosimetry (ImPACT), a 0.5 mm shift will cause a 
change of less than 0.1%.  Therefore c = 0.1 
e. CTDIair displayed/tabulated – If the user does not specifically define 
the CTDIair, ImPACT uses preset tabular values.  These values are based 
upon reported measurements in a survey that was sent out by Shrimpton 
[90, 238].  As mentioned in Gregory  [198], the reported standard 
deviation was 12%.  Manufacturer specifications for the normalized 
weighted CT dose index state that scanners of a particular model should 
not differ by more than +/-20% [239]. 
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f. CTDIair measured – User measured values are considered to be a better 
estimate of the CTDIair.  Assuming that the measurement device is 
capable of measuring the CTDIair within +/- 5%, then u = 2.5%. 
 
The next group of sensitivity components accounts for the modeling of the x-ray 
production by the Monte Carlo codes. 
 
g. Monte Carlo Modeling – Monte Carlo modeling is widely used to assess 
absorbed dose in diagnostic imaging and radiation therapy.  In radiation 
therapy, Monte Carlo modeling is capable of predicting dose within 5% of 
the delivered value.  Even though radiation therapy energies are much 
higher than diagnostic energies, the same physical principles apply to 
diagnostic imaging where Monte Carlo calculations are not as accurate.  
Because of the widespread use of Monte Carlo codes, I went with the 
value listed in Gregory [198], u = 2%. 
h. Photon Spectrum Modeling – Gregory [198] states that photon 
spectrums in a comparison study have the greatest difference, 2%, with 
chest and abdominal studies and most other studies do not differ by more 
than 1%.  Therefore,for head and cervical spine studies, u = 1% and for all 
other studies in this research, u= 2%. 
i. Table Attenuation – For model development, the entrance air kerma 
(EAK) was measured for each trauma scan using an anthropomorphic 
phantom (Table 19).  Table attenuation is a factor in the variance of the 
81 
 
tube current and was measured in the entrance air kerma (EAK) study.  
Listed in the table below are the EAK values.  EAK was measured on the 
center point of the scanning range at four different locations (AP, PA, 
LATR, LATL). 
Table 18.  Measured EAK values. 




Patient LATR Patient 
PA 
Average 
Brain Scan 30.98 41.38 32.59 32.06 34.76 +/- 13% 
Cervical Spine 19.90 22.95 27.92 22.25 23.62 +/- 13% 
Ch/Ab/Pel 13.40 21.11 15.07 13.75 16.44 +/- 20% 
Chest 13.10 29.52 16.70 19.73 21.65 +/- 30% 
Thoracic Spine 6.22 6.75 6.83 7.88 6.97 +/- 9% 
Lumbar Spine 17.00 10.69 11.39 9.99 12.90 +/- 23% 
 
j. HVL – There is +/- 10% in half-value-layer value among manufacturer’s.  
With the GE LightSpeed 16 model, the HVL is 7.4 mmAl for a body scan 
and 6.3 mmAl for a head scan (both scans at 120 kVp).  Gregory [198] 
assumes that the range in HVL among manufacturer’s represents 3 
standard deviations.  Therefore, u = 10/3=3.3.  He also sets the sensitivity 
coefficient, c, at 0.6. 
k. Anode Angle – Anode angles vary by manufacturer and are often 
proprietary information.  A sensitivity study was performed to determine 
how the anode angle affected the overall effective dose.  There was an 
overall 8% difference (greatest angle to smallest angle).  An inverse 
relationship was noted between the increasing anode angle and effective 
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dose.  Therefore, assuming that most anode angles are between 7 degrees 
and 16 degrees, then the uncertainty percentage, u, is 8/2 = 4 with a 
sensitivity coefficient, c, set at 1. 
 
Each Monte Carlo program requires the user to input an initial estimate of the incoming 
radiation.  Therefore, the next group of sensitivity components involves the dose input. 
 
l. EAK Matching – for Model development, entrance air kerma (EAK) 
(mGy) was used as the dose input value.  Uncertainty is % error / 2 (from 
the above table).  All values were measured by a Unfors PSD-4 detector 
which was calibrated by the manufacturer.  These devices adhere to the 
radiation device measurement specifications.  Therefore, u=2.5 and c = 1. 
 
In order to model the effective dose from a wide variety of CT machine types and 
manufacturers, ImPACT matches individual scanners to a data base so the sensitivity in 
the scanner matching must also be taken into consideration. 
 
m. CT Scanner Matching – ImPACT has 23 different data sets that are used 
depending upon the machine model/manufacturer chosen.  The chosen 
machine match to a data set via a calculated factor based upon CTDIair.  
Gregory [198] calculated the difference among the data sets to be +/-54% 
or 2.4% per data set.  Using the GUM method for an assumed rectangular 




The Monte Carlo codes have geometrically designed mathematical phantoms (explained 
in Specific Aim 1) which are used to collect the dose histories and calculate the absorbed 
dose to the individual organ.  The next sensitivity component deals with patient/phantom 
modeling. 
 
n. For ImPACT organ doses, 3% uncertainty is used.  Organ values are 
assumed to be within a 95% confidence interval of the true value.  
Therefore, u = 5%/2 = rounded up for greater conservatism, 3%. 
o. For Model organ doses, uncertainties are listed as calculated by the 
PCXMC model for all 100 phantoms and then weighted (for sensitivity 
coefficient) according to effective dose formulism such that only the 
organs listed make up the total effective dose.  Whereas this isn’t accurate 
according to strict formulism (many organs are not accounted for), this 
does allow for comparisons to be made among the final uncertainty values.   
 
Both the Ht/Wt model development and ImPACT involved simulating the effective dose 
from a CT scan by summing contiguous axial scans.  In practice however, all of the 
trauma protocols, vice Brain Scan, are helically scanned.  Therefore, error is introduced 
when simulating helical scans with axial scans and must be accounted for. 
 
p. CTDosimetry Helical Scanning – ImPACT CTDosimetry is not capable 
of performing helical scanning calculations.  However, adding an 
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additional axial scan on both ends of a scanning range (axial scans) will 
approximate the overscanning (thus additional effective dose) which takes 
place with helical scanning.  Axial scanning is used for Brain scans and 
Cervical Spine scans.  Helical scans are used for all other scanning 
protocols.  Gregory [198] assumed a standard of uncertainty of 10% for 10 
rotation scans and 5% for 20 rotation scans.  Modeling the uncertainty 
trend (exponential) using the standard uncertainties, the below 
uncertainties were calculated.  As more rotations are used, the uncertainty 
in the effective dose is lowered (Table 19). 
Table 19.  Number of rotations per scan protocol. 
Scans Rotations (1 cm slice) + 
2 rotations for helical 
scans 
Uncertainty (%) 
                         
ImPACT PCXMC ImPACT PCXMC 
Brain  16 9.5 7 9.3 
Cervical Spine 23 16 5 7 
Chest Abdomen Pelvis 37 54 2.7 1.25 
Chest 21 29 5.5 3.9 
Thoracic Spine 19 24 6.1 4.8 
Lumbar Spine 17 25 6.6 4.6 
 
The uncertainities are propagated and combined utilizing the method of quadrature.  In 
this method, the overall error in a theorectical measurement output, e, involving two 
measurements with error, m and n, is calculated as below. 
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Therefore, the final values on the sensitivity tables show both the overall error using 
tabulated values and the overall error for using measured values.  The 95% confidence 




q. Tabulated CTDIair – combination of Rows: 1-4,5,7-11,12-22,23-24, and 
25.                  
 
    
r. Measured CTDIair – combination of Rows: 1-4,6,7-11,12-22,23-24, and 
25.                 
 
    
s. 95% Confidence Interval for ucomb (Row 28 – Row 29) 
i. Row 28, Tabulated 95% CI for ucomb – 2* Row 26 
ii. Row 29, Measured 95% CI for ucomb – 2*Row 27 
 
Results 
Multivariable regression is a powerful tool which helps to explain the relationship between 
predictors and the predicted value.  For multiple regression to be used though, there are 
certain assumptions which must be made:  1) existence – for each specific combination of 
values of the independent variables the dependent variable is a random variable with a 
certain probability distribution having finite mean and variance, 2) independence – the 
dependent variable observations are independent of one another, 3) linearity – the mean 
value of the dependent variable for each specific combination of the independent variables 
is a linear function, 4) homoscedasticity – the variance of the dependent variable is the 
same for any fixed combination of the independent variables, and 5) normality – for any 
fixed combination of independent variables the dependent variable is normally distributed 
[240].  In order to achieve a usable solution which can be widely employed, the two 
predictors used are height and weight either individually or within the BMI formulism.  
Until the capability exists to individually assess specific organ doses from a unique patient 
scan, these regression equations will serve to approximate the effective dose per trauma 




Effective dose was modeled best by multivariable regression techniques (Table 18).  This 
approach was primarily suggested through experience and analysis of the coefficient of 
determination, R
2
, which was used as a measure of association between height/weight 
and effective dose.  For four of the scans (chest abdomen pelvis, chest, lumbar spine, and 
thoracic spine), more than 90% of the variation in the effective dose is explained by 
combinations of height and weight.  96% of the variation in the effective dose is 
explained by combinations of height and weight for chest scans while 76% of the 
variation in the effective dose is explained by height and weight for brain scans.  
However, only 65% of the variation in the effective dose is explained by height and 
weight for cervical spine scans.   
 
Table 20.  Ht/Wt mathematical models for calculating the effective dose, E (mSv), by 










Scan Protocol Ht/Wt Model Regression Equation R2 
Brain E = 3.35 – 0.00581*Height – 0.00722*Weight 0.76 
Cervical Spine E = 25.7 – 0.0257*Height + 0.000724*Height2 – 
0.00711*Weight 
0.65 
Ch/Ab/Pel E = 17.2 + 0.0628*Height – 0.102*Weight 0.96 
Chest E = 25.9 – 0.120*Height + 0.000456*Height2 – 
0.124*Weight + 0.000329*Weight2 
0.96 
Lumbar Spine E = 9.16 + 0.0418*Height – 0.0644*Weight 0.93 
Thoracic Spine E = 9.20 + 0.0477*Height – 0.0529*Weight 0.90 
   
From Table 20, we can see that for brain scans, the effective dose decreases by 0.00581 
mSv and 0.00722 mSv for each unit increase in the height (cm) and weight (kg), 
87 
 
respectively.  For the other scans, the effective dose varies with height, height
2
, weight,  or 
weight
2
.   
 
The estimate of the effective dose decreases as the height and the weight increases for brain 
scans, cervical spine scans, and chest scans (Figure 16).  The relationship between weight 
and the estimate of the effective dose appears to be similar for all three scans by visually 
inspecting the slope of the line.  Weight has a steep slope for the weight indicating that the 
weight has more of a strong negative association with the effective dose. However, the 
relationship between height and the estimate of the effective dose is not similar among the 
three scans.  Although there is still a negative association between the height and the 
estimate of the effective dose, the cervical spine scan and the chest scan are definitely more 










Figure 16.  Effects plot of the predictors plotted against effective dose. 95% confidence 
bands are also presented along with the fitted regression line.  (16a) Brain scan, (16b) 
Cervical Spine Scan, and (16c) Chest Scan. 
The phantom height has a positive effect on the estimate of the effective dose for chest 
abdomen pelvis scans, thoracic spine scans, and lumbar spine scans (Figure 17).  
Conversely, the phantom weight has a negative effect on the estimate of the effective dose 
for the three above scans, although the range in the effective dose estimate is less for the 










Figure 17.  Effects plot of the predictors plotted against effective dose. 95% confidence 
bands are also presented along with the fitted regression line.  (17a) Chest Abdomen 
Pelvis Scan, (17b) Thoracic Spine Scan, and (17c) Lumbar Spine Scan. 
 
Uncertainties Involved in Estimating Effective Dose 
The absorbed dose to an organ is dependent upon many different factors.  In addition to the 
various machine parameters (mA, kVp, slice thickness, etc.) the depth (distance from 
surface) of the organ within the body and the size of the organ (including the density of the 
tissue) contributes to the absorbed dose quantity.  As the depth increases the absorbed dose 
will decrease (Figure 18) exponentially.  Assessing the overall absorbed dose to an organ is 
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also made more difficult since organs are neither shaped uniformly nor are all parts of the 
organ at a uniform depth.    
  
Figure 18.  Dose response according to increasing thickness of solid water slabs 
simulating organ depth.   
 
Sensitivity Tables 
Error analysis for independent values is primarily performed using the method of 
propagation as discussed in Gregory et al [235-236] for propagating medical measurement 
uncertainties.  A sensitivity table is presented for both ImPACT (Tables 21,23,25,27,29,31) 
and the regression model output (Tables 22,24,26,28,30,32). 
  
Table 21.  Sensitivity table for ImPACT brain scan calculations. 










       
CT Scanner 
Characteristics 
Tube Current 2.5 1 20 6.25 





Ion Chamber 120 kVp Y=1.51e-0.141x 0.99 
MOSFET 120 kVp Y=1.50e-0.137x 0.96 
OSL Flat 
Orientation 




Tube Voltage 1.5 2.5 20 14.06 
Slice Width/Table 
Movement 
0.5 0.1 20 2.5E-3 
CTDIair 
displayed/tabulated 
12 1 20 144 





2 1 20 4 
Photon Spectrum 
Modeling 
1 1 20 1 
Table Attenuation 2 1 20 4 





1.4 1 20 1.96 
Patient Modeling 




that values are 
within 3%) 
Adrenals/Gall Bladder     
Brain 3 0.22 20 0.44 
Colon     
Esophagus 3 1.76E-3 20 2.79E-5 
Kidney     
Liver 3 1.59E-4 20 2.28E-7 
Lung 3 7.65E-4 20 5.27E-6 
Pancreas     
Thymus 3 1.76E-3 20 2.79E-5 
Thyroid 3 0.06 20 0.032 
Uterus     
Patient 
Positioning 
Vertical Positioning 7.4 0.3 15 4.92 






7 1 20 49 
Total Uncertainty 
Combined (ucomb) 
Tabulated CTDIair,                 
 




Measured CTDIair,                 
 
    
10 
  Tabulated 95% CI for Ucomb 30 
 Measured 95% CI for Ucomb 20 
 
Table 22.  Sensitivity table for predictive Ht/Wt model brain scan calculations. 










       
CT Scanner 
Characteristics 
Tube Current 2.5 1 20 6.25 
Exposure Time 0.03 1 20 0.0009 
Tube Voltage 1.5 2.5 20 14.06 
Slice Width/Table 
Movement 
1 0.2 20 0.04 




CTDIair measured     
Modeling X-ray 
production 
Monte Carlo Modeling 2 1 20 4 
Photon Spectrum 
Modeling 
1 1 20 1 
Table Attenuation 7 1 20 49 
HVL 3.3 0.6 20 3.92 
Anode Angle 4 1  16 
Dose Input EAK Matching 2.5 1  6.25 
Patient Modeling Adrenals/Gall 
Bladder* 
NA    
Brain 0.3 0.91  0.075 
Colon NA    
Esophagus 20 0.0054  0.012 
Kidney* NA    
Liver 15 6.76e-4  0.0001 
Lung 4 0.023  0.00085 
Pancreas* NA    
Thymus 50 0.0043  0.046 
Thyroid 12 0.057  0.47 
Uterus* NA    
Patient 
Positioning 
Vertical Positioning 10 .1  1 




Scanning (9 rotations) 
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 95% CI for Ucomb 28 
 
Cervical Spine Scan Sensitivity Table 
Table 23.  Sensitivity table for ImPACT cervical spine scan calculations. 










       
CT Scanner 
Characteristics 
Tube Current 2.5 1 20 6.25 
Exposure Time 0.03 1 20 0.0009 
Tube Voltage 1.5 2.5 20 14.06 
Slice Width/Table 
Movement 
1 0.2 20 0.04 
CTDIair 
displayed/tabulated 
12 1 20 144 
CTDIair measured 2.5 1 20 6.25 
Modeling X-ray 
production 
Monte Carlo Modeling 2 1 20 4 




Table Attenuation 2 1 20 4 





1.4 1 20 1.96 
Patient Modeling 




that values are 
within 3%) 
Adrenals/Gall Bladder 3    
Brain 3 0.068  0.042 
Colon 3    
Esophagus 3 0.031  0.0086 
Kidney 3    
Liver 3 0.0018  2.92E-5 
Lung 3 0.12  0.13 
Pancreas 3    
Thymus 3 0.031  0.0086 
Thyroid 3 0.75  5 
Uterus 3    
Patient 
Positioning 
Vertical Positioning 7.4 0.3 15 4.92 




Scanning (23 rotations) 




Tabulated CTDIair,                 
 





Measured CTDIair,                 
 
    
9 
  Tabulated 95% CI for Ucomb 30 
 Measured 95% CI for Ucomb 18 
 
Table 24.  Sensitivity table for predictive Ht/Wt model cervical spine scan calculations. 










       
CT Scanner 
Characteristics 
Tube Current 2.5 1 20 6.25 
Exposure Time 0.03 1 20 0.0009 
Tube Voltage 1.5 2.5 20 14.06 
Slice Width/Table 
Movement 
1 0.2 20 0.04 
CTDIair 
displayed/tabulated 
    
CTDIair measured     
Modeling X-ray 
production 
Monte Carlo Modeling 2 1 20 4 
Photon Spectrum 
Modeling 
1 1 20 1 
Table Attenuation 2 1 20 4 
HVL 3.3 0.6 20 3.92 
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 Anode Angle 4 1  16 
Dose Input EAK Matching 2.5 1  6.25 
Patient Modeling Adrenals/Gall Bladder*     
Brain 2.7 .078  .044 
Colon     
Esophagus 20 .014  .078 
Kidney*     
Liver 18 0.00064  .00013 
Lung 6.4 .026  .028 
Pancreas*     
Thymus 35 .0079  .076 
Thyroid 10 .86  73.96 
Uterus*     
Patient 
Positioning 
Vertical Positioning 10 .1  1 




Scanning (16 rotations) 





                
 
   
 
13 
 95% CI for Ucomb 26 
 
Chest Abdomen Pelvis Scan Sensitivity Table 
Table 25.  Sensitivity table for ImPACT chest abdomen pelvis scan calculations. 










       
CT Scanner 
Characteristics 
Tube Current 2.5 1 20 6.25 
Exposure Time 0.03 1 20 0.0009 
Tube Voltage 1.5 2.5 20 14.06 
Slice Width/Table 
Movement 
1 0.2 20 0.04 
CTDIair 
displayed/tabulated 
12 1 20 144 
CTDIair measured 2.5 1 20 6.25 
Modeling X-ray 
production 
Monte Carlo Modeling 2 1 20 4 
Photon Spectrum 
Modeling 
1 1 20 1 
Table Attenuation 2 1 20 4 





1.4 1 20 1.96 
Patient Modeling 
(error is not 
Adrenals/Gall Bladder 3 .054 20 .026 






that values are 
within 3%) 
Colon 3 .19 20 .32 
Esophagus 3 .089 20 .071 
Kidney 3 .054 20 .026 
Liver 3 .074 20 .049 
Lung 3 .24 20 .52 
Pancreas 3 .054 20 .026 
Thymus 3 .089 20 .071 
Thyroid 3 .10 20 .090 
Uterus 3 .054 20 .026 
Patient 
Positioning 
Vertical Positioning 7.4 0.3 15 4.92 




Scanning (37 rotations) 




Tabulated CTDIair,                 
 





Measured CTDIair,                 
 
    
7.55 
  Tabulated 95% CI for Ucomb 28 
 Measured 95% CI for Ucomb 15 
 
Table 26.  Sensitivity table for predictive Ht/Wt model chest abdomen pelvis scan 
calculations. 










       
CT Scanner 
Characteristics 
Tube Current 2.5 1 20 6.25 
Exposure Time 0.03 1 20 0.0009 
Tube Voltage 1.5 2.5 20 14.06 
Slice Width/Table 
Movement 
1 0.2 20 0.04 
CTDIair 
displayed/tabulated 
    
CTDIair measured     
Modeling X-ray 
production 
Monte Carlo Modeling 2 1 20 4 
Photon Spectrum 
Modeling 
1 1 20 1 
Table Attenuation 2 1 20 4 
HVL 3.3 0.6 20 3.92 
 Anode Angle 4 1  16 
Dose Input EAK Matching 2.5 1  6.25 
Patient Modeling Adrenals/Gall Bladder* 1 .06  .0036 
Brain 1 .0002  4E-8 
Colon 2 .2  .16 
Esophagus .3 .09  .00073 
Kidney* 1 .06  .0036 
100 
 
Liver .06 .09  2.9E-5 
Lung .09 .3  .00073 
Pancreas* 1 .06  .0036 
Thymus .6 .07  .0017 
Thyroid .5 .08  .0016 
Uterus* 1 .06  .0036 
Patient 
Positioning 
Vertical Positioning 10 .1  1 




Scanning (54 rotations) 





                
 
   
 
14 
 95% CI for Ucomb 28 
 
Chest Scan Sensitivity Table 
Table 27.  Sensitivity table for ImPACT chest scan calculations. 










       
CT Scanner 
Characteristics 
Tube Current 2.5 1 20 6.25 
Exposure Time 0.03 1 20 0.0009 
Tube Voltage 1.5 2.5 20 14.06 
Slice Width/Table 
Movement 
1 0.2 20 0.04 
CTDIair 
displayed/tabulated 
12 1 20 144 
CTDIair measured 2.5 1 20 6.25 
Modeling X-ray 
production 
Monte Carlo Modeling 2 1 20 4 
Photon Spectrum 
Modeling 
1 1 20 1 
Table Attenuation 2 1 20 4 





1.4 1 20 1.96 
Patient Modeling 




that values are 
within 3%) 
Adrenals/Gall Bladder 3 .024  .0052 
Brain 3 0.00029  7.57E-7 
Colon 3 .0087  6.81E-4 
Esophagus 3 0.087  .068 
Kidney 3 .024  .0052 
Liver 3 0.055  .027 
Lung 3 .24  .52 
Pancreas 3 .024  .0052 
Thymus 3 .087  .068 
Thyroid 3 0.055  .027 





Vertical Positioning 7.4 0.3 15 4.92 




Scanning (21 rotations) 




Tabulated CTDIair,                 
 





Measured CTDIair,                 
 
    
9 
  Tabulated 95% CI for Ucomb 30 
 Measured 95% CI for Ucomb 18 
 
Table 28.  Sensitivity table for predictive Ht/Wt model chest scan calculations. 










       
CT Scanner 
Characteristics 
Tube Current 2.5 1 20 6.25 
Exposure Time 0.03 1 20 0.0009 
Tube Voltage 1.5 2.5 20 14.06 
Slice Width/Table 
Movement 
1 0.2 20 0.04 
CTDIair 
displayed/tabulated 
    
CTDIair measured     
Modeling X-ray 
production 
Monte Carlo Modeling 2 1 20 4 
Photon Spectrum 
Modeling 
1 1 20 1 
Table Attenuation 2 1 20 4 
HVL 3.3 0.6 20 3.92 
 Anode Angle 4 1  16 
Dose Input EAK Matching 2.5 1  6.25 
Patient Modeling Adrenals/Gall 
Bladder* 
20 .042  .71 
Brain 23 .00028  .000041 
Colon 20 .0085  .029 
Esophagus 6 .10  .36 
Kidney* 1 .042  .0018 
Liver 3 .082  .061 
Lung 1.2 .49  .35 
Pancreas* 11 .042  .21 
Thymus 11 .13  2 
Thyroid 33 .028  .85 
Uterus* 67 .042  7.91 
Patient 
Positioning 
Vertical Positioning 10 .1  1 
Lateral Positioning     
Modern Scanner PCXMC helical 2.9 1  15.21 
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8 
 95% CI for Ucomb 16 
 
Thoracic Spine Sensitivity Table 
Table 29.  Sensitivity table for ImPACT thoracic spine scan calculations. 










       
CT Scanner 
Characteristics 
Tube Current 2.5 1 20 6.25 
Exposure Time 0.03 1 20 0.0009 
Tube Voltage 1.5 2.5 20 14.06 
Slice Width/Table 
Movement 
1 0.2 20 0.04 
CTDIair 
displayed/tabulated 
12 1 20 144 
CTDIair measured 2.5 1 20 6.25 
Modeling X-ray 
production 
Monte Carlo Modeling 2 1 20 4 
Photon Spectrum 
Modeling 
1 1 20 1 
Table Attenuation 2 1 20 4 





1.4 1 20 1.96 
Patient Modeling 




that values are 
within 3%) 
Adrenals/Gall Bladder 3 .029  .0076 
Brain 3 .00033  9.80E-7 
Colon 3 .0045  .0018 
Esophagus 3 .1  .09 
Kidney 3 .029  .0076 
Liver 3 .045  .018 
Lung 3 .27  .66 
Pancreas 3 .029  .0076 
Thymus 3 .1  .09 
Thyroid 3 .063  .036 
Uterus 3 .029  .0076 
Patient 
Positioning 
Vertical Positioning 7.4 0.3 15 4.92 




Scanning (19 rotations) 




Tabulated CTDIair,                 
 







Measured CTDIair,                 
 
    
9 
  Tabulated 95% CI for Ucomb 30 
 Measured 95% CI for Ucomb 18 
 
Table 30.  Sensitivity table for predictive Ht/Wt model thoracic spine scan calculations. 










       
CT Scanner 
Characteristics 
Tube Current 2.5 1 20 6.25 
Exposure Time 0.03 1 20 0.0009 
Tube Voltage 1.5 2.5 20 14.06 
Slice Width/Table 
Movement 
1 0.2 20 0.04 
CTDIair 
displayed/tabulated 
    
CTDIair measured     
Modeling X-ray 
production 
Monte Carlo Modeling 2 1 20 4 
Photon Spectrum 
Modeling 
1 1 20 1 
Table Attenuation 2 1 20 4 
HVL 3.3 0.6 20 3.92 
 Anode Angle 4 1  16 
Dose Input EAK Matching 2.5 1  6.25 
Patient Modeling Adrenals/Gall Bladder* 20 .016  .10 
Brain 15 .0036  .0029 
Colon 17 .0038  .0042 
Esophagus 5.4 .10  .29 
Kidney* 1 .016  .00026 
Liver 2.8 .039  .012 
Lung 1.1 .58  .41 
Pancreas* 11 .016  .031 
Thymus 6.3 .18  1.29 
Thyroid 19 .033  .39 
Uterus* 67 .016  1.1 
Patient 
Positioning 
Vertical Positioning 10 .1  1 




Scanning (24 rotations) 
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Lumbar Spine Sensitivity Table 
Table 31.  Sensitivity table for ImPACT lumbar spine scan calculations. 










       
CT Scanner 
Characteristics 
Tube Current 2.5 1 20 6.25 
Exposure Time 0.03 1 20 0.0009 
Tube Voltage 1.5 2.5 20 14.06 
Slice Width/Table 
Movement 
1 0.2 20 0.04 
CTDIair 
displayed/tabulated 
12 1 20 144 
CTDIair measured 2.5 1 20 6.25 
Modeling X-ray 
production 
Monte Carlo Modeling 2 1 20 4 
Photon Spectrum 
Modeling 
1 1 20 1 
Table Attenuation 2 1 20 4 





1.4 1 20 1.96 
Patient Modeling 




that values are 
within 3%) 
Adrenals/Gall Bladder 3 .072  .047 
Brain 3 .000014  1.76E-9 
Colon 3 .32  .92 
Esophagus 3 .0062  .00035 
Kidney 3 .072  .047 
Liver 3 .17  .26 
Lung 3 .20  .36 
Pancreas 3 .072  .047 
Thymus 3 .0062  .00035 
Thyroid 3 .00098  8.64E-6 
Uterus 3 .072  .047 
Patient 
Positioning 
Vertical Positioning 7.4 0.3 15 4.92 




Scanning (17 rotations) 




Tabulated CTDIair,                 
 





Measured CTDIair,                 
 
    
10 
  Tabulated 95% CI for Ucomb 30 




Table 32.  Sensitivity table for predictive Ht/Wt model lumbar spine scan calculations. 










       
CT Scanner 
Characteristics 
Tube Current 2.5 1 20 6.25 
Exposure Time 0.03 1 20 0.0009 
Tube Voltage 1.5 2.5 20 14.06 
Slice Width/Table 
Movement 
1 0.2 20 0.04 
CTDIair 
displayed/tabulated 
    
CTDIair measured     
Modeling X-ray 
production 
Monte Carlo Modeling 2 1 20 4 
Photon Spectrum 
Modeling 
1 1 20 1 
Table Attenuation 2 1 20 4 
HVL 3.3 0.6 20 3.92 
 Anode Angle 4 1  16 
Dose Input EAK Matching 2.5 1  6.25 
Patient Modeling Adrenals/Gall Bladder* 5.0 .085  .18 
Brain 37 1.3E-5  2.31E-7 
Colon 1.6 .25  .16 
Esophagus 5.7 .056  .10 
Kidney* 1.2 .085  .010 
Liver .81 .16  .017 
Lung 2.0 .19  .14 
Pancreas* 2.3 .085  .038 
Thymus .20 .0097  3.76E-6 
Thyroid 50 .00097  .0024 
Uterus* 8.6 .085  .53 
Patient 
Positioning 
Vertical Positioning 10 .1  1 




Scanning (25 rotations) 





                
 
   
 
8.3 
 95% CI for Ucomb 17 
 
The greatest contribution to the overall uncertainty in the Ht/Wt model (up to 7%) came 
from the adaptation of axial scanning to helical scanning.  However, with ImPACT, the 
greatest contributor to the overall uncertainty came from using tabular values for the 
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CTDIair (up to 13%).  Since the Ht/Wt model uses direct measurement (entrance air 
kerma) values as initial inputs in Monte Carlo code, the Ht/Wt model did not have this 
large contributor.  Still, the Ht/Wt model sensitivities are within statistical agreement of the 
sensitivities calculated for ImPACT for all six trauma protocols.  
Conclusion 
Regression analysis was performed in order to show the relationship between height and 
weight and effective dose.  The goal of using height and weight as predictors is to obtain 
minimally confounded estimate of the effect of patient dimensions on effective dose from 
CT trauma protocols.  These predictors can be obtained from the semi-annual physical 
fitness tests that every Soldier in the U.S. Army completes.  Therefore, from an individual 
medical record, a clinician can review the results of a CT scan and by applying the patient 
values of height and weight, from a date near when the CT scans were performed, in the 
regression equation determine an estimate of the effective dose. 
 
The regression equations will be more widely used if they are straight-forward.  In this 
study only height and weight were used as predictors.  BMI alone does not adequately 
express the variance in effective doses in some models as well as using BMI in conjunction 
with the other two predictors, height and weight.  Specific machine characteristics were not 
assessed as predictors because this information is often not known for retrospective 
assessment of effective dose from CT scans.  The coefficient of determination, R
2
, was 
used to describe the variability in the calculated effective dose explained by the linear 




The models explain the variability in the effective dose well for all scans except for the 
cervical spine scan (R
2
 = 0.65).  This lack of variability explanation is due to the cervical 
spine area not increasing as much by overall size as the phantoms height and weight are 
increased.  This corresponds with what was observed in the initial patient study scanning 
range presented in Specific Aim 1. In the patient study, the mean scanning range of 32 
patients was 23.35 cm with the 25% quartile being 20.64 cm and the 75% quartile being 
25.26 cm.   For all other scans, the regression equations represent the strong relationship 
between the effect of height and weight upon the effective dose.  
  
The effective dose for the chest scan is more affected by weight than by height.  This is 
explained by the location of the body which changes (increases or decreases in overall size) 
as a patient’s weight changes.  The circumference of the torso for most people will increase 
as a person increases in weight.  As a result, we see that effective dose decreases similar to 
previously published research with cardiac patients [199, 225, 241-244].  
 
Ht/Wt model verification (Specific Aim 3) will provide the confidence that both the 
PCXMC code is accurately describing the radiation dose to a patient from a CT scan and 




CHAPTER 5.  Specific Aim 3:  Verify effective dose models by measuring absorbed 
dose s in organs using optically stimulated luminescent dosimetry and 
anthropomorphic phantoms.  
 
Introduction 
This chapter will address the experimental verification of the estimate of the effective dose 
models developed in the Chapter 4.  Experimental verification will be conducted by 
comparing organ dose measurements from anthropomorphic phantoms with organ dose 
values calculated using the mathematical phantoms used in Chapter 4. 
Experimental dose assessments for CT scans in the diagnostic energy range are in practice 
typically measured with metal oxide semi-conductor field effect transistors (MOSFET) and 
thermoluminescent dosimeters (TLD).  Both detectors are used because of their favorable 
characteristics with energy response, linearity, and reproducibility of irradiation.  MOSFET 
is an electronic device which integrates radiation dose whereas TLDs incorporate a 
crystalline powder or chip to capture the ionizations occurring within the sensitive volume 
[245].  Both detectors have the key advantages of being small, good spatial resolution, and 
simple to use.  Compared to TLDs, MOSFETs have additional significant advantages: 
immediate readout capability, reuse, and permanent storage of dose.   
 
This specific aim is going to focus on the use of a more recent dosimeter, optically 
stimulated luminescent (OSL) material, which offers advantages similar to MOSFET 
detectors and is starting to achieve industry-wide use.  OSL has some distinct advantages 
over traditional detector systems such as radiochromic dye films, plastic scintillators, 
TLDs, diode detectors, or MOSFET detectors [246].  Many detectors require a separate 
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post-irradiation evaluation of the dosimeters because the readout system is not coupled 
directly to the detector.  OSL is not restricted by the single use disadvantage of film or the 
limited lifetime disadvantage of MOSFET.  MOSFET detectors accumulate dose and 
become saturated as they are used until they are unable to respond generally at accumulated 
doses over 200 Gy.  Additionally, MOSFET lifetime will be further decreased when used 
in different sensitivity modes which influence their response to irradiations [247].   
 
In order to verify that the modeled organ dose results are within expected ranges, the 
modeled dose results will be compared against experimental results.  Patient equivalent 
anthropomorphic phantoms obtained from Computerized Imaging Reference Systems Inc 
[248] will be used.  These anthropomorphic phantoms adhere to the requisite ICRP 
guidelines for reference man tissue equivalency [83].  These phantoms have been modified 
by the manufacturer based upon the requirements of this research so that internal 
dosimeters can be inserted into the various organ locations within the body.  The internal 
dosimeters to be used are OSL dosimeters (Figure 19) purchased from Landauer Inc[249].  
The active volume of the dosimeter is located within holders approximately 10-millimeters 
square.   
 
Figure 19.  Landauer Inc. nanoDot OSL dosimeter used in this research (Photo courtesy 
of Landauer Inc.). 
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Characterization of the OSL dosimeters for diagnostic energies required experiments to be 
performed in order to assess energy dependence, linearity, reproducibility, material 
characteristics, and lower limits of detection.  Material characteristics and composition 
were also experimentally assessed to determine if the geometry of the dosimeter compared 
to the x-ray beam direction plays a factor in absorbed dose.  These experiments were 
important to determine the inherent dosimeter shielding.  
 
Anthropomorphic phantoms provide realistic human equivalent dimensions and 
tissue/organ/muscle densities which provide realistic photon and electron scattering thus 
yielding realistic dose characterization [55, 250-251]. Using phantoms simulating different 
sexes and ages allows for a more accurate dose assessment based upon appropriate tissue 
simulation.  Experimental measurements were conducted using the CIRS anthropomorphic 
phantoms and a GE LightSpeed 16 CT machine for each of the six trauma protocols (brain, 
cervical spine, chest abdomen pelvis, chest, thoracic spine, and lumbar spine).  
Anthropomorphic phantoms were used as opposed to water phantoms to simulate non-
homogeneous tissue densities.  The phantoms account for different elements within human 
tissue (carbon, oxygen, hydrogen, nitrogen, calcium, phosphorus, magnesium, aluminum, 
and chlorine).  Tissue simulated in CIRS phantoms are average soft tissue, average bone 
tissue (eliminates the problem of air voids found in trabecular regions of natural bone), 
cartilage, spinal cord, spinal disks, lung, brain, sinus, trachea and bronchial cavities. The 





Optically Stimulated Luminescent Dosimetry 
Use of OSL dosimeters is advantageous because:  they have the ability to be read many 
times without the need for annealing, they display very little fading over time, and they are 
small in size.  OSL dosimeters have been used for accident dosimetry, medical dosimetry, 
and natural dosimetry.  The primary physical structure of the dosimeter is that of a crystal.  
The crystal lattice provides semiconductor-like physics where ionizing radiation causes 
electron-hole pairs to separate and drift to their respective junctions (n- or p-junctions).  
The freed electrons are of primary concern because these electrons are captured by energy 
traps where they stay until enough stimulated energy is provided for the electron to escape 
and reach the junction.  This excess energy leaves the electron via luminescence as the 
electron drifts towards the junction.  The amount of luminescence directly relates to the 
amount of initial radiation caused the separation of the electron-hole pair (Figure 20).  The 
ideal dosimeter relates the trapped charge population linearly with the absorbed radiation 
dose in the absence of stimulation [252]. 
 
The primary distinction between OSL dosimetry and thermoluminescent (TL) dosimetry is 
the origin of the stimulated energy used to prompt a readable signal.  With TL the 
stimulated energy comes from heat.  As the TL dosimeter is heated up, the electrons in the 
traps absorb enough of the energy to leave the trap and as the electron drifts to the ground 
state, the excess energy provides the luminescence to be measured.  There is some TL 
though in an OSL dosimeter, but the OSL dosimeter is primarily concerned with 
luminescence originating from different traps.  As can be seen below (Figure 20), there are 
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Figure 20. Physical processes of the optically stimulated dosimeter [252]. 
A distinct benefit of using OSL dosimetry is that the energy used to stimulate the electron 
in the trap can be tuned via different wavelengths.  There are three main types of energy 
stimulation.  The most common type is continuous wave OSL (CW-OSL). CW-OSL 
stimulates with a constant intensity and constant wavelength.  Constant intensity refers to a 
constant photon flux over time.  The wavelength is usually provided by a laser or more 
recently, a high intensity LED (light emitting diode).  CW-OSL is very dependent upon 
temperature (having to do with the thermal trap depth, generally describing the entropy 
change of the system).  At low temperatures, a reduced signal is observed due to 
competitive trapping of the released charge from a deeper trap to a shallower more stable 
trap which will not contribute to the luminescence.  At higher temperatures, the effect of 
the shallow traps is negligible and the OSL signal is much higher.  Intermediate 
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temperatures yield a shifted signal peak reflecting the trapping of the charge into the 
shallow traps and subsequent release providing the luminescence. An ideal CW-OSL signal 
will approximate a simple exponential decay curve which can be approximated by first 
order kinetics.  The signal will deviate from the exponential decay curve when re-trapping 
takes place into the shallow traps from deeper traps, and the presence of more than one 
recombination center.  Linear modulated OSL (LM-OSL) keeps the constant wavelength 
but varies the intensity of the stimulation source in a linear manner.  The OSL is monitored 
throughout the ramping up of the intensity.  This linear ramp has an advantage over CW of 
resolving the trap’s de-trapping rates (fast, medium, and slow).  The general shape of the 
signal shows a linearly increasing function in proportion to the linear increase in 
stimulation power which is then followed by a Gaussian decrease in OSL intensity as the 
traps depopulate.  The positioning of the signal peak reflects both the wavelength and the 
linear modulation rate.  The resolving advantage of LM over CW eliminates the signal 
superposition of different trap depth depletion.  Pulsed OSL (POSL) maintains the 
absorbed energy per pulse but varies the intensity and pulse time.  An inverse relationship 
is used between intensity and pulse time.  POSL keeps a constant wavelength throughout 
[246]. 
     
Scientists have found both natural-occurring crystals and have grown synthetic crystals for 
OSL.  One of the most common naturally-occurring crystals is feldspar (located in sand).  
Feldspar has been used to measure background radiation found in nature and has also been 
used to determine the amount of radiation given off in accidents (i.e. Chernobyl) [246].  
Common synthetic crystals include Al2O3:C, halides (KCl, KBr, NaCl, RbI, CaF2 doped 
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with Mn, BaF(Br, Cl, I) doped with Eu), Sulfates (MgSO4, CaSO4), Sulphides (MgS, SrS, 
CaS, BaS), and Oxides (BeO, fused quartz doped with Cu).  The most commonly used 
synthetic material is probably Al2O3:C [253-267].  This synthetic material is extremely 
sensitive (emitted luminescence photons per unit radiation dose) to both TL and OSL.  
Al2O3:C as a TL dosimeter has a disadvantage of being extremely sensitive to heat; higher 
sensitivity at lower temperatures as opposed to higher temperatures.  However, this 
temperature dependence is not of concern when used as an OSL material, and the 
characteristic of phototransfer of charge from deep states (traps) to shallower states is 
favorable.  The wavelength of light used to stimulate the luminescence for Al2O3:C is best 
between 475 and 500 nm, with the peak being about 480 nm [246].  Note though that the 
tunable wavelengths can be used to depopulate specific traps.  Environmental dosimetry is 
often concerned with the electrons in the shallower traps whereas medical dosimetry is 
concerned with the electrons in the deeper traps.  Providing the necessary stimulated energy 
to depopulate shallow traps will not affect the charge in the deep traps.  One of the ideal 
characteristics with OSL dosimetry is that the crystal can be read multiple times without 
depleting the electron traps.  Zeroing the crystal is also fairly easy by thermal annealing or 
bleaching with stimulation light [252]. 
 
The type of OSL system that will be used in the study will be the Landauer InLight
TM
 
personal dosimetry system.  This system is a continuous-wave OSL that uses bright LEDs 
(green wavelength) to stimulate the OSL utilizing the Al2O3:C crystal.  The LEDs provide 
longer read-out capabilities as compared to pulsed OSL and has very little signal depletion.  
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The operational dose range for this system is up to 10 Gy with photon energies greater than 
5 keV and electron energies greater than 150 keV [249, 268]. 
 
The below figure (Figure 21) illustrates the fundamental approach to reading the OSL 
dosimeter.  The light source is filtered to the desired wavelength most optimal for 
luminescence and then used to stimulate the dosimeter.  The luminescence within the 
dosimeter is then read by the photo multiplier tubes which amplify the luminescent light to 
be measured by the attached electronics.  
 
Figure 21.  Light stimulation diagram describing how the OSL signal 
is obtained [269]. 
OSL and radioluminescence responses of Al2O3:C fiber probes have been found to increase 
linearly with dose rate and the absorbed dose in the radiotherapy range (0.5 – 85 Gy) with 




Although Al2O3:C is becoming the standard crystal, other materials, KBr:Eu, have shown 
the desired characteristics for real-time dosimetry [271].  Additionally, studies [272] have 
shown that OSL can be used for in vivo dosimetry on patients using a buildup cap for 
entrance dose measurements.   
 
For this study, the reproducibility of the study dosimeters (Landauer Dots) was about 2.5% 
(within one standard deviation) with the stability of the system showing that a given batch 
of dosimeters can be used with a single calibration factor.  A single calibration factor can 
also be used for dose ranges 0.5 to 4 Gy as the response from the dosimeters is linear. 
 
OSL research is still a narrow field.  AAPM annual meetings have averaged only about 3-4 
presentations per year since 2005 [269].  OSL characteristics look to be promising for 
innovative therapy technologies such as proton therapy and heavy ion therapies but 
research hasn’t been conducted.  Additionally, OSL techniques applied to computed 




Anthropomorphic phantoms have many uses in medical physics.  They are designed to 
approximate the shape and the different tissue densities which make up the human body.  
Radiation detectors can often be inserted into the phantom so that the readings approximate 
the radiation absorbed dose at that specific location.  There are many different types of 




One of the most popular anthropomorphic phantoms used today is the Rando-Alderson 
phantom (Alderson Radiation Therapy Phantom, Radiology Support Devices, Inc., Long 
Beach, California) and has been in use for more than 30 years.  These phantoms are molded 
of tissue-equivalent material and follow ICRU-44 standards [273].  Typically, the 
phantoms are ordered and designed for use with TLD dosimeters.   
 
CIRS (Computerized Imaging Reference Systems, Norfolk, Virginia) also manufactures 
and designs anthropomorphic phantoms in accordance with ICRU 44 [273], ICRP 23 , and 
ICRP 89 specifications [248].  These phantoms can be ordered in a variety of sizes from 
adults down to pediatrics and have been in use since the late 1980s.  For this research, we 
ordered an adult male (height equals 173 cm, weight equals 73 kg, thorax dimensions equal 
23 cm x 32 cm) and an adult female (height equals 160 cm, weight equals 55 kg, thorax 
dimensions equal 20 cm x 25 cm).  We specifically asked the company to make 
modifications to the phantoms prior to shipment so that the phantoms would accommodate 
a 14-mm diameter plug designed for use with a Landauer, Inc. nanoDOT dosimeter.  
 
Researchers have regularly used anthropomorphic phantoms to experimentally verify 
mathematical estimates of effective dose.  Hurwitz et al [274] used a CIRS female phantom 
for MOSFET comparison against effective dose calculations using conversion coefficients 
and found that the use of conversion coefficients underestimate the effective dose by up to 
37%.   Salvado et al [275] experimentally verified the effective dose in voxelized Rando 
Alderson phantoms against EGS4 simulations of a HiSpeedLX/i (GE Medical Systems, 
Milwaukee, Wisconsin) CT system to good agreement.  Other researchers [276] have 
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further compared the Cristy mathematical phantoms used by ImPACT with voxelized 
anthropomorphic phantoms and have also found that geometrical phantoms (Cristy) will 
also underestimate the effective dose when compared against voxelized phantoms.  
Comparisons between physical phantoms and computer have shown that the difference in 
organ dose is the smallest when either organs that are small in volume and can be easily 
represented by an averaged point dose estimate, or for those large organs which receive a 
fairly uniform absorbed dose throughout its volume, or when the organ is large but receives 
a properly volume averaged absorbed dose gradient [250].   
 
OSL Characterization 





Landauer, Inc., Glenwood, Illinois) (Figure 22) with an 80 kVp calibration. The dosimeters 
were exposed to diagnostic x-rays (maximum energy of 140 kVp).  The dosimeters were 
then stimulated with a wavelength in the visible green spectrum which caused an emission 
of blue light which was quantified for dosimetric assessment.  The dosimeters were not 
manipulated upon receipt and still possessed the pre-determined manufacturer 




Figure 22.  InLight
TM
 MicroStar® System. 
Very low energy irradiations (22 kVp – 35 kVp) were performed using a standard 
mammography machine (General Electric Senographe Essential 2000D, General Electric 
Healthcare: Chalfont St. Giles, United Kingdom) and a PMMA (poly-methyl methacrylate) 
mammography phantom.  Low-energy irradiations (50 kVp – 140 kVp) were performed 
using a radiographic-fluoroscopic unit (Philips EasyDiagnost Eleva, Philips Healthcare, 
Andover Massachusetts) and a 20 cm x 20 cm x 20 cm Lucite phantom. 
 
Proper calibration procedures as listed by the manufacturer were followed prior to 
irradiating the dosimeters.  For the purposes of this study, the 80 kVp calibration set was 
used.  Following the initial irradiation, each dosimeter was subjected to 3 sets of 




Dosimeters were evaluated for energy response both on-phantom and free-in-air with five 
dosimeters were each exposed to different energies of 22, 35, 50, 80, 120 and 140 kVp.  
The energy response was normalized to 80 kVp.  Dosimeter results were compared to 
results from a calibrated ion chamber (Model 10X6, Radcal Corporation, Monrovia, 
California) measured both on-phantom and free-in-air.  Each was exposed at 22, 35, 50, 80, 
120 and 140 kVp.  The angular response for horizontal rotation was determined by 
exposing 5 dosimeters each at varying incident angles (0, 45, 90, 135 and 180 degrees) 
using an 80 kVp x-ray beam.  Energy dependence of the dosimeter was compared against 
the calibrated ion chamber.  The ion chamber chosen is designed for low-level radiation 
measurements and has a 6 cm
3
 active volume with an energy dependence of plus or minus 
5% in the energy range from 33 keV to 1.33 MeV.  
 
Characterization Results  
Energy dependence was shown to be within plus or minus 15% when exposed free-in-air 
over the diagnostic energy range between 22 to 140 kVp.  The dosimeters when similarly 
compared with the ion chamber gave results within plus or minus 15% when exposed free-
in-air (Figure 23).  Energy dependence was also shown to be within plus or minus 17% 
when exposed on-phantom over the diagnostic energy range between 22 to 140 kVp.  The 
dosimeters were then compared with the ion chamber and the results agreed within plus or 




Figure 23.  Results of dosimeter to ion chamber comparison when 
placed free-in-air. 
 
Figure 24.  Results of dosimeter to ion chamber comparison when 
placed on a phantom. 
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Horizontal angular response differences at 45, 135, and 180 degrees were shown to be 
within 3% of the zero degree response.  A 15% reduction in response was identified when 
the dosimeter was exposed on-edge (90 degrees) (Figure 25).  As expected, the dosimeters 
were shown to have a linear response from 100 µGy through 20 Gy (See Figure 26) with a 
coefficient of determination value of 0.9997. 
 




Figure 26. Dosimeter linearity with a coefficient of determination 
(R
2
) value of 0.9997 between delivered dose and measured dose. 
Discussion   
The results of this study confirm the previous literature references which outlined the 
characterization of the dosimeters utilizing the radioisotope, 
137
Cs [268, 277].  The 
dosimeters are extremely proficient at measuring low-energy x-rays produced by basic 
radiographic machines as proven by these measurements and confirmed in the existing 
literature.  The unique low-profile dosimeters can be placed on equipment and personnel in 
radiation environments.  The angular response variation was expected due to the low 
photon energy and the minor self-shielding of the holder material.  The inherent 
construction of the dosimeter allows for appropriate skin dose monitoring [278].  The 
multiple readout, rapid analysis, and size advantages of OSL technology make the 




OSL Characterization Conclusion  
The results of the basic measurements in this study show that small OSL dosimeters are 
suitable for patient in the low energy range (22 kVp – 140 kVp).  Small size aluminum 
oxide OSL dosimeters and portable readers can be a convenient methodology for patient 
dosimetry applications across the diagnostic imaging energy range.  The dosimeters can be 
quickly read and analyzed.  OSL technology should prove extremely useful in assessing 
skin dose [280].  The dosimeters are linear over a large dose range and compare well with 
ion chamber results, having acceptable energy and angular dependence. 
 
OSL Depth Response  
In order to judge the response of the OSL with varying tissue thicknesses, a separate 
experiment was performed using solid water slabs to replicate varying thicknesses of tissue.  
Based off of the characterization experiment presented above, the OSL dosimeters were 
placed within a radiographic field next to both MOSFET detectors and an ion chamber 
(Figure 27).  Three different diagnostic energies were assessed (80 kVp, 100 kVp, and 120 
kVp) and the MOSFET detectors were calibrated to the beam quality HVL (7.4-mm Al) in 
a GE LightSpeed 16 CT machine (General Electric Medical Systems, Milwaukee, 
Wisconsin).  Solid water slabs of varying thicknesses were used to simulate tissue.  
Numerical analysis and graphing was performed using Microsoft Excel.      
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a.  b.  
Figure 27.  Experimental setup for assessing depth response. Figure 23a shows the 
detector set up without slabs of solid water.  Figure 23b shows the setup with the solid 
water slabs on top of the blue support cushions. 
OSL Depth Response Results 
As expected the response from all three detectors (OSL, MOSFET, and ion chamber) 
exponentially decreased as the solid water thickness increased (Figures 28-30).  
Interestingly, both detectors (OSL and MOSFET) have a similar response ratio (Figure 31) 
at depths up to approximately 4-cm solid water, although the OSL over-responds and the 
MOSFET under-responds when compared with the ion chamber.  However, at thicknesses 
greater than 5-cm solid water, the response ratios change.  Both detectors respond within 





Figure 28. Detector response at varying depths of solid water at 80 
kVp. 
 





Figure 30. Detector response at varying depths of solid water at 120 
kVp. 
 
Figure 31.  Ratio of OSL and MOSFET detectors with the ion 
chamber (IC).  Both detectors have a response ratio of within +/- 
20%. 
 
Table 33 presents the fitted exponential regression equations for the three detectors and the 
coefficient of determination, R
2
.  The high coefficient of determination indicates that there 
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is a strong relationship between the depth and the detector response and also indicates that 
the response of each detector would be linear when graphed on a log scale.  This is in 
keeping with the results shown in the OSL characterization section of this chapter. 
 
Table 33. Detector response and fitted exponential regression equations at the three 
experimentally assessed beam qualities. The predicted value, y, represents the detector 
response, and x, represents the depth (cm). 




Ion Chamber 80 kVp y=0.2649e
-0.198x
 0.9971 
MOSFET 80 kVp y=0.2526e
-0.172x
 0.9665 
OSL Flat Orientation 80 kVp y=0.2967e
-0.195x
 0.9978 
OSL Edge Orientation 80 kVp y=0.2768e
-0.186x
 0.9978 
Ion Chamber 100 kVp y=0.4844e
-0.183x
 0.9970 
MOSFET 100 kVp y=0.4733e
-0.17x
 0.9728 
OSL Flat Orientation 100 kVp y=0.4821e
-0.18x
 0.9891 
OSL Edge Orientation 100 kVp y=0.4636e
-0.175x
 0.9965 
Ion Chamber 120 kVp y=1.5118e
-0.141x
 0.9862 
MOSFET 120 kVp y=1.4995e
-0.137x
 0.9556 




The ratio of the response of each OSL orientation (Figure 32) was shown to be within +/- 
12% when the dosimeter was placed along the direction of the primary beam or orthogonal 




Figure 32.  Ratio of the OSL orientation (OSL Flat to OSL Edge) at varying thicknesses 
of solid water for both 80 kVp and 100 kVp. 
OSL Depth Response Discussion 
The OSL responds as expected to radiation at various depths simulated by increasing 
thicknesses of solid water slabs.  The dose response of the OSL is similar to the dose 
response of the more widely used MOSFET detectors.   Both dose responses are within +/- 
20% of the calibrated ion chamber.  When the OSL nanoDot is placed within the 
anthropomorphic phantom, care should be taken to ensure that the dosimeter is aligned in 
the anthropomorphic organ plugs in the same manner for every experimental run.  This will 
ensure that the dosimeter has a consistent response between experiments. 
  
Responses of the OSL tend to varying more at lower diagnostic energies.  For this reason, I 
assessed the responses of the OSL place on edge to the primary beam to the response of an 
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OSL placed flat (orthogonal) to the primary beam.  The primary energies assessed were 80 
kVp and 100 kVp.  The responses were within +/- 12%.   
 
OSL Depth Response Conclusion 
OSL dosimeters have a similar response to a calibrated ion chamber when placed under 
increasing thicknesses of solid water simulating tissue.  The overall response was 
exponentially decreasing as the thickness increased.  The OSL response was within +/- 20 
% of the ion chamber for all thicknesses of solid water.  Additionally, the response did not 
vary more than +/- 12% when the dosimeter was placed along the direction of the primary 
beam or orthogonal to the primary beam.  OSL can be used in an anthropomorphic 
phantom to assess radiation dose from a CT machine.  The orientation of the OSL to the 
primary beam will have no significant affect on how the OSL dosimeter responds which is 
important when measuring the overall absorbed dose to a specific location from both 
primary radiation and scatter radiation.  
 
Methodology 
In order to verify the model development, the six trauma CT scans (Tables 34 and 35) were 
conducted on the anthropomorphic female and male phantoms with OSL dosimeters placed 
in different organ locations.  The measured absorbed organ doses were compared against 







Table 34.  General technique factors used for the experimental measurements of the male 
anthropomorphic phantom (Dude).  Scanning ranges are shown in Specific Aim 2. 






Brain Axial 120 kVp 155 mA 5 mm 
Cervical 
Spine 























Table 35. General technique factors used for the experimental measurements for the 
female anthropomorphic phantom (Daisy).  Scanning ranges are shown in Specific Aim 
2. 






Brain Axial 120 kVp 155 mA 5 mm 
Cervical 
Spine 























Phantom placement (Figure 33a) on the CT machine couch is the same as a typical human 
placement for CT scanning. Soft tissue plugs of appropriate density were inserted at 
various locations in the different slabs where organs of interest are located (Figure 33b).  
The anthropomorphic phantoms have been designed and manufactured in accordance with 
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ICRU 30 specifications for elemental composition of human tissues (Table 36) [248].  
Some organs are more easily identified by their location and general shape (note the lungs 
(pink) in Figure 33b) than others which will take on the same color (generally gray) as 
normal tissue.   
a.  b.  
Figure 33.  Representative photo of an anthropomorphic phantom on the CT scanning 
couch (Figure 33a) and a cross-section view of a 2.5-cm slab of the anthropomorphic 
phantom (Figure 33b). 
Table 36.  Material elemental composition for CIRS, Inc. adult anthropomorphic 
phantoms. 
Adult Phantom Material Elemental Composition 








0.3703 0.3566 0.0483 0.0097 0.1524 0.0290 0.0619 0.0005 0.0000 1.60 5.030E+23 
Soft 
Tissue 
0.5744 0.2459 0.0847 0.0165 0.0000 0.0000 0.0762 0.0019 0.0000 1.05 3.434E+23 
Spinal 
Cord 
0.5427 0.2659 0.0736 0.0217 0.0000 0.0000 0.0937 0.0022 0.0000 1.07 3.448E+23 
Spinal 
Disks 
0.4627 0.3082 0.0675 0.0188 0.0000 0.0000 0.1407 0.0020 0.0000 1.15 3.694E+23 
Lung 0.6336 0.2046 0.0832 0.0315 0.0000 0.0000 0.0000 0.0137 0.0000 0.21 6.820E+22 
Brain 0.5360 0.2649 0.0816 0.0153 0.0000 0.0000 0.0998 0.0019 0.0000 1.07 3.470E+23 
 
Determination of which organs to be measured was made by conducting a separate 
experiment assessing which organ doses contributed the most to the overall effective dose 
from each scan.  There is a difference in the overall number of organ locations assessed 
when comparing the female phantom (Daisy) (Table 37) to the male phantom (Dude) 
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(Table 38). This is due to limitations on the number of soft tissue plugs (representing 
different organ densities) on hand at the time during the scanning experiments.  When 
experimental scanning was conducted on Dude, more soft tissue plugs were obtained from 
the manufacturer and used. 
Table 37.  Table presenting the number of dosimeters and their locations in the female 
phantom (Daisy). 
Organ Number of Dosimeters 




Spinal Cord 1 
Esophagus 1 
Eye 3 (1 in eye socket, 2 surface) 













Table 38.  Table presenting the number of dosimeters and their locations in the male 
phantom (Dude). 















Adrenals / Gall Bladder 1 
Testes 2 
Total Number of Plugs 41 
 
All dosimeters were read in a dosimeter reader at least three times and then the readings 
were averaged.  The dosimeter reader was calibrated using the manufacturer’s 80 kVp, 
2.9-mm Al HVL calibration technique.  Final readings were adjusted to account for CT 
scanning (120 kVp) by multiplying each final reading by 115% based upon our energy 
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response curve (Figure 24).  The averaged dose to an individual organ is calculated 
according to the below equation (equation 13). 
 
   
 
 
                                       -     
 
                                  13                                                                   
 
The following tables present the absorbed dose from the experimental measurements 
compared against those calculated using the specific dimensions of the phantoms (height 
and weight) as input into PCXMC.  Some differences (experimental versus calculated) 
between the specific organ absorbed doses were expected based upon literature review 
[46, 59, 123, 190, 250, 281-282].  Overall, equivalent dose differences were expected to 
be within 30% for those organs within the primary range of the scan.  Absolute percent 
differences are calculated according to equation 14. 
 
                             
                   
                       
                            14 
 
Results 
Brain Scan   
Table 39 lists the organ doses (mGy) for both the experimentally measured quantity and 
the calculated quantity for Daisy and Dude.  Absorbed doses to the eyes is not able to be 
mathematically calculated with the PCXMC program primarily due to eyes not having an 
internationally agreed upon radiation sensitivity by which an equivalent dose can be 
calculated.   
 
Table 39.  Specific organ absorbed doses. 



























 Eye 34 +/-3  
(each) 
NA  22.9 +/- 
0.7 
NA  
Brain 30 +/- 5 33.80 +/- 
.09 





139% 0.8 +/- 0.2 0.15 +/- 
0.03 
137% 




57% 0.2 +/- 0.1 .024 +/- 
0.001 
157% 




























Table 40 lists the equivalent dose for each organ.  Equivalent dose is determined by 
multiplying the absorbed dose by the ICRP 103 tissue weighting factor.  Note that there is 
no ICRP 103 tissue weighting factor, therefore, the absorbed dose measured for the eyes 
is not a part of the summed equivalent dose (referred to as the modified effective dose). 
 
Table 40.  Modified effective dose per scan and the influence of the equivalent dose on 










































































































Cervical Spine Scan 
 
Table 41 lists the organ results for a cervical spine scan while Table 42 lists the 
equivalent doses and modified effective dose.  The organs directly within the scanning 
field of view are the thyroid and lower portion of the brain.  The esophagus is partially 
scanned.   
Table 41.  Cervical Spine specific organ absorbed dose. 

























 Eye 34 +/- 2  
(each) 
NA  18.6 +/- 
0.7 
NA  





10.9 +/- 0.3 19% 7 +/- 4 6.5 +/- 0.2 7% 
Thyroid 44.5 +/-.05 30 +/- 3 39% 21 +/- 1 28 +/- 2 29% 
Lung 0.5 +/- 0.1 0.31 +/- 
0.02 
47% 4 +/- 3 0.83 +/- 
0.04 
131% 
Thymus 8.0 +/- 0.2 0.26 +/- 
0.09 
187% 14.2 +/- 
0.2 
0.7 +/- 0.2 181% 
Esophagus 1.83 +/- 
0.02 
0.5 +/- 0.1 114% 13.5 +/- 
0.2 
1.5 +/- 0.2 160% 
Liver 0.221 +/- 0.022 +/- 164% 0.6 +/- 0.046 +/- 171% 
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0.005 0.004 0.4 0.007 
 
Table 42.  Cervical Scan modified effective dose per scan and the influence of the 
equivalent dose on the overall modified effective dose. The absolute percent difference 
between the effective dose values is lower when only considering those organs within the 















































































































The percent difference in the different methods for the modified effective dose is 50% for 
Daisy and 60% for Dude.  When calculated using only those organs within the FOV, the 
percent difference is 35% for Daisy and 26% for Dude.  For only those organs that lie 
within the scanning FOV (Thyroid, Brain, and Esophagus), the percent difference for 
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Dude (Measured (1.45 mSv) and Calculated (1.25 mSv)) is 15%.  The percent difference 
for Daisy (Measured (1.94 mSv) and Calculated (1.33 mSv)) is 37%. 
Chest Abdomen Pelvis Scan 
Tables 43 and 44 list the absorbed doses and the modified effective dose for a chest 
abdomen pelvis scan.  All of the organs listed in the tables are included within the primary 
scanning field of view except the brain (and of course the eyes). 
 
Table 43.  Organ absorbed doses for a chest abdomen pelvis scan. 































29% 27.9 +/- 
0.4 
38 +/- 8 31% 













21% 28 +/- 5 35 +/- 2 22% 
Esophagus 25 +/- 1 29.4 +/- 
0.1 
16% 22.1 +/- 
0.4 
25 +/- 4 12% 
Eye 0.495 +/- 
0.008  
NA  0.74 +/- 
0.08 
NA  




14% 24.2 +/- 
0.8 (each) 
45 +/- 2  7% 




40% 26.3 +/- 
0.9 
47 +/- 1 56% 




18% 24 +/- 1 
(each) 
43 +/- 3 11% 




22% 28.5 +/- 
0.2 
25 +/- 4 13% 













102% 30.2 +/- 
0.8 
1.4 +/- 0.7 182% 





















































3.4 +/- 0.6 4.2 +/- 0.2 






1.0 +/- 0.2 












5.8 +/- 0.2 5.2 +/- 0.4 






































The percent difference between the modified effective doses determined using either the 
mathematical phantom or experimental measurement is very small, 17% for Daisy and 1% 
for Dude.  When accounting for only those organs within the scanning field of view (all 






Tables 45 and 46 list the organ absorbed doses and modified effective dose for a chest scan.  
Organs within the scanning field of view for a chest scan include the esophagus, liver, lung, 
pancreas, thymus, adrenals/gall bladder, kidney, and thyroid. 
 
Table 45. Organ absorbed doses for a chest scan. 





























3.5 +/- 0.7 34% 3.90 +/- 
0.04 
3.1 +/- 06 23% 






















26% 20.5 +/- 
0.3 
22 +/- 1 7% 
Eye 0.29 +/- 
0.02 
NA  0.61 +/- 
0.09 
NA  
Kidney 2.16 +/- 
0.03 
(each) 
4.2 +/- 0.4 3% 2.8 +/- 
0.7 (each) 
3.1 +/- 0.3 57% 




18% 14 +/- 9 14.6 +/- 
0.5 
4% 









Pancreas 2.43 +/- 
0.03 
13 +/- 1  137% 5.62 +/- 
0.08 
11 +/- 1 65% 




8% 27.2 +/- 
0.4 
32 +/- 3 16% 
Thyroid 8.3 +/- 
0.7 
4 +/- 1 70% 25 +/- 2 6 +/- 2 123% 








































































0.6 +/- 0.4 0.58 +/- 
0.02 
Lung 0.12 2 +/- 1 3.12 +/- 
0.04 
5.4 +/- 0.2 4.66 +/- 
0.05 






1.3 +/- 0.1 


















Modified Effective Dose 
(mSv) 
4 +/- 1 5.62 +/- 
0.08 
34% 9.3 +/- 0.5 8.2 +/- 0.2 13% 
 
The percent difference between the two values for the modified effective dose is 34% for 
Daisy and 13% for Dude.  The percent difference between the two values when only 
accounting for those organs within the scanning field of view is 29% for Daisy and 13% 
for Dude. 
Thoracic Spine Scan 
Tables 47 and 48 list the absorbed doses and modified effective dose for a thoracic spine 
scan.  The organs within the field of view for a thoracic spine scan include the esophagus, 
liver, lung, pancreas, thymus, adrenals/gall bladder, kidney, and thyroid. The scanning 




Table 47. Organ absorbed doses for a thoracic spine scan. 

























Adrenals 8.9 +/- 
0.2  
4.0 +/- 0.8 76% 7.3 +/- 
0.1 
6.9 +/- 0.6 6% 


















Esophagus 8.8 +/- 
0.2 
9.3 +/- 0.5 6% 20.0 +/- 
0.3 
20 +/- 1 0% 
Eye 0.19 +/- 
0.02 
NA  0.7 +/- 
0.1 
NA  




180% 5 +/- 1 11.0  +/- 
0.7 
9% 
Liver 9.3 +/- 
0.2 
3.6 +/- 0.1 88% 20 +/- 4 6 +/- 1 108% 









Pancreas 7.5 +/- 
0.2 
2.7 +/- 0.3 94% 14.0 +/- 
0.2 
5.2 +/- 0.6 92% 
Thymus 7.7 +/- 
0.2 
16 +/- 1 70% 27.4 +/- 
0.5 
8.8 +/- 0.3  103% 
Thyroid 2.87 +/- 
0.07 
3.1 +/- 0.6 8% 25 +/- 3 13 +/- 2 63% 








































































0.8 +/- 0.2 0.24 +/- 
0.04 
Lung 0.12 2.3 +/- 0.1 2.12 +/- 
0.02 
4.8 +/- 0.5 4.80 +/- 
0.06 












1.0 +/- 0.1 0.52 +/- 
0.08 










Modified Effective Dose 
(mSv) 
4.4 +/- 0.1 3.65 +/- 
0.06 
19% 9.5 +/- 0.6 7.4 +/- 0.2 25% 
 
The percent difference between the two values for the modified effective dose is 19% for 
Daisy and 25% for Dude.  The percent difference between the two values, measured and 
calculated, when only accounting for those organs within the scanning field of view is 
19% for Daisy (4.41 mSv and 3.62 mSv) and 24% for Dude (9.40 mSv and 7.41 mSv). 
Lumbar Spine Scan 
Tables 49 and 50 list the absorbed doses and modified effective dose for a lumbar spine 
scan.  The organs within the field of view for a lumbar spine scan include the liver, lung, 
pancreas, adrenals/gall bladder, kidney, and uterus/testes.  
 
Table 49. Organ absorbed doses for lumbar spine scan. 





























20 +/- 1 11% 22.3 +/- 
0.9 

















10% 22 +/- 3 33.9 +/- 
0.7 
43% 
Esophagus 1.36 +/- 
0.03 
8.7 +/- 0.5 146% 0.227 +/- 
0.006 
3 +/- 1 172% 
Eye (each) 0.069 +/- 
0.001 
NA  0.07 +/- 
0.01 
NA  





26% 18.7 +/- 
0.8 
(each) 
36 +/- 1 4% 




42% 13 +/- 1 26 +/- 1 67% 




3% 2 +/- 1 1.9 +/- 0.3 5% 




25% 21.1 +/- 
0.3 
22 +/- 3 4% 
Thymus 0.39 +/- 
0.01 
1.5 +/- 0.3 117% 0.290 +/- 
0.006 
0.4 +/- 0.2 32% 









Uterus/Testicles 14.8 +/- 
0.4 
3.5 +/- 0.3 123% 2.07 +/- 
0.01 
5 +/- 2 83% 
 
















































2.6 +/- 0.4 4.07 +/- 
0.08 
 






















0.5 +/- 0.1 0.23 +/- 
0.04 
 




















Pancreas 0.12* 2.49 +/- 
0.02 
2.1 +/- 0.1 2.49 +/- 
0.03 
2.9 +/- 0.1  




Kidney 0.12*  




6.2 +/- 0.1 7% 6.1 +/- 0.4 8.4 +/- 0.1 32% 
 
The percent difference between the two values for the modified effective dose is 7% for 
Daisy and 32% for Dude.  The percent difference between the two values, measured and 
calculated, when only accounting for those organs within the scanning field of view is 
0.23% for Daisy (4.29 mSv and 4.28 mSv) and 17% for Dude (3.51 mSv and 4.17 mSv). 
 
Experimental Uncertainties 
Uncertainties of the experimental study are shown below for each scanning protocol 
(Tables 51 – 56).  The sensitivities of the organs represented are an average of the Daisy 
and Dude organ sensitivity.  This was calculated in order to better equate to the model 
which is non-gender specific.  The determination of the rest of the sensitivities is explained 
in Specific Aim 2. 
 
Brain Scan 
Table 51.  Experimental sensitivity for Brain Scan. 











     
CT Scanner 
Characteristics 
Tube Current 2.5 1 20 6.25 
Exposure Time 0.03 1 20 0.0009 
Tube Voltage 1.5 2.5 20 14.06 
Slice Width/Table 
Movement 





    





    
Brain 10 .66  44 
Colon     
Esophagus 7 .055  .15 
Kidney     
Liver 21 .0045  .0089 
Lung 32 .050  2.6 
Pancreas     
Thymus 1.5 .073  .012 
Thyroid 2.5 .17  .18 





   NA 













1.5 1 20 2.25 
Radiation Edges 
Incidence 
7.5 0.2 20 2.25 
Calibration 
Variation 
2.5 1 20 6.25 
Energy Response 8.7 1 20 75.69 
Standard Deviation 
of Measurement 
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 95% CI for Ucomb 24 
 
Cervical Spine Scan 
Table 52.  Experimental sensitivity for Cervical Spine Scan. 











     
CT Scanner Tube Current 2.5 1 20 6.25 
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Characteristics Exposure Time 0.03 1 20 0.0009 
Tube Voltage 1.5 2.5 20 14.06 
Slice Width/Table 
Movement 
1 0.2 20 0.04 
CTDIair 
displayed/tabulated 
   NA 





   NA 
Brain 31 0.030  0.86 
Colon    NA 
Esophagus 0.64 0.12  0.0059 
Kidney     
Liver 17 0.006  0.010 
Lung 12 0.11  1.7 
Pancreas    NA 
Thymus 0.98 0.19  0.035 
Thyroid 1.2 0.55  0.44 





   NA 













1.5 1 20 2.25 
Radiation Edges 
Incidence 
7.5 0.2 20 2.25 
Calibration 
Variation 
2.5 1 20 6.25 
Energy Response 8.7 1 20 75.69 
Standard Deviation 
of Measurement 
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 95% CI for Ucomb 22 
 
Chest Abdomen Pelvis 
Table 53.  Experimental sensivity for Chest Abdomen Pelvis Scan. 
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Tube Current 2.5 1 20 6.25 
Exposure Time 0.03 1 20 0.0009 
Tube Voltage 1.5 2.5 20 14.06 
Slice Width/Table 
Movement 
1 0.2 20 0.04 
CTDIair 
displayed/tabulated 
   NA 





0.40 0.050  4.0E-4 
Brain 12 0.00030  1.3E-3 
Colon 5.0 0.19  0.90 
Esophagus 1.0 0.06  3.6E-3 
Kidney 1.0 0.05  2.5E-3 
Liver 1.0 0.06  3.6E-3 
Lung 2.0  0.38  0.58 
Pancreas 0.60 0.050  9.0E-4 
Thymus 0.80 0.060  2.3E-3 
Thyroid 1.0 0.12  1.4E-2 





   NA 













1.5 1 20 2.25 
Radiation Edges 
Incidence 
7.5 0.2 20 2.25 
Calibration 
Variation 
2.5 1 20 6.25 
Energy Response 8.7 1 20 75.69 
Standard Deviation 
of Measurement 
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Table 54.  Experimental sensitivity for Chest Scan. 











     
CT Scanner 
Characteristics 
Tube Current 2.5 1 20 6.25 
Exposure Time 0.03 1 20 0.0009 
Tube Voltage 1.5 2.5 20 14.06 
Slice Width/Table 
Movement 
1 0.2 20 0.04 
CTDIair 
displayed/tabulated 
   NA 





0.36 0.016  3.3E-5 
Brain 11 0.00059  4.2E-5 
Colon 2.4 0.0033  6.3E-5 
Esophagus 0.77 0.11  5.9E-3 
Kidney 6.6 0.016  1.1E-2 
Liver 16 0.088  2.0 
Lung 11 0.54  35 
Pancreas 0.66 0.016  1.1E-4 
Thymus 1.1 0.12  1.7E-2 
Thyroid 4.1 0.095  0.15 





   NA 













1.5 1 20 2.25 
Radiation Edges 
Incidence 
7.5 0.2 20 2.25 
Calibration 
Variation 
2.5 1 20 6.25 
Energy Response 8.7 1 20 75.69 
Standard Deviation 
of Measurement 
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 95% CI for Ucomb 24 
 
Thoracic Spine Scan 
Table 55.  Experimental sensitivity for Thoracic Spine Scan. 











     
CT Scanner 
Characteristics 
Tube Current 2.5 1 20 6.25 
Exposure Time 0.03 1 20 0.0009 
Tube Voltage 1.5 2.5 20 14.06 
Slice Width/Table 
Movement 
1 0.2 20 0.04 
CTDIair 
displayed/tabulated 
   NA 





0.90 0.039  1.2E-3 
Brain 23 0.00051  1.4E-4 
Colon 1.9 0.0073  1.9E-4 
Esophagus 0.94 0.08  5.7E-3 
Kidney 5.6 0.039  0.048 
Liver 5.5 0.084  0.21 
Lung 3.0 0.51  2.3 
Pancreas 1.0 0.039  1.5E-3 
Thymus 1.1 0.093  0.010 
Thyroid 3.6 0.066  0.056 





   NA 













1.5 1 20 2.25 
Radiation Edges 
Incidence 
7.5 0.2 20 2.25 
Calibration 
Variation 
2.5 1 20 6.25 
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Energy Response 8.7 1 20 75.69 
Standard Deviation 
of Measurement 
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 95% CI for Ucomb 22 
 
Lumbar Spine Scan 
Table 56.  Experimental sensitivity for Lumbar Spine Scan. 











     
CT Scanner 
Characteristics 
Tube Current 2.5 1 20 6.25 
Exposure Time 0.03 1 20 0.0009 
Tube Voltage 1.5 2.5 20 14.06 
Slice Width/Table 
Movement 
1 0.2 20 0.04 
CTDIair 
displayed/tabulated 
   NA 





1.6 0.11  0.031 
Brain 7.4 0.000060  2.0E-7 
Colon 4.1 0.33  1.8 
Esophagus 1.2 0.0054  4.2E-5 
Kidney 1.7 0.11  0.035 
Liver 2.5 0.098  0.060 
Lung 14 0.14  3.8 
Pancreas 0.93 0.11  0.010 
Thymus 1.2 0.0023  7.6E-6 
Thyroid 1.9 0.0013  6.1E-6 





   NA 













1.5 1 20 2.25 






2.5 1 20 6.25 
Energy Response 8.7 1 20 75.69 
Standard Deviation 
of Measurement 
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The experimental sensitivity for the brain scan, thoracic spine scan, and lumbar spine scan 
is ±12%.  The experimental sensitivity for the cervical spine scan, chest abdomen pelvis 
scan, and chest scan is ±11%.  The greatest contribution to the overall uncertainty for each 
of the scans is from the dosimeter energy response uncertainty, 8.7%. As expected, the 
scanning experimental sensitivities for the different scans are less (therefore have more 
precision) than the scanning sensitivities calculated by using Monte Carlo techniques.   
This is because experimental sensitivities reflect what is truly happening with the 
measurements rather than attempting to simulate reality. 
Discussion 
The models developed (Chapter 4) for the six CT trauma scans can be used with 
confidence.  Experimental verification compared the scanning techniques used in the model 
development with the scanning techniques used on physical phantoms in a real computed 
tomography scanner.  In all scans (vice the cervical spine scan for Daisy), the absolute 
percent difference between the experimentally measured modified effective dose and the 
calculated (same technique as that used in the model development) modified effective dose 
was under 30%.  The 37% absolute percent difference between the two methods for 
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calculating the modified effective dose for Daisy in the cervical spine scan was driven by 
the slightly higher equivalent dose to the thyroid (1.780 +/- 0.002 mSv for experimentally 
measured and 1.2 +/- 0.1 mSv for the calculated value) from the experimentally measured 
scan.  This is probably due to the difference in the sizes of the thyroid between the 
mathematical phantom and the anthropomorphic phantom.  Experimentally measured 
higher absorbed doses in organs as compared to calculated values are not uncommon [46, 
59, 123, 190, 250, 281-282].   
 
Values between anthropomorphic phantoms and mathematical phantoms will compare well 
when the organ is small in volume and can be represented by a centrally located point dose.  
However, when the organ is large and the dose is not uniform throughout the organ due to 
only a partial volume of the organ being irradiated or due to low x-ray energies, a higher 
absolute percent difference will be seen.  But when the organ is large and the dose is fairly 
uniform across the organ due to the entire organ being in the scanning field-of-view, the 
absolute percent difference will be low [250].  This was observed in the measurement 
sensitivity analysis.  Likewise, organs within the scanning field-of-view will generally 
contribute the more equivalent dose to the overall effective dose than organs not within the 
scanning field-of-view.  Organs outside the scanning field-of-view will have a higher 
percent error associated with the absorbed dose.    
 
Anthropomorphic phantoms have been used extensively to measure the radiation dose to 
specific locations within the human body.  Researchers can design and develop their own 
phantoms but will often purchase the anthropomorphic phantoms from a manufacturer 
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equipped to design, manufacture, and modify the phantoms to the researcher specifications.  
In my research, I purchased the anthropomorphic phantoms from CIRS (Norfolk, Virginia) 
modified for my specific purpose of measuring radiation dose to an exact location with 
optically stimulated luminescent dosimeters.  The phantoms replicate reference male and 
reference female dimensions as defined by ICRU 44 and ICRP 23 specifications.  
Experiments were conducted in order to characterize the dose response of optically 
stimulated luminescent dosimeters designed by Landauer, Inc.  These dosimeters are 
extremely small (approximately 1 cm x 1 cm x 0.2 cm) and can be inserted into the 
specifically designed tissue plugs in the anthropomorphic phantoms.  Our experiments 
confirmed the linearity and response of the manufacturer specifications (reporting dose 10 
mrad to 1500 rad, energy range 5 keV up to 20+ MeV, and an accuracy of +/- 5%) [249, 
268, 283].  Additionally, our experiments also assessed the dose response of the dosimeters 
at varying thicknesses of solid water used to simulate increasing depths of tissue.  The 
results confirmed that the dosimeters have an expected exponential response and when 
compared with a calibrated ion chamber, the response is within +/- 20% at depths down to 
14 cm. 
 
Acceptance of the verification measurements to within 30% is driven by both literature and 
statistical analysis.  Since the measurements are assumed to be normally distributed, then 
about 68% of the data will lie within one standard deviation of the mean.  Therefore, if two 
measures are within 30% of each other, then one can assume that the two measures are 
within one standard deviation of the true mean.  There are several reasons why 
experimental measurements differ from the mathematical modeling.  The calculated 
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method uses a stylized mathematical Cristy phantom (Figure 10) while the measurement 
values were obtained using a physical anthropomorphic phantom (Figure 33).  Even when 
Struelens et al [59] compared an MCNP voxelized Rando-Alderson phantom with a 
physical Rando-Alderson phantom, results were said to in agreement with most absorbed 
doses within the scanning field-of-view being within +/- 15% and for those organs outside 
the field-of-view being within +/- 30%.  Struelens attributed the difference to the energy 
and geometrical dependence of the detectors, difference in material compositions, field 
sizes, and phantom positioning.  Experiments performed with PCXMC and Rando-
Alderson phantoms have shown strong correlation of the computed doses to experimental 
doses being within 30% with the primary reason for the difference being anatomic [209].  
Also of note is that differences in the field size can either increase the dose (resulting from 
more organs being included within the field-of-view) or decreasing the dose (resulting from 
fewer organs being included within the field-of-view). Comparisons between two methods 
of calculating effective doses, experimental using TLDs and weighted CTDI methods, 
Cohnen et al found that excellent correlation between the two calculations could be 
demonstrated for differences up to 30% [284].  
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CHAPTER 6.  Specific Aim 4:  Validate the effective dose models against current 
DLP methods for estimating effective doses using a pilot study of representative 
trauma patient CT scans. 
 
Introduction 
Chapter 6 will address the comparison of effective doses estimated by use of the Ht/Wt 
model developed in Chapter 4 against current effective dose estimation methods.  Data 
from a real MSKCC patient population will be used as inputs for the two methods.  The 
two effective dose estimation methods will be statistically analyzed for repeatability and 
interchangeability.  Finally, the two effective dose estimation methods will be applied to a 
hypothetical example of a CT scanning history for a Soldier who sustained traumatic 
injuries. 
  
Validation of the effective dose methodology occurred with data collected in a Memorial 
Sloan-Kettering Cancer Center Institutional Review Board approved (approval number 
WA0313-10) retrospective study of patients from 2005 to 2010 who underwent CT scans 
of the aforementioned six scanning protocols (brain, cervical spine, chest abdomen pelvis, 
chest, thoracic spine, and lumbar spine).  Although MSKCC patients tend to be older and 
have less muscle mass than the average soldier in the U.S. Army, the scanning ranges for 
the different scans will be very similar and are based upon anatomic locations as opposed 
to age, muscle mass, or gender. All patients were chosen at random and only pediatric 
patients were excluded due to difference in scanning machine technique factors and 




The statistical comparisons used in this chapter will be performed using Bland-Altman 
plots.  Bland-Altman plots represent the difference of two measurements versus the average 
of the two measurements [285].  Other techniques use standard regression analysis for the 
two measurements, but regression analysis only shows a measure of the association 
(correlation) between the two measurements rather than show any information concerning 
agreement.  Bland-Altman plots are more informative and allow us to determine how 
repeatable the measurements are and how well the two measurements agree.   
 
In order to validate the Ht/Wt model developed in Chapter 4, I compared the modeled 
effective dose results to the current accepted method for estimating effective dose 
calculates the effective dose from a computed tomography scan by multiplying the dose-
length-product from the scan, obtained from the individual CT dose report, with an 
effective dose conversion coefficient.  The conversion coefficients are accepted values 
(AAPM [286], NCRP [14], and ICRU [287]) based upon Monte Carlo modeling of the 
beam characteristics, the scanning field-of-view, the photon simulation inside a patient, and 
the modeling of the patient themselves.  Conversion coefficients are designed for specific 
organs and are therefore applied to each slice thickness in accordance with the location of 
the CT scan.  Conversion coefficients typically have a higher degree of statistical 
uncertainty for the organs that lie outside of the scanning field-of-view than for those 
organs that lie within the scanning field-of-view [66, 201].  However, the effective dose 
contributions from these organs are generally low and are of less importance than those 
organs within the primary scanning field-of-view.  Researchers from respected agencies 
(Center for Devices and Radiological Health, GSF-National Research Center for 
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Environment and Health, and National Radiological Protection Board) have published 
conversion coefficients specifically for calculating the effective dose [288].   
 
The probability risk estimates of cancer incidence and cancer mortality can be calculated 
using BEIR VII methodology [29].  This methodology has been previously used to quantify 
the risks from CT scans [21].  
 
Methods 
Radiation doses from six different CT protocols (10 adult scans of each protocol; brain, 
cervical spine, chest-abdomen-pelvis, chest, thoracic spine, and lumbar spine) were 
collected and analyzed for dose variability.  The information collected from the PACS 
database was age, gender, height/weight (obtained from patient electronic records), CTDI, 
DLP, scanning range and CT machine techniques (mA, kVp, pitch, and slice thickness). 
This information was used to validate the Ht/Wt models. 
 
Previous research that we conducted showed that the variability in dose-length-product can 
range from 2.5-fold to 5-fold among different manufacturers and CT models when using 
identical technique factors.  The highest variation occurred with CT scans covering the 
abdominal portion of the body.  Other published research has shown that the effective dose 
can vary by 13-fold (difference between lowest effective dose and highest effective dose) 
with abdominal and pelvis CT scans among machines from four different institutions [289].  
Our preliminary research using an anthropomorphic phantom with two different detectors 
on one machine showed that the effective dose (calculated from established DLP to 
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effective dose conversion coefficients) can vary by 2-fold for brain, chest-abdomen-pelvis, 
and lumbar spine scans. 
 
Results 
Brain Scan Comparison 
In accordance with MSKCC IRB (approval number WA0313-10), data on ten patients who 
underwent a brain scan were collected (Table 57). All the patients were adults.  The 
population means +/- SD were: height 172 +/- 11 cm, weight 74 +/- 17 kg, DLP 719 +/- 18 
mGy cm, and scan range 17.5 +/- 0.6 cm.  
 
Table 57. Brain scan patient information. Ht/Wt model dose estimate, conversion 













Dose (mSv)   
Effective Dose (mSv) 







SD     0.0021   0.0023 




0.9 - 4 
172.8 59.4 710.84 18.3 1.92 ±0.26 1.49 1.63 
173 60.5 710.84 17.0 1.91 ±0.26 1.49 1.63 
178 65.3 752.65 18.0 1.84 ±0.26 1.58 1.73 
179.1 84.4 752.65 18.1 1.69 ±0.20 1.58 1.73 
193 108.9 710.84 18.3 1.44 ±0.26 1.49 1.63 
162 60.9 710.84 17.1 1.97 ±0.26 1.49 1.63 
165 58.7 710.84 17.0 1.97 ±0.26 1.49 1.63 
175.3 74 710.84 17.0 1.80 ±0.26 1.49 1.63 
153 92.7 710.84 17.0 1.80 ±0.27 1.49 1.63 
 
The population average and standard deviation of predicted effective dose is 1.8 +/- 0.2 
mSv.  The average and standard deviation of the effective dose using the conversion 




Cervical Spine Scan Comparison 
Data on ten patients who underwent a cervical spine scan was collected (Table 58). All the 
patients were adults.  The population means +/- SD were:  height 166 +/- 10 cm, weight 67 
+/- 15 kg, DLP 464 +/- 42 mGy cm, and scan range 21 +/- 2 cm. 
 
Table 58. Cervical Spine patient information. Ht/Wt model dose estimate, conversion 














(mSv)   
Effective Dose (mSv) 






SD 0.0048 0.0054 0.0059 






171 72.5 417.18 17.41 2.41 ±0.04 2.00 2.25 2.46 
175.3 49.9 439.06 23.59 2.54 ±0.09 2.11 2.37 2.59 
162 48.5 441.15 19.41 2.72 ±0.07 2.12 2.38 2.60 
144 46.8 459.98 19.66 3.37 ±0.10 2.21 2.48 2.71 
161 66.3 480.42 23.78 2.62 ±0.06 2.31 2.59 2.83 
177 77.7 493.44 22.60 2.34 ±0.05 2.37 2.66 2.91 
159.1 89.8 500.41 20.91 2.50 ±0.08 2.40 2.70 2.95 
170 68 502.68 20.91 2.45 ±0.06 2.41 2.71 2.97 
168.8 77.6 519.45 23.92 2.40 ±0.05 2.49 2.81 3.06 
 
The population average and standard deviation of predicted effective dose is 2.6 +/- 0.3 
mSv.  The average and standard deviation of the effective dose using the conversion 
coefficients for the three coefficients are 2.2 +/- 0.2 mSv, 2.5 +/- 0.2 mSv, and 2.7 +/- 0.2 




Chest Abdomen Pelvis Scan Comparison 
Data on ten patients who underwent a chest abdomen pelvis scan was collected (Table 59). 
All the patients were adults.  The population means +/- SD were:  height 167 +/- 8 cm, 
weight 81 +/- 19 kg, DLP 1114 +/- 248 mGy cm, and scan range 68 +/- 4 cm. 
 
Table 59.  Chest abdomen pelvis patient information. Ht/Wt model dose estimate, 
conversion coefficient model dose estimate, and comparison to nominal values for chest 











The population average and standard deviation of predicted effective dose is 19 +/- 2 mSv.   
The average and standard deviation of the effective dose using the conversion coefficients 

























SD 0.015  0.017  
164 83.6 1414.61 67.62 18.97 ±1.07 21.22 24.05 
C
h











3 - 25 
162.9 60.8 842.61 65.62 21.23 ±1.07 12.64 14.32 
173 78.6 1017.59 71.01 20.05 ±1.05 15.26 17.30 
157.5 65.8 902.81 62.48 20.38 ±1.07 13.54 15.35 
159 63.7 951.82 61.64 20.69 ±1.06 14.28 16.18 
180 114 1213.6 67.87 16.88 ±1.07 18.20 20.63 
174.2 114.3 1586.81 71.09 16.48 ±1.08 23.80 26.98 
166 68 960.56 72.60 20.69 ±1.07 14.41 16.33 
173 84.5 1291.96 72.10 19.45 ±1.06 19.38 21.96 




Chest Scan Comparison 
Data on ten patients who underwent a chest scan was collected (Table 60). All the patients 
were adults.  The population means +/- SD were:  height 169 +/- 10 cm, weight 84 +/- 15 
kg, DLP 479 +/- 33 mGy cm, and scan range 13 +/- 1 cm. 
 
Table 60. Chest scan patient information. Ht/Wt model dose estimate, conversion 











Predicted Effective Dose 
(mSv)   






Range Ht/Wt Model SD 0.014  0.017 0.018  









172 69.6 435.29 10.4 11.71 ±1.36 6.09 7.40 7.84 
181 95.6 458.5 12.78 10.27 ±1.37 6.42 7.79 8.25 
157 73 471.89 12.88 11.00 ±1.37 6.61 8.02 8.49 
170 75.5 473.43 12.5 11.19 ±1.35 6.63 8.05 8.52 
160 85 480.79 12.53 10.21 ±1.37 6.73 8.17 8.65 
183 97 492.15 12.66 10.28 ±1.35 6.89 8.37 8.86 
181 100.4 496.85 12.78 9.99 ±1.36 6.96 8.45 8.94 
166.5 68.1 509.16 12.38 11.64 ±1.35 7.13 8.66 9.16 
161 67 538.72 14.13 11.57 ±1.36 7.54 9.16 9.70 
 
The population average and standard deviation of predicted effective dose is 10.7 +/- 0.9 
mSv.  The average and standard deviation of the effective dose using the conversion 
coefficients for the three coefficients is 6.7 +/- 0.5 mSv, 8.1 +/- 0.6 mSv, and 8.6 +/- 0.6 
mSv respectively.   
 
Thoracic Spine Scan Comparison 
Data on ten patients who underwent a thoracic spine scan was collected (Table 61). All the 
patients were adults.  The population means +/- SD were:  height 169 +/- 9 cm, weight 76 




Table 61. Thoracic spine scan patient information. Ht/Wt model dose estimate, 
conversion coefficient model dose estimate, and comparison to nominal values for 














Effective Dose (mSv) 
using Conversion 








SD 0.014  0.017  0.018 






182 128.9 1213.95 41.1 11.309 ±0.663 17.00 20.64 21.85 
170 59.8 1079.82 37.4 14.440 ±0.654 15.12 18.36 19.44 
165 64.6 1155.71 37.7 13.919 ±0.652 16.18 19.65 20.80 
165 60 651.33 38.4 14.209 ±0.653 9.12 11.07 11.72 
158.6 53.7 874.82 38.4 14.328 ±0.656 12.25 14.87 15.75 
176 72 773.31 36.8 14.002 ±0.651 10.83 13.15 13.92 
159 74.5 972.19 35.9 12.931 ±0.654 13.61 16.53 17.50 
177 70.6 947.64 34.2 14.124 ±0.651 13.27 16.11 17.06 
160 61.9 811.53 38.4 13.841 ±0.654 11.36 13.80 14.61 
 
The population average and standard deviation of predicted effective dose is 13 +/- 1 mSv.  
The average and standard deviation of the effective dose using the conversion coefficients 
for the three coefficients is 13 +/- 2 mSv, 16 +/- 3 mSv, and 17 +/- 3 mSv respectively.  
The average values are skewed because the second patient’s BMI (38.9 kg/cm2) is outside 
of the model predictive value of BMI’s between 18 kg/cm2 and 36 kg/cm2.  This type of 
patient results in a lower predicted effective dose.  The predicted effective dose is low 
because the dose values are based off of a single entrance skin dose value which is used for 
all predicted BMIs.  The high DLP value for the obese patient will reflect the adjustment 




Lumbar Spine Scan Comparison 
Data on ten patients who underwent a lumbar spine scan was collected (Table 62). All the 
patients were adults.  The population means +/- SD were:  height 169 +/- 9 cm, weight 86 
+/- 29 kg, DLP 888 +/- 173 mGy cm, and scan range 32 +/- 6 cm. 
 
Table 62. Lumbar spine scan patient information. Ht/Wt model dose estimate, conversion 













Dose (mSv)   










SD 0.012  0.015  0.017  






155 62.4 949.15 32.4 11.32 ±0.70 11.39 14.24 16.14 
160.6 62.2 978.96 39.0 11.79 ±0.70 11.75 14.68 16.64 
157 62 762.08 25.9 11.52 ±0.70 9.14 11.43 12.96 
170 68 727.48 25.2 11.82 ±0.70 8.73 10.91 12.37 
167 70.5 726.22 27.2 11.21 ±0.70 8.71 10.89 12.35 
180.3 98.2 967.51 34.1 7.71 ±0.70 11.61 14.51 16.45 
167.5 77.1 579.19 26.7 10.28 ±0.70 6.95 8.69 9.85 
151 68.9 893.42 25.2 10.15 ±0.70 10.72 13.40 15.19 
175 61.4 805.92 27.4 13.11 ±0.69 9.67 12.09 13.70 
 
The population average and standard deviation of predicted effective dose is 11 +/- 2 mSv.  
The average and standard deviation of the effective dose using the conversion coefficients 
for the three coefficients is 9 +/- 2 mSv, 12 +/- 3 mSv, and 14 +/- 3 mSv respectively.  The 
predicted model average absolute difference to each of the conversion coefficient values is 




Determination of acceptability (agreement) was performed by analyzing the data via Bland-
Altman plots.  These plots show the average of the means of the two values calculated by 
using the two different effective dose estimation methods on the x-axis.  On the y-axis, the 
differences between the values calculated by using the two different effective dose 
estimation methods are shown. This difference represents a measurement of the bias 
between the two effective dose estimation methodologies.  A positive bias indicates that the 
Ht/Wt model is biased towards a higher effective dose estimation value than the DLP-CC 
method whereas a negative bias would indicate that the Ht/Wt model is biased towards a 
lower effective dose estimation value than the DLP-CC method.  The 95% confidence 
interval of the mean of the differences illustrates the magnitude of the systematic 
difference.  The value of zero shows the measure of equality (there is no difference 
between the means of the two values).  If the measure of equality, zero, is not in the 
interval, there is a significant systematic difference.  The 95% confidence interval lines (+/- 
1.96 SD) show the upper and lower limits of agreement.  When the values on the plot are 
within the mean +/- 1.96 SD and are not clinically important, the models may be used 
interchangeably [285, 290]. 
 
Brain Scan Bland-Altman Plot 
Figure 34 shows the Bland-Altman plot for the two methods of calculating the effective 
dose from a brain scan.  I used the average effective dose values of the two conversion 
coefficients.  As can be seen from the plot, the Ht/Wt model has a slight positive bias in 
estimating the effective dose compared to the DLP-CC method.  The bias is small though, 
indicating that there is good agreement between the two methods on average.   There is no 
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significant systematic difference because the line of equality is within the +/-1.96 SD lines.  
All plot values are within two standard deviations. 
 
Figure 34. Bland-Altman plot of two methods for calculating the effective dose from a 
brain scan.  DLP-CC method represents the average of the doses from the two different 
conversion coefficients. 
Cervical Spine Bland-Altman Plot 
Figure 35 shows the Bland-Altman plot for the two methods of calculating the effective 
dose from a cervical spine scan.  I used the average effective dose values of the three 
conversion coefficients.  As can be seen from the plot, the model has a slight positive bias 
compared to the average of the conversion coefficients.  The bias is small though, 
indicating that there is good agreement between the two methods on average.   There is no 
significant systematic difference because the line of equality is within the +/-1.96 SD lines.  




Figure 35. Bland-Altman plot of two methods for calculating the effective dose from a 
cervical spine scan. DLP-CC method represents the average of the doses from the three 
different conversion coefficients. 
Chest Abdomen Pelvis Scan Bland-Altman Plot 
Figure 36 shows the Bland-Altman plot for the two methods of calculating the effective 
dose from a chest abdomen pelvis scan.  I used the average effective dose values of the two 
conversion coefficients.  As can be seen from the plot, the model has a slight positive bias 
compared to the average of the conversion coefficients.  The bias is large indicating that the 
Ht/Wt model consistently estimated higher effective doses than the DLP-CC method.  This 
is to be expected because there is no specifically derived conversion coefficient listed for 
Chest Abdomen Pelvis scans only for Chest scans and Abdomen Pelvis scans.  There is no 
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significant systematic difference because the line of equality is within the +/-1.96 SD lines.  
All plot values are within two standard deviations. 
 
Figure 36. Bland-Altman plot of two methods for calculating the effective dose from a 
chest abdomen pelvis scan. DLP-CC method represents the average of the doses from the 
two different conversion coefficients. 
Chest Scan Bland-Altman Plot 
Figure 37 shows the Bland-Altman plot for the two methods of calculating the effective 
dose from a chest scan.  I used the average estimate of the effective dose values of the three 
conversion coefficients to compare against the Ht/Wt model.  As can be seen from the plot, 
the Ht/Wt model has a positive bias compared to the estimated effective dose calculated 
using the DLP-CC method.  The 95% CI limits of agreement do not include zero so it is 
very unlikely that the two methods will ever agree. There is a significant systematic 
difference because the line of equality is not within the +/-1.96 SD lines.  There is good 
agreement with between the two methods because the values are within the 95% CI limits 




Figure 37. Bland-Altman plot of two methods for calculating the effective dose from a 
chest scan. DLP-CC method represents the average of the doses from the three different 
conversion coefficients. 
Thoracic Spine Scan Bland-Altman Plot 
Figure 38 shows the Bland-Altman plot for the two methods of calculating the effective 
dose from a thoracic spine scan.  I used the average effective dose values of the three 
conversion coefficients.  As can be seen from the plot, the model has a slight negative bias 
away from the model towards the conversion coefficients.  There is no significant 
systematic difference and there is good agreement with between the two methods because 




Figure 38. Bland-Altman plot of two methods for calculating the 
effective dose from a thoracic spine scan. DLP-CC method represents 
the average of the doses from the three different conversion 
coefficients. 
Lumbar Spine Scan Bland-Altman Plot 
Figure 39 shows the Bland-Altman plot for the two methods of calculating the effective 
dose from a lumbar spine scan.  I used the average effective dose values of the three 
conversion coefficients.  As can be seen from the plot, the model has a slight negative bias 
away from the model towards the conversion coefficients.  There is no significant 
systematic difference and there is good agreement with between the two methods because 





Figure 39. Bland-Altman plot of two methods for calculating the effective dose from a 
lumbar spine scan. DLP-CC method represents the average of the doses from the three 
different conversion coefficients. 
The additional risk of cancer to a female and male Army Soldier of age 30 who received a 
chest abdomen pelvis scan is calculated using the BEIR VII methodology (Table 64). BEIR 
VII calculates the lifetime attributable risk (LAR) for cancer incidence and mortality 
according to the formulaic using tables in BEIR VII on page 311 [29].   
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Table 63.  Estimation of cancer incidence and mortality from one chest abdomen pelvis 
CT scan. 
Risk of one helical CAP scan to a reference sized Female (Daisy) and Male 





Lifetime Risk of 
being diagnosed 
with cancer in that 
organ 
Lifetime Risk of 
dying of cancer in 
that organ 







6 in 10,000 6 in 10,000 3 in 10,000 3 in 10,000 
Brain 0.29 +/- 0.02 0.7 +/- 0.3 6 in 
1,000,000 




Colon 22.3 +/- 0.7 28 +/- 5 2 in 10,000 4 in 10,000 8 in 
100,000 
4 in 10,000 
Esophagus 25 +/- 1 22.1 +/- 
0.4 
5 in 10,000 4 in 10,000 3 in 10,000 2 in 10,000 
Eye 0.50 +/- 0.02  0.74 +/- 
0.08 
NA NA NA NA 




5 in 10,000 5 in 10,000 3 in 10,000 2 in 10,000 
Liver 26.0 +/- 0.2 26.3 +/- 
0.9 






Lung 27 +/- 1 
(each) 
24 +/- 1 
(each) 
7 in 10,000 3 in 10,000 6 in 10,000 3 in 10,000 
Pancreas 25.9 +/- 0.4 28.5 +/- 
0.2 
5 in 10,000 6 in 10,000 3 in 10,000 3 in 10,000 
Thymus 23.5 +/- 0.3 27.0 +/- 0.5 5 in 10,000 5 in 10,000 2 in 10,000 3 in 10,000 
Thyroid 12.3 +/- 0.4 30.2 +/- 0.8 5 in 100,000 3 in 10,000 1 in 10,000 3 in 
100,000 





Likewise, the lifetime attributable risks can be estimated for all the trauma scans assessed 
(Tables 65 and 66).  For those organs not specifically listed in BEIR VII Table 12D-1 and 
Table 12D-2 [29], the cancer incidence and cancer mortality risk is calculated using values 
for Other.  The Daisy and Dude measured absorbed dose values (Specific Aim 3) are used 
for dose inputs. 
 
Table 64.  Estimation of cancer incidence and mortality for each trauma scan for a female 
age 30 patient. 
Specific Organ Doses and Lifetime Attributable Risks to a 30-year old reference 
Female 






those organs not 
explicitly listed, 
the category 
OTHER was used) 
Mortality (for 
those organs not 
explicitly listed, 
the category 
OTHER was used) 
Brain Scan 
  Eye 34 +/-3  (each) NA NA 
  Brain 30 +/- 5 6 in 10,000 3 in 10,000 
  Thyroid 2.82 +/-.05 1 in 100,000 3 in 100,000 
  Lung 0.13 +/- .03 (each) 3 in 1,000,000 3 in 1,000,000 
  Thymus 1.31 +/- .05 3 in 100,000 1 in 100,000 
  Esophagus 0.286 +/- .007 6 in 1,000,000 3 in 1,000,000 
  Liver 0.054 +/- .002 5 in 100,000,000 5 in 100,000,000 
Cervical Cancer 
  Eye 34 +/- 2  (each) NA NA 
  Brain 9 +/- 6  2 in 10,000 9 in 100,000 
  Thyroid 44.5 +/-.05 2 in 10,000 5 in 10,000 
  Lung 0.5 +/- .1 (each) 1 in 100,000 1 in 100,000 
  Thymus 8.0 +/- .2 2 in 10,000 8 in 100,000 
  Esophagus 1.83 +/- .02 4 in 100,000 2 in 100,000 
  Liver 0.221 +/- .005 2 in 10,000,000 2 in 10,000,000 
Chest Abdomen Pelvis Scan 
  Adrenals/Gall    
  Bladder 
26.90 +/- 0.03 6 in 10,000 3 in 10,000 
  Brain 0.29 +/- 0.02 6 in 1,000,000 3 in 1,000,000 
  Colon 22.3 +/- 0.7 2 in 10,000 8 in 100,000 
  Esophagus 25 +/- 1 5 in 10,000 3 in 10,000 
  Eye 0.50 +/- 0.02 (each) NA NA 
  Kidney 24.2 +/- 0.5 (each) 5 in 10,000 3 in 10,000 
  Liver 26.0 +/- 0.2 5 in 10,000 2 in 100,000 
  Lung 27 +/- 1 (each) 7 in 10,000 6 in 10,000 
  Pancreas 25.9 +/- 0.4 5 in 10,000 3 in 10,000 
  Thymus 23.5 +/- 0.3 5 in 10,000 2 in 10,000 
  Thyroid 12.3 +/- 0.4 5 in 100,000 1 in 10,000 
  Uterus 25.6 +/- 0.1 5 in 100,000 1 in 100,000 
Chest Scan 
  Adrenals/Gall  
  Bladder 
4.92 +/- 0.02 1 in 10,000 5 in 100,000 
  Brain 0.26 +/- 0.01 5 in 1,000,000 3 in 1,000,000 
  Colon 0.134 +/- 0.006 1 in 1,000,000 5 in 10,000,000 
  Esophagus 12.5 +/- 0.2 3 in 10,000 1 in 10,000 
  Eye 0.29 +/- 0.02 NA NA 
  Kidney 2.16 +/- 0.03 (each) 4 in 100,000 2 in 100,000 
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  Liver 11.1 +/- 0.1 1 in 100,000 1 in 100,000 
  Lung 10 +/- 4 (each) 2 in 10,000 2 in 10,000 
  Pancreas 2.43 +/- 0.03 5 in 100,000 3 in 100,000 
  Thymus 13.1 +/- 0.4 3 in 10,000 1 in 10,000 
  Thyroid 8.3 +/- 0.7 3 in 100,000 9 in 100,000 
  Uterus 0.112 +/- 0.003 2 in 10,000,000 4 in 100,000,000 
Thoracic Spine Scan 
  Adrenals / Gall    
  Bladder 
8.9 +/- 0.2  2 in 10,000 9 in 100,000 
  Brain 0.17 +/- 0.07 4 in 1,000,000 2 in 1,000,000 
  Colon 0.36 +/- 0.009 3 in 1,000,000 1 in 1,000,000 
  Esophagus 8.8 +/- 0.2 2 in 10,000 9 in 100,000 
  Eye 0.19 +/- 0.02 NA NA 
  Kidney (each) 7.6 +/- 0.2 2 in 10,000 8 in 100,000 
  Liver 9.3 +/- 0.2 9 in 1,000,000 8 in 1,000,000 
  Lung (each) 9.5 +/- 0.8 2 in 10,000 2 in 10,000 
  Pancreas 7.5 +/- 0.2 2 in 10,000 8 in 100,000 
  Thymus 7.7 +/- 0.2 2 in 10,000 8 in 100,000 
  Thyroid 2.87 +/- 0.07 1 in 100,000 3 in 100,000 
  Uterus 0.44 +/- 0.01 8 in 10,000,000 2 in 10,000,000 
Lumbar Spine Scan 
  Adrenals/Gall  
  Bladder 
18.0 +/- 0.4 4 in 10,000 2 in 10,000 
  Brain 0.0378 +/- 0.0009 8 in 10,000,000 4 in 10,000,000 
  Colon 11.6 +/- 0.3 1 in 10,000 4 in 100,000 
  Esophagus 1.36 +/- 0.03 3 in 100,000 1 in 100,000 
  Eye (each) 0.069 +/- 0.001 NA NA 
  Kidney 16.4 +/- 0.4 (each) 3 in 10,000 2 in 10,000 
  Liver 16.0 +/- 0.4 2 in 100,000 1 in 100,000 
  Lung 9.7 +/- 0.5 (each) 2 in 10,000 2 in 10,000 
  Pancreas 17.3 +/- 0.4 4 in 10,000 2 in 10,000 
  Thymus 0.39 +/- 0.01 8 in 1,000,000 4 in 1,000,000 
  Thyroid 0.190 +/- 0.005 8 in 10,000,000 2 in 1,000,000 
  Uterus 14.8 +/- 0.4 3 in 100,000 6 in 1,000,000 
 
Table 65.  Estimation of cancer incidence and mortality for each trauma scan for a male 
age 30 patient. 
Specific Organ Doses and Lifetime Attributable Risks to a 30-year old reference 
Male 








(mGy) those organs not 
explicitly listed, 
the category 
OTHER was used) 
those organs not 
explicitly listed, 
the category 
OTHER was used) 
Brain Scan 
  Eye 22.9 +/- 0.7 NA NA 
  Brain 21 +/- 1 4 in 10,000 2 in 10,000 
  Thyroid 0.8 +/- 0.2 7 in 10,000,000 8 in 1,000,000 
  Lung 0.2 +/- 0.1 2 in 1,000,000 2 in 1,000,000 
  Thymus 0.26 +/- 0.01 5 in 1,000,000 2 in 1,000,000 
  Esophagus 0.680 +/- 0.007 1 in 100,000 6 in 1,000,000 
  Liver 0.04 +/- 0.02 9 in 100,000,000 6 in 100,000,000 
Cervical Cancer 
  Eye 18.6 +/- 0.7 NA NA 
  Brain 7 +/- 4 1 in 10,000 7 in 100,000 
  Thyroid 21 +/- 1 2 in 100,000 2 in 10,000 
  Lung 4 +/- 3 4 in 100,000 4 in 100,000 
  Thymus 14.2 +/- 0.2 3 in 10,000 1 in 10,000 
  Esophagus 13.5 +/- 0.2 3 in 10,000 1 in 10,000 
  Liver 0.6 +/- 0.4 1 in 1,000,000 1 in 1,000,000 
Chest Abdomen Pelvis Scan 
  Adrenals/Gall  
  Bladder 
27.9 +/- 0.4 6 in 10,000 3 in 10,000 
  Brain 0.7 +/- 0.3 1 in 100,000 7 in 1,000,000 
  Colon 28 +/- 5 4 in 10,000 4 in 10,000 
  Esophagus 22.1 +/- 0.4 4 in 10,000 2 in 10,000 
  Eye 0.74 +/- 0.08 NA NA 
  Kidney 24.2 +/- 0.8 (each) 5 in 10,000 2 in 10,000 
  Liver 26.3 +/- 0.9 5 in 1,000,000 5 in 1,000,000 
  Lung 24 +/- 1 (each) 3 in 10,000 3 in 10,000 
  Pancreas 28.5 +/- 0.2 6 in 10,000 3 in 10,000 
  Thymus 27.0 +/- 0.5 5 in 10,000 3 in 10,000 
  Thyroid 30.2 +/- 0.8 3 in 10,000 3 in 100,000 
  Testes 8 +/- 4 2 in 10,000 8 in 100,000 
Chest Scan 
  Adrenals/Gall  
  Bladder 
3.90 +/- 0.04 8 in 100,000 4 in 100,000 
  Brain 0.5 +/- 0.2 1 in 1,000,000 5 in 1,000,000 
  Colon 0.20 +/- 0.01 3 in 1,000,000 3 in 1,000,000 
  Esophagus 20.5 +/- 0.3 4 in 10,000 2 in 10,000 
  Eye 0.61 +/- 0.09 NA NA 
  Kidney 2.8 +/- 0.7 (each) 6 in 100,000 3 in 100,000 
  Liver 14 +/- 9 3 in 1,000,000 3 in 1,000,000 
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  Lung 22.6 +/- 0.7 (each) 2 in 10,000 2 in 10,000 
  Pancreas 5.62 +/- 0.08 1 in 10,000 5 in 100,000 
  Thymus 27.2 +/- 0.4 5 in 10,000 3 in 10,000 
  Thyroid 25 +/- 2 2 in 100,000 2 in 100,000 
  Testes 0.045 +/- 0.006 1 in 1,000,000 4 in 10,000,000 
Thoracic Spine Scan 
  Adrenals / Gall  
  Bladder 
7.3 +/- 0.1 1 in 10,000 7 in 100,000 
  Brain 0.6 +/- 0.3 1 in 100,000 5 in 1,000,000 
  Colon 0.38 +/- 0.02 5 in 1,000,000 5 in 1,000,000 
  Esophagus 20.0 +/- 0.3 4 in 10,000 2 in 10,000 
  Eye 0.7 +/- 0.1 NA NA 
  Kidney (each) 5 +/- 1 1 in 10,000 5 in 100,000 
  Liver 20 +/- 4 4 in 1,000,000 4 in 1,000,000 
  Lung (each) 22.9 +/- 0.8 (each) 2 in 10,000 2 in 10,000 
  Pancreas 14.0 +/- 0.2 3 in 10,000 1 in 10,000 
  Thymus 27.4 +/- 0.5 5 in 10,000 3 in 10,000 
  Thyroid 25 +/- 3 2 in 100,000 2 in 100,000 
  Testes 0.064 +/- 0.004 1 in 1,000,000 6 in 10,000,000 
Lumbar Spine Scan 
  Adrenals/Gall  
  Bladder 
22.3 +/- 0.9 4 in 10,000 2 in 10,000 
  Brain 0.033 +/- 0.009 6 in 10,000,000 3 in 10,000,000 
  Colon 22 +/- 3 3 in 10,000 3 in 10,000 
  Esophagus 0.227 +/- 0.006 4 in 1,000,000 2 in 1,000,000 
  Eye (each) 0.07 +/- 0.01 NA NA 
  Kidney 18.7 +/- 0.8 (each) 4 in 10,000 2 in 10,000 
  Liver 13 +/- 1 3 in 1,000,000 3 in 1,000,000 
  Lung 2 +/- 1 2 in 100,000 2 in 100,000 
  Pancreas 21.1 +/- 0.3 4 in 10,000 2 in 10,000 
  Thymus 0.290 +/- 0.006 6 in 1,000,000 3 in 1,000,000 
  Thyroid 0.177 +/- 0.009 2 in 10,000,000 2 in 10,000,000 
  Testes 2.07 +/- 0.01 4 in 100,000 2 in 100,000 
 
Discussion 
Although the two different methods for estimating the effective dose per scan is not 
consistent, the Ht/Wt model agrees with current literature which states that the DLP-CC is 
known to underestimate the effective dose per scan [66, 286, 291-292].  Utilizing Bland-
Altman [285, 290] plots to compare two measures allows us to determine whether or not 
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the two measures can be used interchangeably.  When the values for the difference between 
the two methods lie within 2 standard deviations of the mean, either method can be used.  
Therefore, since the Bland-Altman plots for all six trauma protocols showed values for the 
difference between the two methods being within +/- 1.96 SD then either method can be 
used.   
 
The American Association of Physicists in Medicine (AAPM) advocates the use of 
estimating the value of the effective dose by means of the DLP and conversion coefficients 
[286].  In fact, the AAPM purports that the values estimated by DLP and the calculations 
by more rigorous methods are consistent with maximum deviation from the mean of 15% 
[286].  However, this method of effective dose estimation requires knowledge of the 
machine technique (DLP) and ensuring that the scanning ranges of the patient and the 
mathematical phantom are similar.  Real patient scans, especially for the chest scan, are 
often different than the scans on stylized mathematical phantoms due to either the anatomy 
of the individual patient or the CT technician’s ability to localize the scan range based off 
of the scout images.  This was observed by the strong positive bias in the Bland-Altman 
plot of the chest scan.  The positive bias indicates that the model will systematically result 
in higher effective dose values for the chest scan.  When we compare the scanning range 
for calculating the effective dose using the DLP method against our predictive model 
(Figure 40), we see that the positive bias is primarily due to the difference in how we 




a.   b.  
Figure 40.  Comparison of scanning areas for the chest scan.  (40a) Mathematical 
phantom and scanning range used to calculate the effective dose conversion coefficient 
[66].  (40b) Representative patient scan and mathematical phantom scanning areas used 
in model development.  
Literature shows that experimental measurements of effective dose will often be higher 
than DLP-conversion coefficient methods for calculating effective dose because DLP-
conversion coefficient methods can underestimate the effective dose by up to 37% [274, 
291-292].   
 
Li et al [293] estimates that the use of DLP and conversion coefficients can underestimate 
the effective dose by 30% to 48% when compared against a hybrid computational full body 
computer model of an infant and 12-year old pediatric patient.  Li also points out that the 
effective dose to both patients from an abdomen pelvis scan is nearly double that from a 
chest scan as a result of higher technique values (kVp and/or mA) and a larger irradiated 
body volume.   
 
Part of the reason for this difference in estimation is that conversion factors are dependent 
upon the size of the phantom used and the scanning length [66].  DLPs also can 
underestimate the total energy imparted over the scanning length [286].  When scanning 
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lengths are increased or decreased organs are either brought into the scanning field-of-view 
or removed from the scanning field-of-view.  For scanning regions which include fewer 
major organs (brain scan and cervical spine scan), differences between various methods of 
calculating effective doses results from dimensional differences between phantoms and 
patients.  These differences can range from 17-25% for brain CT scans to 15-19% for neck 
and face examinations [294]. 
 
Variations between physical phantoms and computer will yield the smallest difference in 
organ dose when either organs that are small in volume and can be easily represented by an 
averaged point dose estimate, or for those large organs which receive a fairly uniform 
absorbed dose throughout its volume, or when the organ is large but receives a properly 
volume averaged absorbed dose gradient [250].  
 
Since the DLP-conversion coefficient method of calculating the effective dose will 
typically underestimate the effective dose when compared to an organ dose-based effective 
dose method, the Ht/Wt model is a more accurate means of assessing the estimate of the 
effective dose per trauma procedure based upon a patient’s height and weight at the time of 
the scan.  Additionally, the predictive model was developed for a wide range of heights and 
weights.  On the contrary, the DLP-conversion coefficient method depends upon machine 
parameters and a singular mathematical standard-sized phantom. 
   
Ultimately, effective dose describes the relationship between the probability of stochastic 
effects and equivalent dose.  Effective dose represents the total health detriment from 
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uniform radiation to the whole body by summing all the tissues and organs in the body 
[32].  As a result of the increased use of diagnostic scans and the use of multiple scans on 
an individual patient, the general radiology and research community has become more 
aware and concerned with long term consequences of the increased doses to patients [14].  
While radiation-induced cancers are not thought to be risk from general diagnostic 
radiology, researchers are becoming more concerned and aware of accumulated dose from 
multiple diagnostic scans.  BEIR VII [29] can be used to calculate estimates of the 
probability of cancer incidence and mortality [19, 21, 295-297].  BEIR VII reports that the 
probability of cancer incidence decreases with age (Figure 41).   
 
Figure 41.  Lifetime cancer mortality risks as a function of age at exposure based on 




Part of the reason for this decreasing susceptibility is the relatively long latency period 
between the health detriment and the manifestation of the disease.  As a result, pediatrics 
will have the greatest probability of cancer (4 to 5 times) incidence than an adult.  The U.S. 
Army population falls within the age framework older than a pediatric but young for an 
adult.   
 
The American Cancer Society estimates that the risk of developing a cancer (all cancers) is 
37.76 per 100 or approximately 1 in 3.  Additionally, the risk of dying from a cancer is 
19.58 per 100 or approximately 1 in 5 [298].  BEIR VII estimates that for a single dose of 
radiation, 0.1 Gy, a male of age 30 will have a 6 in 100 chance of cancer incidence (all 
cancers) with a 3 in 100 chance of dying from cancer (all cancers).  The probability of 
incidence and mortality actually increases for a female receiving the same dose.  This was 
shown in Tables 65 and 66 for a female and male Soldier respectively. The probability of 
incidence for all cancers increases to 10 in 100 and the probability of dying from a cancer 
(all cancers) increases to 5 in 100.   
 
We can see that for each scan (Tables 65 and 66), the estimation of cancer incidence and 
mortality is relatively low and the benefit of the scan as opposed to the risk is very high.  
The next chapter will illustrate how a Soldier involved in a traumatic experience can 
undergo multiple scans and that the accumulation of dose is not trivial.   
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CHAPTER 7.  Specific Aim 5:  Recommend action points for the U.S. Army based 
upon this research.  
 
There is concern about the potential health effect of repeated CT scan exposures and 
studies have shown that the lifetime cancer mortality risks from CT scans are not negligible 
[19, 21, 297].  The scientific community remains divided on the long-term health effects of 
CT radiation dose, primarily because few studies of populations exposed to CT are 
available.  There is no debate though about how the diagnostic information from justified 
CT scans contributes to saving the lives of thousands of people on a daily basis. 
 
Ultimately, reducing radiation dose to the patient is the goal while still obtaining 
appropriate diagnostic images.  Previous dose reduction techniques have focused on 
adjusting for patient size and machine scanning characteristics while innovations in x-ray 
beam collimation, filters, image processing algorithms, automatic tube current modulation, 
and more efficient detector configuration have led to systemic dose reduction [299-302].  
However, a common dose reduction technique, limitation of scanning length, is not a 
luxury that physicians have when triaging patients of whole body trauma.   
 
Being able to establish any association between low-dose radiation and long term health 
effects hinges not only on the statistical model used but also on how the study is designed 
and employed.  This is particularly important in the recommendation for a future study.  
U.S. Army Soldiers change duty stations frequently over the course of their career in the 
Armed Forces.  As such, the Army Medical Department interlinks all the hospitals through 
a system called the Armed Forces Health Longitudinal Technology Application (AHLTA).  
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Currently, almost all Soldier medical records are maintained digitally in AHLTA.  Military 
medical professionals have access to AHLTA in order to assess Soldier clinical 
information.  There are also efforts being made towards ensuring a seamless transition of 
Soldier medical information from when a Soldier is on active duty to when a Soldier is 
seen by the Veterans Administration hospitals. 
 
The majority of epidemiologic radiation effect studies are ecologic (based upon population 
comparisons) and as such causal inferences cannot be made since confounding factors or 
selection bias cannot be controlled.  The following discussion will show how effective 
doses can be used in future studies.  Previous radiation cohort studies involved 
occupationally exposed workers who potentially receive more radiation (up to 0.05 mSv 
per year) than the normal population yet still have relatively low exposure to radiation.  
Trauma patients can easily experience more than this amount of radiation [303-305].   
 
Need for Study (Example) 
The following is a hypothetical (but not atypical) scenario. 
 
While deployed to a remote outpost in Afghanistan in support of Operation Enduring 
Freedom, a 25-year old male Soldier was in a tactical vehicle convoying from one location 
to another.  Half-way through the convoy trip, the lead vehicle stopped in order to 
investigate an unusual section of the dirt road.   Unfortunately the rest of the convoy 
stopped in what is referred to as a kill zone.  Improvised explosive devices (IEDs) had been 
dug into the road where the convoy now stopped.  The IEDs were remotely detonated by 
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wireless communication signals (often in the form of cell phones) and the vehicle 
containing the Soldier was hit in the underbelly.  Shrapnel and explosives were sent flying 
into and through the vehicle killing one occupant and severely injuring the Soldier and the 
driver of the vehicle.  During the blast, the Soldier was thrown violently against the 
restraining harness (seat belt) and severely hit his head against both the side bullet proof 
window and the windshield.  Other Soldiers in the convoy immediately laid down 
suppressive fire against the enemy and the combat medics initiated first aid to the wounded.  
After securing the zone by running off the enemy combatants, helicopter evacuation was 
called for and when arrival seemed imminent the evacuation of the wounded Soldier 
commenced to the forward support hospital located 40 miles away.  The Soldier, while 
unconscious, was evacuated via the helicopter and received immediate emergency medical 
attention at the forward support hospital.  While the Soldier’s vital signs were stabilized, 
the Army physicians noticed lower leg fractures and suspected severe internal bleeding.  
CTs were ordered in order to better assess the extent of the injuries.  The Soldier received 
two chest-abdomen-pelvis scans (ordered to assess the internal bleeding), one cervical 
spine scan (ordered to assess any cervical spine damage), and since the on-site combat 
medics noticed cracks in the windshield and the side window, a brain scan was ordered to 
assess any potential brain injury.  A total of four CT scans were ordered in the first 6-hours 
following the IED explosion.  12-hours after the explosion, the Soldier was evacuated back 
to Balad Air Field in Iraq where the next higher level of medical assistance could be 
obtained.  Either the diagnostic images were too damaged in transit or they never reached 
the attending physicians at Balad.  As a result, the physicians immediately ordered a chest-
abdomen-pelvis scan, another cervical spine scan, and a brain scan.  The scans were also 
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ordered to assist in the initial diagnosis while the swelling from the internal damage 
obfuscated the injury extent.  The Soldier was then evacuated back to Landstuhl Regional 
Medical Center in Kaiserslautern, Germany for further evacuation coordination could be 
initiated to fly the Soldier back to Walter Reed Medical Center in Silver Springs, 
Maryland.  While at Landstuhl Regional Medical Center the Soldier received another chest-
abdomen-pelvis scan in order to ensure that the internal bleeding was stabilized enough for 
evacuation to Walter Reed.  The Soldier remained at Walter Reed Medical Center for more 
than 4 weeks and underwent three surgical operations designed to assist in the healing of 
wounds received in the lumbar spine (from shrapnel coming through the floor board in the 
vehicle) and the chest area (from flying debris caused by explosions coming up through the 
radio area).  Diagnostic imaging was performed in order to assist the surgeons in their 
preparations and during follow-up (2 chest scans (with and without contrast), 2 lumbar 
spine scans (with and without contrast), and 2 brain scans (with and without contrast)).  
During the rehabilitation which occurred over the course of the next year three more brain 
scans were performed to help with assessing the traumatic brain injury and two more spinal 
scans were performed (one lumbar spine scan and one thoracic spine scan).  A total of 19 
scans were performed for this one traumatic event (seven brain scans, two cervical spine 
scans, four chest-abdomen-pelvis scans, two chest scans, one thoracic spine scan, and three 
lumbar spine scans).  While the Soldier was still in the operational theater (Afghanistan and 
Iraq), CT machine techniques from the CT scanning machines were not collected.  
Scanning information from the CT machines is only known from the Landstuhl Regional 
Medical Center and Walter Reed Regional Medical Center.  Table 67 is a list of 




Table 66. Dose estimation for the above 19 scans. 
Location Scanning Types Assigned Effective Dose 
(mSv) 
Forward Support Hospital in 
Afghanistan 
2-CAP 34 (2 x 10 (average for Ab-
Pel), and 2 x 7 (average for 
chest)) 
1-CS 6 (average for c-spine) 
1-Brain 2 (average for head) 
Combat Support Hospital in 
Balad, Iraq 
1-CAP 17 (based on above) 
1-CS 6 (same as above) 
1-Brain 2 (same as above) 
Landstuhl Regional Medical 
Center 
1-CAP 18 (based upon average of 
CAP patients in validation 
study using DLP method) 
Walter Reed Regional 
Medical Center 
2-Chest  15.6 (2 x 7.8 (average of 
chest patients in validation 
study using DLP method) 
3-Lumbar 39 (3 x 13 (average of 
lumbar patients in validation 
study using DLP method)) 
5-Brain 8 (5 x 1.6 (average of Brain 
patients in validation study 
using DLP method) 
1-Thoracic 15.3 (average of thoracic 
patients in validation study 
using DLP method) 
19 Total Scans Total Effective Dose = 123 
mSv 
 
Assuming that the CT ranges used are similar to ranges used in the model development, 
and assuming that no other information is known except for the Soldier’s height and weight 
measured at the beginning of the deployment (6’2” (188 cm) and 200 lbs (91 kg)) and 
noting that the Soldier gained 10 pounds while at Walter Reed (6’2” (188 cm) and 210 lbs 
(96 kg)), the total effective dose is shown (Table 68). 
 
Table 67.  Ht/Wt predictive model dose estimation for the above 19 scans. 




Forward Support Hospital in 
Afghanistan 
2-CAP 54 (2 x 27.12) 
1-CS 2.36 
1-Brain 1.6 





Landstuhl Regional Medical 
Center 
1-CAP 27.12 
Walter Reed Regional 
Medical Center (assume new 
ht/wt) 
2-Chest 21.26 (2 x 10.63) 
3-Lumbar 32.71 (3 x 10.90) 
5-Brain 7.84 (5 x 1.57) 
1-Thoracic 13.14 
19 Total Scans Total Effective Dose ≈ 200 
mSv 
 
The Ht/Wt model estimates an accumulated effective dose 47% higher than by estimating 
the effective dose using DLP-conversion coefficients and standard NCRP effective dose 
values.  Assuming that the total effective dose from the 19 total scans over the course of 
one year can be modeled as a single acute dose, the BEIR VII excess relative risk (ERR) 
for solid cancer incidence can be modeled, where ERR is defined as the rate of the disease 
in an exposed population divided by the rate of disease in an unexposed population minus 
1.0 [29].   
 
Figure 42 presents how the age-time patterns in the radiation-associated risks for all solid 
cancer mortality is different for a male Soldier who received an exposure of 123 mSv at 
age 25 opposed to that same Soldier receiving an exposure of 200 mSv at age 25.  The 
initial ERR reflects the exposure of 200 mSv which is 62% higher than an exposure of 





Figure 42.  Hypothetical Soldier effective dose chart showing how the ERR decreases 
over time but is greater for a higher initial effective dose.  Age-time patterns represent the 
radiation-associated risks for all solid cancer mortality. 
The effective dose study was conducted for one hypothetical situation.  However, many 
Soldiers have been on multiple deployments and could have sustained wounds which 
resulted in evacuation multiple times.  This type of situation while not frequent is not rare 
especially with Special Operations personnel.  Spinal injuries are on the rise [306] as are 
traumatic brain injuries [116, 307-310].  Therefore, developing and utilizing the predictive 
model for specific trauma scans will better estimate a patient’s total effective dose than 
utilizing standard methods. 
 
Recommendations 
BEIR VII states that future medical radiation studies are needed to assist in understanding 
the effects of low-dose radiation.  Organizing a population study within an Army 
population will help to achieve some of the aims stated in BEIR VII Research Need 8 [29].  






























period of cancer development can be up to 20 years.  However, with a Soldier population, 
this study period is possible because subjects can be tracked through both the Army 
medical system and the Veterans Affairs hospital system.   
  
Population studies are fairly common with research using Veterans Affairs (VA) hospitals 
and military subjects.  In other populations, management difficulties can arise because 
people die, move away, or develop other medical conditions.  A Soldier population may be 
followed with minimal disruptions as long as Soldiers are observed in an Army or VA 
medical facility.  Difficulty will arise of a Soldier is sent to a civilian hospital for treatment 
and diagnostic scans are not properly inputted into the Soldier’s medical records.  Special 
procedures should be put into place to account for this common occurrence.   
 
Medical records should be adjusted to account for the total number of diagnostic scans that 
are performed not just inputs for the best diagnostic scan performed.  For example, if two 
CT scans are performed in order to get one diagnostic quality image, then there needs to be 
input variables for the first scan (which didn’t yield a diagnostic quality image) in order to 
track the dose.  Although the PACS system archives the patient images, there are still 
patient image records which do not include a dose report which reflects the scanning range, 
CTDIvol, and DLP.  Therefore, the Ht/Wt models should be used to estimate the effective 







Soldiers are receiving higher effective dose per scan than is currently being reported in 
literature.  This has been shown in the preceding dissertation chapters.  Even though it 
looks as though increased weight provides somewhat of a shielding effect, CT machines 
can automatically adjust for changes in tissue density and thickness of tissue in order to 
achieve a certain diagnostic picture quality.  Therefore, heavier patients (thus greater cross-
sectional area per slice thickness) will actually get higher doses.  The Ht/Wt models do not 
account for higher entrance skin doses since only one entrance skin dose value was used for 
modeling the radiation dose of all 100 mathematical phantoms modeled.  What we see 
from the above hypothetical example is that the predictive model predicts a total effective 
dose 47% higher than using standard methods.  Potentially, the total effective dose may be 
another 10%-20% higher than the predictive model estimation.  Therefore, for patients 
receiving multiple diagnostic CT scans, absorbed doses are indeed an area of concern and 
researchers should emphasize investigations of low-dose radiation effects on the human 
body. 
 
Research Needs  
The research predictive models could be improved upon with further research.  Further 
research is needed to collect experimental absorbed dose information on a wide variety of 
CT machines and CT manufacturers.  While the predictive model is an accurate estimate of 
the absorbed dose, further experiments will shrink errors that lead to a lack of precision.  
Experiments can be performed at large medical facilities which have different types of 
machines/manufacturers.  Once absorbed dose data has been collected for both the male 
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and female reference phantom, the predictive model should be adjusted as necessary and 
then validated against a patient population with the largest number of patients possible.  
Effective dose estimation of pediatric patients is also important since Army combat support 
hospitals will often treat pediatric patients from the host nation [311].  Theocharopoulus et 
al [197] determined that even though pediatric patients absorb less energy per scan, the 
effective dose is up to 24% higher than adult patients.   
193 
 
CHAPTER 8:  Conclusion 
 
The goal of this study was to develop predictive models for estimating the effective dose 
from common CT scans that are used to diagnose and assist in the rehabilitative efforts of 
Soldiers who have experienced traumatic injuries while serving Operation Iraqi Freedom 
and Operation Enduring Freedom, as well as future such activities. The hypothesis 
examined is the extent to which a patient’s height and weight is associated with the 
effective dose from CT scans. My models are more accurate than current methods for 
estimating effective dose based upon CT machine parameters and conversion coefficients.  
Additionally, my models can be used as a means of estimating the effective dose when 
machine parameters are not known.  My models support recent literature which states that 
current effective dose estimating methods appear to underestimate the accumulated 
effective doses from multiple CT diagnostic scans. 
 
Conference presentations to appropriate professional societies are planned in order to share 
this research and associated results with the greater health physics community. The 
research results will also be presented to authorities in the U.S. Army medical system. 
These presentations will be conducted with the senior Army health physicists and other 
senior officers within the Army’s Environmental, Safety, and Occupational Health 
community.   
 
My research was unique in four different areas: specific focus on a U.S. Army Soldier 
population involved in defense of our Country through involvement in Operation Iraqi 
Freedom and Operation Enduring Freedom, predictive models designed to estimate the 
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effective dose from six specific trauma protocols based off of patient heights and weights, 
verification of models using specifically designed anthropomorphic phantoms for use with 
OSL dosimeters, and validation of results against a pilot study of trauma patient 
representative CT scans. 
 
Specific areas for continuation of this research include verification of the predictive models 
with a wider variety of CT machine types and manufacturers.  Additionally, more research 
should be conducted into the establishment of long-term cohorts as requested in BEIR VII 
for low-dose medical radiation health effects.   
 
I am extremely thankful and appreciative of the dedicated Army physicians, surgeons, and 
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